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Abstract
Enzymes belonging to the CTX-M family are now the most prevalent extended 
spectrum p-lactamases, conferring resistance to multiple p-lactams. In 2009 an 
outbreak of CTX-M harbouring Enterobacteriaceae occurred at UK pig farm in which 
the pigs had received multiple rounds of antibiotic treatment. The aim of this study 
was to characterise the outbreak CTX-M strains and to identify the fitness 
contribution of the outbreak CTX-M plasmids beyond antimicrobial resistance.
CTX-M producing Escherichia coli, Klebsiella pneumoniae and Salmonella enterica 
of serovars 4,5,12,i:- and Bovismorbificans were isolated indicating an instance of 
non-clonal spread o f resistant organisms. Plasmid characterisation revealed that a 
CTX-M-14 plasmid of 50kb and unknown incompatibility group was harboured by 
two E. coli strains. A second plasmid type was a CTX-M-1, sul2 and floR  Incll 
plasmid of 104kb found in all three species o f bacteria. Sequencing o f the CTX-M-1 
plasmid revealed that it was a novel plasmid that had arisen by the acquisition of two 
resistance islands by a CoUb-p9-like plasmid.
A curing method specific for Incll plasmids was developed and successfully used to 
cure lab strains harbouring the outbreak plasmids, outbreak K. pneumoniae strain 
B3791 and wild type E. coli strains harbouring unrelated Incll plasmids. 
Additionally, a plasmid free Salmonella 4,5,I2,i:- strain was obtained from the 
outbreak farm and used, together with B3791, to investigate the phenotypic 
contribution of the outbreak plasmids. Competitive fitness studies showed that 
carriage of the outbreak plasmid imposed a burden on K. pneumoniae strain B3791 
whilst being neutral to the growth of Salmonella 4,5,12,i;- S348/1I. No effect was 
seen in the virulence or biofilm formation in either strain.
In conclusion, the outbreak of CTX-M within this farm was caused by the incursion 
and spread of a successful, novel CTX-M-1-Incll plasmid, plFM3804. Relating to the 
prevalence of this plasmid, carriage of multiple resistance genes together with the use 
of multiple antibiotics could partly explain its widespread presence within this farm.
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Chapter 1:
Introduction
Chapter 1 : Introduction
Human and animal health has benefitted during the past century from the use of 
antibiotics, compounds that inhibit bacteria by causing cessation of growth 
(bacteriostatic) and in some cases by killing them (bactericidal). Their use in 
controlling diseases has had a profound impact on quality of life and life expectancy, 
especially in the developed world. The problem of emerging resistant pathogens, 
including multi-resistant strains is well publicised in the media. This problem is 
further aggravated by the lack o f new broad spectrum antibiotics able to replace those 
important empirical treatments against which resistance is on the increase. In the 
introduction to this thesis it is intended to give a sufficiently broad overview o f the 
organisms that carry resistance and the mechanisms of resistance. This is a truly vast 
field, and it is not possible in some 30 pages to cover all aspects o f the bacteria, their 
pathogenic properties, the resistances carried and so on in great depth and therefore I 
have approached this introduction with a view to giving a broad overview. It is hoped 
that this introduction will give sufficient depth in the fields o f antibiosis and the 
pathogenic properties of the organisms relating to this thesis. I then aimed to give a 
more in depth analysis of the specific topic of the recently emerged extended 
spectrum p-lactamases, one class of which is the topic o f this thesis before moving 
onto the current literature regarding plasmid phenotypic studies.
1.1 Antibiotics
Clinically, antibiotics are compounds able to interfere with an essential structure or 
process of bacteria without causing significant harm to their eukaryotic host, although 
for many antibiotics there is some toxicity for the eukaryotic host. There are a number 
of key processes that antibiotics target (Table 1.1), which are either completely absent 
in eukaryotes (e.g. peptidoglycan synthesis) or, if present, they differ sufficiently so 
as not to be affected by the antibiotic (Yoneyama and Katsumata, 2006).
The p-lactam antibiotics, which include the penicillins, cephalosporins and 
carbapenems, are a major group heavily relied upon by physicians for the treatment of
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infectious diseases (Denton, 2007). The p-lactams inhibit the cross-linking of the 
peptide strands of the peptidoglycan layer, which confers the bacterial cell wall 
rigidity. The way p-lactams stop the cross-linking is by acylating the transpeptidase 
enzyme active site which renders it inactive (Yoneyama and Katsumata, 2006). Some 
of the effects o f this inhibition resulting from the loss of integrity o f the cell wall are 
changes in cell morphology, interference with cell division, maintenance of the cell 
structures and increased osmotic sensitivity (Kong et a l, 2010).
Another major class o f antibiotics which interfere with cell wall synthesis are the 
glycopeptides, the main example of which is vancomycin. Glycopeptides bind non- 
covalently to the peptide strands of the peptidoglycan, thus effectively removing the 
substrate of the cross-linking enzymes (Yoneyama and Katsumata, 2006).
An additional process targeted by antibiotics is protein synthesis, which is viable as a 
target for antibiotic therapy due to the substantial differences between the eukaryotic 
and prokaryotic translation machinery (Yoneyama and Katsumata, 2006). The 
macrolides, such as erythromycin, interfere with protein synthesis by binding to the 
50S ribosomal unit, stimulating the dissociation of the peptidyl-tRNA (Abu-Gharbieh 
et a l, 2004). Chloramphenicol also interacts with the 50S subunit but instead it 
blocks the enzyme peptidyl transferase (Dzidic et a l, 2008). The aminoglycosides 
and tetracyclines exert their effect by interacting with the 30S subunit of the ribosome 
(Yoneyama and Katsumata, 2006).
Nucleic acid synthesis is another essential step that can be targeted by antibiotics. 
Fluoroquinolones target the enzymes DNA gyrase and topoisomerase IV leaving the 
bacterial cells unable to carry out DNA replication (Jayaraman, 2009). In the case o f 
rifamicyn B derived compounds it is transcription that is affected. Their mode of 
action consists of inhibiting RNA polymerase (Yoneyama and Katsumata, 2006).
Inhibition o f enzymes involved in key metabolic stages, such as those in folate 
metabolism, is yet another way to exert selective toxicity. The sulphonamides, in use 
since the 1930s (Moellering, 1995), have the effect in prokaryotes of shutting down
folate production, which is necessary for the production of purines and the amino 
acids glycine and methionine (Yoneyama and Katsumata, 2006).
1.1.1 B-lactams
The importance of p-lactams in modern medicine is undisputed, these being the most 
prescribed antibiotic class in primary care in the UK in 2009, where they accounted 
for 50% of the daily defined doses (Adriaenssens et a l, 2011). Furthermore, their 
importance in veterinary medicine is also marked by their being the second most sold 
antimicrobial class by weight of active compound in 2011 and representing 25% of 
all veterinary antibiotic sales (VMD, 2012).
Biochemically, the members o f this family are characterised by the presence o f the 
four membered carbonyl lactam structure (Figure 1.1), which is responsible for their 
activity. The p-lactams can broadly be classified into penicillins, cephalosporins, 
carbapenems and monobactams, differing in the type of side ring or lack thereof 
(Finch et al., 2010). In the case of the penicillins the azetidinone ring is bound to a 
saturated 5 membered ring, for the cephalosporins it is a 6 membered ring, whilst the 
carbapenems are distinguished by the presence of a 5 membered unsaturated ring 
(Bryskier, 2005). In contrast, in the case of monocyclic p-lactams, of which the only 
commercially available example is aztreonam, the azetidinone ring is not bound to a 
side ring (Finch et al., 2010). A further class of P-lactam related compounds are the p- 
lactamase inhibitors. These are compounds which, although on their own they have 
very weak antimicrobial activity, they are potent inhibitors of the p-lactamases, which 
inactivate p-lactams (Wilke et al., 2005).
The p-lactam antibiotics target the Penicillin Binding Proteins (PBPs), tranpeptidases 
which are in charge of crosslinking the petydoglican (Kong et al., 2010). The 
crosslinking of the peptydoclican lends the cell wall its rigidity and helps maintain 
cell shape in a hypertonic and hostile environment (Drawz and Bonomo, 2010). Due 
to their stereochemical similarity to the substrate of the PBPs, the terminal moiety D- 
alanine-D-alanine, the p-lactam antibiotics covalently bind the PBPs blocking the 
transpeptidation reaction (Wilke et al., 2005). The presence of weakly cross-linked
Figure 1.1: Structure and hydrolysis of p-lactam antibiotics
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Hydrolysis of the four membered p-lactam ring by p-lactamases at the carbonyl to 
nitrogen bond renders antibiotics from this family inactive. Adapted from Pratt and 
Comely (2004).
peptidoglycan ultimately results in bacterial cell elongation, increased osmotic 
sensitivity and eventually bacterial cell lysis (Tomasz, 1986).
1.1.2 Antibiotic Resistance
Through widespread use and subsequent selective pressure, it is not surprising that 
resistance often arises after the introduction of new antibiotics (Kong et al., 2010). 
There are three mechanisms by which bacteria can become resistant to an antibiotic 
(Table 1.1). In the first instance a bacterium may become less sensitive by decreasing 
its influx or increasing its efflux from the place of action, as for example occurs for 
Pseudomonas aeruginosa and carbapenem resistance (Yoneyama and Katsumata, 
2006). A second mechanism is to develop resistance by modifying the antibiotic 
target. In the case of the P-lactams, new PBPs (penicillin binding proteins) have 
arisen by mutation or have been acquired which have much lower affinity for the P- 
lactams, as is the case for example of Methicillin-Resistant Staphylococcus aureus 
(MRSA) (Yoneyama and Katsumata, 2006). The third mechanism, and most 
significant for Gram negative human pathogens in the case of the p-lactams, is the 
inactivation o f the antibiotic by hydrolysis or chemical modification (Kong et ah, 
2010) (Bonnet, 2004). The p-lactam ring, which gives the group its name, is liable to 
hydrolysis by enzymes called p-lactamases. Such enzymes are common, with 890+ 
types having been described (Bush and Jacoby, 2010) and have varying degrees of 
substrate preference (Dzidic et al., 2008). A remarkable group of P-lactamases is 
formed by the extended-spectrum p-lactamases (ESBLs). The ESBLs are unlike other 
P-lactamases in that they possess a wide range of substrate preference, being able to 
hydrolyse most penicillins, cephalosporins and monobactams (Dzidic et al., 2008) 
(Denton, 2007).
Resistance to all the other major classes of antibiotics has been documented by one or 
more of the mechanisms aforementioned. Minimising the accumulation of the 
antibiotic at its site of action by influx and efflux pumps can confer resistance to 
fluoroquinolones, tetracyclines (Jayaraman, 2009) and macro lides (Dzidic et a l, 
2008). A very well studied example o f such systems is the de-repressed AcrAB/TolC
system which shuttles out the compounds from the cytoplasm and through both the 
inner and outer membranes (Jayaraman, 2009). Alteration of the target site for an 
antibiotic is frequently found as the mode o f resistance to synthetic antibiotics such as 
the sulphonamides, the fluoroquinolones and the macrolides and less frequently 
naturally derived ones such as vancomycin and rifampicin (Yoneyama and 
Katsumata, 2006). In the case o f sull and sul2, they encode for dihydropteroate 
synthases that are not sensitive to inhibition by sulphonamides, therefore bypassing 
the effect o f the antibiotic on the folate pathway (Skold, 2000). A further example of 
resistance by means o f modification of the antibiotic’s target is provided by resistance 
to the fluoroquinolones. In gram negative bacteria the main target of fluoroquinolones 
is DNA gyrase with mutations in DNA gyrase subunit determinants gyrA and gyrB 
able to confer resistance (Hooper, 1999).
Inactivation o f the antibiotic by enzymatic means, such as hydrolysis or group 
transfer is a mode of resistance that has only been observed against natural or at most 
semi-synthetic antibiotics. As well as the P-lactams, other examples o f antibiotics 
inactivated in this way are rifampicin, the aminoglycosides, and the tetracyclines 
(Bockstael and Van Aerschot, 2009).
1.1.3 Impact of antimicrobial resistance
The advent of modem antimicrobial therapy in the early 20^  ^ century led to a major 
downward shift in the mortality rate associated with infectious diseases (Kong et a l, 
2010). However, the emerging trend of antibiotic resistance and multiple antibiotic 
resistances among human and animal pathogens presents a growing threat (Dzidic et 
a l, 2008). The first consequence that a patient infected with a resistant strain faces is 
the delay of an effective therapy (Cosgrove and Carmeli, 2003). This delay has been 
associated with higher morbidity and mortality rates, longer hospital stays and switch 
to non-first line drugs which are often more expensive and have more potent side 
effects (Cosgrove and Carmeli, 2003). Furthermore, once it is clear that a patient is 
carrying a resistant strain, the implementation of extraordinary measures o f infection 
control such as isolation rooms may further increase costs of treatment (Mulvey and 
Simor, 2009).
1.1.4 Mobilisation of resistance genes
An issue further compounding the problem of antimicrobial resistance is the 
prevalence of horizontal gene transfer (HGT) amongst prokaryotes, especially that 
mediated by mobile genetic elements (MGE). Bacteriophages are one type o f such 
elements, which can accidentally mediate the transfer of host DNA to a new 
bacterium through the accidental packaging o f host DNA in a viral capsid and 
subsequent injection and recombination into the genome o f the new host (Frost et al,
2005). This process is known as transduction and it can be also involved in the 
transfer o f important virulence genes (Canchaya et al, 2003). Plasmids are 
independently replicating, generally circular, molecules of DNA that as well as 
carrying genes essential for plasmid replication may carry additional accessory genes 
that under certain circumstances may be beneficial to the host bacterium. An 
interesting feature of many plasmids is their ability to promote their own transfer into 
a new host bacterium, a process known as conjugation, or in the case of mobilisable 
plasmids, to be mobilised by conjugative plasmids (Frost et a l, 2005).
Another example o f a MGE is the Insertion sequence (IS) which are short DNA 
sequences that code for a transposase which is able to excise and re-insert the IS, and 
often adjacent genes, into new genetic locations, either elsewhere within the 
chromosome or onto a plasmid or other MGE (Siguier et a l, 2006). Transposons, 
similarly to ISs, code for a transposase, but are generally regarded as more complex 
genetic elements carrying multiple determinants (Normark and Normark, 2002). A 
special class of transposons is that made by the conjugative transposons, which in a 
similar manner to plasmids, and after having excised themselves fi-om the genome, 
are able to mediate their own transfer into a new bacterial host (Salyers et a l, 1995). 
Intégrons are a further type of genetic element of marked importance for HGT. 
Although not technically mobile, they are highly effective gene capture and 
expression systems which can be present within transposons or plasmids and often 
provide multiple resistance determinants (Partridge et a l, 2009).
1.2 The Enterobacteriaceae
The Enterobacteriaceae are a family o f Gram negative, non-sporulating, rod shaped 
bacteria belonging to the phylum of Proteobacteria. The family is composed of genera 
which are often motile, grow well on common laboratory media and are facultative 
anaerobes (Jones, 1988). They are further characterised by their lack o f cytochrome 
oxidase activity, and their ability to ferment glucose. The Enterobacteriaceae range in 
size between 0.5-2 x 2-4pm (Gillespie and Hawkey, 2005). The Enterobacteriaceae 
family is widespread and is extremely diverse in terms of their ecological niche, host 
range and pathogenicity, ranging fi*om harmless saprophytes to clinically and 
economically important human and animal pathogens (Jones, 1988).
In terms of medical relevance, the Enterobacteriaceae represent 80% of clinically 
important Gram negative bacilli (Gillespie and Hawkey, 2005). Of those genera that 
are pathogenic many cause infections within the gastrointestinal (GI) tract. Other 
common infections caused by Enterobacteriaceae include urinary tract (for example 
E. coli and Proteus) and respiratory infections (e.g. Klebsiella) (Murray et a l, 1997).
Traditionally the classification of bacteria within a family was based on appearance 
under the microscope, biochemistry and whether they were pathogenic or not (Jones, 
1988). Commonly used tests are those which detect the presence of certain enzymes 
(e.g. urease, lysine decarboxylase, arginine dihydrolase), the production of certain 
metabolites (e.g. H2S) or their ability to metabolise a determined carbon source (e.g. 
glucose, sorbitol, arabinose) (Farmer et a l, 1985). Whereas, originally, this testing 
was not standardised and relied on individual labs devising their own discriminating 
media, fi*om the late 1960s, a shift towards the use of commercial testing kits which 
included pre-packed reagents such as the API system of Biomerieux occurred 
(Gillespie and Hawkey, 2005). Automated versions have since been developed in 
which cartridges containing different reagents are inoculated and incubated and 
changes in colour intensity are automatically monitored, such as the Bio log system 
(Miller and Rhoden, 1991). Furthermore fast and reliable identification has been 
achieved through the use of Matrix-Assisted Laser Desorption lonization-Time-Of- 
Flight (MALDI-TOF). In this technique a MALDI-TOF profile of a bacterial colony
is generated and compared against an extensive database to obtain identification to 
the genus and in many cases species level (Mellmann et a l, 2008).
Later on, with the advent of molecular biology techniques used for the study of 
nucleic acids, the genetic relatedness of bacteria has also been assessed, with the 
consequence of many rearrangements within family and genera clades o f the 
taxonomic tree (Jones, 1988).
1.2.1 Escherichia coli
Escherichia coli (E. coli) is an environmentally ubiquitous Gram negative bacterium 
that belongs to the family of Enterobacteriaceae (Gillespie and Hawkey, 2005). The 
organism was first described by Theodor Escherich in 1885 who believed it to be just 
a commensal organism. However, shortly after, the organism was isolated from a 
number of extraintestinal infections (Orskov and Orskov, 1985). E. coli is able to 
perform both aerobic and anaerobic respiration which enables it to survive both in the 
environment and the lower gut of its host, greatly facilitating its spread (Blattner et 
a l, 1997). E. coli are part of the normal microbiota of the GI tract of warm blooded 
animals including humans which they generally colonise shortly after birth (Sousa, 
2006). Whilst commonly found in water, food or soil, this is mostly as a result of 
faecal contamination (Gillespie and Hawkey, 2005). As well as harmless 
commensals, both opportunistic and pathogenic strains exist. The pathogenic strains 
are fiirther subdivided into extraintestinal pathogenic E. coli (ExPEC) for those 
associated with infection within the normally sterile cavities (i.e. the urinary tract, 
sepsis) and the intestinal pathogenic E. coli (IPEC), the causative agents of many 
distinct diarrhoeal syndromes (Gillespie and Hawkey, 2005).
ExPEC strains of E. coli differ from normal commensal strains in the pathogenic 
determinants they harbour, as well as serologically (Gillespie and Hawkey, 2005). A 
number of clonal groups belonging to a limited number of serogroups have been 
identified in E. coli associated with infections of the urinary tract, the uropathogenic 
E. coli (UPEC). UPEC contain pathogenicity islands carrying groups of genes not 
present in the genome of commensal faecal strains (Kaper et a l, 2004). Characteristic
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of UPEC strains is the expression of adhesion factors such as fimbriae which 
facilitate colonisation and toxins such as haemolysin which are the cause o f the 
cytotoxic effect on the epithelial cells (Gillespie and Hawkey, 2005). The course of 
infection commonly starts with gut colonisation by the UPEC strain followed by 
faecal contamination of the periurethral area. The bacteria then migrate up the urethra 
into the bladder and occasionally ascend to the kidneys. If  the tubular epithelial 
barrier is crossed bacteria reach the blood stream causing bacteraemia (Kaper et a l,
2004). Another subset within ExPEC is responsible for causing bacteraemia and 
newborn meningitis (Gillespie and Hawkey, 2005).
A number of pathotypes are described within the IPEC. Enteropathogenic E. coli 
(EPEC) is the main cause of infantile diarrhoea in the developing world (Sousa,
2006). It causes a classical histopathology, known as “attaching and effacing lesions”, 
in which the bacteria are intimately attached to the host cells and a cytoskeletal 
structure rich in actin forms under the attached bacteria (Kaper et a l, 2004). Most 
strains of EPEC carry their virulence factors in the locus of enterocyte effacement 
(LEE) pathogenicity island and the EPEC adherence factor (EAF) plasmid, although 
atypical strains have also been described which have lost the EAF plasmid (Gillespie 
and Hawkey, 2005).
Enterohaemorrhagic E. coli (EHEC) can cause both bloody and non-bloody diarrhoea 
and the complication known as haemolytic uraemic syndrome (HUS) and other 
serious sequelae especially in the very young and the elderly. EHEC is considered a 
zoonotic infection with the GI tract of cattle being its natural reservoir. The most 
prevalent serotype of EHEC presenting in North America, UK and Japan is 0157:H7, 
however, other serotypes can also cause disease. The distinguishing virulence factor 
of this serotype is the Shigella toxin, Stx, (which is also known as Verocytotoxin, VT, 
as this cell type was first used to describe the cytopathic effect o f the toxin). As the 
name implies, this toxin is homologous with that seen in Shigella spp. Stx cleaves 
rRNA bringing protein synthesis to a halt (Kaper et a l, 2004). As well as Stx, EHEC 
strains require the locus of enterocyte effacement (LEE) pathogenicity island for 
virulence, as strains containing only the stx virulence determinant do not seem to 
cause disease in humans (Kaper et a l, 2004).
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Enterotoxigenic E. coli (ETEC) cause watery diarrhoea ranging from mild to serious 
disease. The increase in secretions in the intestine is caused by the production of LT 
(heat labile toxin) and/or ST (heat stable toxin) (Sousa, 2006). The bacteria colonise 
the gut through a range of specific fimbrial adhesins which mediate attachment to 
host factors, with K88, K99 and 987P associated with strains isolated from pigs and 
K99 and F41 common in strains isolated from ruminants (Nagy and Fekete, 1999).
Enteroinvasive E. coli (EIEC) is a pathotype formed by strains that are very similar to 
Shigella species genetically, biochemically and pathogenically. The site o f infection 
is mainly the colon and the disease presents with watery diarrhoea which contains 
mucus and in severe cases blood (Gillespie and Hawkey, 2005). Although the 
mechanism is not well understood, large virulenee plasmids coding virulence opérons 
such as ipa and vir have been implicated in the invasion phenotype (Venkatesan et 
a l, 1989).
Enteroaggregative E. coli (EAggEC) have been associated with persistent diarrhoea 
in developing countries (Sousa, 2006). They are characterised by their attachment to 
HEp-2 cells and their brick-layer stack appearance upon attachment (Gillespie and 
Hawkey, 2005). A number of fimbrial structures have been identified that mediate the 
enteroaggregative phenotype, such as Aggregative Adherence Fimbriae I (AAF/I) and 
AAF/II, however these are not universally present in EAggEC strains with 
colonisation possibly mediated by additional fimbrial antigens (Nataro et a l, 1998)
1.2.2 Klebsiella
The genus Klebsiella also belongs to the family Enterobacteriaceae and is unique 
among the family for its pronounced mucoid capsule (Sahly and Podschun, 1997). 
Klebsiella species were first isolated in the 1880s from patients suffering from 
rhinoscleroma, a disease of the nose and upper respiratory tract, and they were named 
in honour of the German microbiologist Edwin Klebs (Brisse et a l, 2006). Klebsiella 
are non-motile organisms, they can grow at temperatures between 12 and 43°C and 
will survive extended periods o f drying (Greenwood et a l, 2002). Although they 
often colonise the mucosal surfaces of mammals such as humans, horses and pigs.
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they are not restricted to these environments also being found on plants, soil and in 
open bodies of water (Sahly and Podschun, 1997).
Klebsiella spp. are frequently isolated as opportunistic pathogens, causing community 
acquired pneumonia among chronic alcoholics and nosocomial infection in patients 
who are immunocompromised or suffering severe underlying diseases (Podschun and 
Ullmann, 1998). The main route of transmission for hospitalised patients is via the 
hands resulting in subsequent ingestion. Within the GI tract the bacteria attach to 
mucosal cells by means of Type I fimbriae FimH and Type III fimbriae MrkD 
(Klemm and Schembri, 2000). Once established the bacteria can enter the blood and 
migrate to other mucosal sites (Gillespie and Hawkey, 2005) giving rise to diseases 
such as septicaemia, pneumonia, urinary tract infection (UTI) and soft tissue 
infections (Podschun and Ullmann, 1998). Their prominent polysaccharide capsule 
helps survival o f the bacteria after invasion, as it is crucial in the avoidance o f 
phagocytosis and hinders activation of the complement system (Podschun and 
Ullmann, 1998).
1.2.3 Salmonella
The genus Salmonella belongs to the family Enterobacteriaceae and its members are 
closely related to E. coli (Gillespie and Hawkey, 2005). Once considered as 
individual species, more than 2500 serological types of Salmonella, based on their 
antigenic structure, have been described (Velge et a l, 2005). Molecular analysis has 
shown that all serotypes of Salmonella are related enough to be re-classified into just 
two species, S. enterica, which comprises most serovars, and S. bongori (Gillespie 
and Hawkey, 2005). S. enterica is further subdivided in to six subspecies of which 
just S. enterica subspecies enterica causes 99% of Salmonella related infections in 
warm blooded animals (Velge et a l, 2005).
S. enterica subsp. enterica (for simplicity here after referred to as S. enterica) 
serotypes widely vary in their host preference (Rabsch et a l, 2002). Some strains 
have a very narrow range, such as S. enterica serotype Typhi {Salmonella Typhi) 
which only infects humans and higher primates causing a severe disease known as
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enteric fever (Velge et a l, 2005). Other serotypes such as Salmonella Typhimurium 
and Salmonella Enteritidis are able to infect both humans and many animal species 
(Rabsch et a l, 2002) and tend to cause milder forms o f GI infections (Velge et a l,
2005). Due to their broad host range the non-typhoid Salmonellae are prevalent 
among farm animals (often as asymptomatic carriers) which facilitates their reaching 
of the food chain, causing outbreaks of food poisoning (Gillespie and Hawkey, 2005). 
In the case of typhoid strains their only reservoir is the human with the main route of 
transmission being the faecal oral route (Gillespie and Hawkey, 2005).
Infection course and clinical presentation differs between Typhi and non Typhi 
strains. In enteric fevers the bacteria breach the intestine and invade 
reticuloendothelial cells where the bacteria can multiply intracellularly. Following an 
incubation period in which the bacteria multiply the bacteria start to be released and 
cause secondary bacteraemia and seeding of other organs (Huang and DuPont, 2005). 
Typhoid is characterised by fever, abdominal pain, diarrhoea or constipation and 
sometimes a raised red rash (Ohl and Miller, 2001). Non typhoid salmonelloses on 
the other hand tend to be constrained to the intestine, Typhimurium strains being an 
exception in that they can occasionally cause “enteric fever”-like disease (Gillespie 
and Hawkey, 2005). The incubation period fi*om the time that the bacteria are 
ingested to the time the clinical symptoms present is short (8-48 hrs). Symptoms 
range fi'om looser than normal stool to full blown debilitating diarrhoea often 
accompanied by abdominal pain and dehydration (Greenwood et a l, 2002).
1.3 B-lactamases
Although other mechanisms have been described, resistance to the ^-lactams in Gram 
negative organisms is largely due to the production of p-lactamases, enzymes capable 
of hydrolysing the four membered p-lactam ring (Figure 1.1) therefore rendering it 
inactive against PBPs (Babic et a l, 2006). These enzymes are numerous, with more 
than 890 types described (Bush and Jacoby, 2010) and they are known to predate the 
introduction of p-lactams as clinical agents (D/'Costa et al., 2011), possibly 
originating as a defence mechanism against p-lactams produced by soil organisms 
(Bradford, 2001). Based on their sequence analysis, these enzymes are thought to
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share a common ancestor with PBPs (Kong et ah, 2010). Historically, penicillinase 
producing staphylococci were isolated within a year o f the clinical introduction of 
penicillin, followed by increasing reports o f resistant staphylococci (Kong et a l, 
2010). Furthermore, the introduction of semisynthetic broad spectrum agents with 
activity on Gram negative organisms in the 1960 was also quickly followed by the 
emergence of resistance due to p-lactamases, such as TEM-1, TEM-2 and SHV-1 
(Livermore, 2008). As a response to this, a number of agents that were resistant to the 
hydrolytic action o f p-lactamases were developed, among them, the oxyimino- 
cephalosporins which rapidly became widely used for the treatment of serious Gram- 
negative infections (Bradford, 2001). However, as it had previously been the case, the 
appearance o f resistance to these agents swiftly ensued, with the first isolation of one 
such p-lactamase occurring in Germany in 1983 in the way of SHV-1 and SHV-2 
mutants (Kliebe et a l, 1985). Often these p-lactamases are carried by plasmids or 
transposons, facilitating their spread drastically (Bradford, 2001).
The number of described p-lactamases is large and multiple classification systems 
have been proposed. One of the most widely used is that proposed by Ambler, 
whereby the enzymes are grouped based on amino acid sequence similarity (Bush and 
Jacoby, 2010). O f the four Ambler classes A, C and D are serine based enzymes 
whilst class B enzymes, which are the metallo-P-lactamases, depend on zinc for their 
action (Kong et a l, 2010). More recent functional classification schemes attempt to 
relate the enzymes to their clinical significance, such as the Bush, Jacoby, Medeiros 
scheme which groups the enzymes according to their substrate specificity and their 
susceptibility to inhibition (Bush et a l, 1995).
1.3.1 The extended spectrum p-lactamases (ESBLs)
The extended spectrum p-lactamases are Ambler class A enzymes characterised by 
their ability to hydrolyse penicillins, first, second and third generation cephalosporins 
and monobactams but not cephamycins or carbapenems and their susceptibility to 
inhibition by p-lactamase inhibitors such as clavulanic acid and tazobactam (Babic et 
a l, 2006). As such, the ESBLs have been classified as belonging to functional group 
2be (Bush et a l, 1995). The original ESBL’s arose by mutation fi-om TEM and SHV,
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themselves penicillinases belonging to functional class 2b. The changes occurred in 
the active site of the enzyme, causing its enlargement which resulted in the ability to 
accommodate the larger side chains of the oxyimino-cephalosporins and a relative 
loss of activity against penicillins (Babic et ah, 2006). During the 1980s and 90s by 
and large the majority of ESBLs detected belonged to TEM and SHV families, 
however sporadic reports of other enzymes families were also made (Livermore et a l,
2007).
1.3.2 The CTX-M family and its origins
The CTX-M family of enzymes are a family o f ESBLs phylogenetically distinct from 
TEM and SHV families that were first isolated in Japan from the intestinal flora o f a 
laboratory dog used for p-lactam pharmacokinetic studies and originally named FEC- 
1 (Matsumoto et a l, 1988). Sporadic reports of frirther CTX-M family members 
followed, such as the description and characterisation in Germany o f a plasmidic 
ESBL isolated from a clinical E. coli strain. This enzyme was the first designated 
CTX-M, which referred to its hydrolytic profile (cefotaxime) and its place o f isolation 
(Munich) (Bauernfeind et a l, 1990). Nevertheless, the worldwide occurrence of 
CTX-M enzymes remained rare throughout the 1990s, with the exception o f an 
expansion of CTX-M-2 in Enterobacteriaceae strains in South America (Bonnet, 
2004). However, following almost worldwide expansion during the late 1990s, the 
CTX-M family of p-lactamases had become, as early as 2004, the most prevalent 
family of ESBL (Bonnet, 2004). Additional changes observed in the epidemiology of 
ESBLs with the rise to prominence o f the CTX-Ms was the change in association 
from mostly nosocomial infections, as was the case with TEMs and SHVs, to a surge 
of infections originating within the community setting (Canton and Coque, 2006).
As of August 2013 over 140 different CTX-M enzymes had been identified 
(http://www.lahey.org/studies/webt.htm) which have been traditionally clustered 
according to amino acid sequence homology into 5 groups, 1, 2, 8, 9 and 25 (Bonnet, 
2004) and more recently, as more diverse types have been identified into 7 groups, 2, 
3 (corresponding to previous 1), 8, 14 (corresponding to previous 9), 25 and the 
newly added groups 45 and 64 (Zhao and Hu, 2012).
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The CTX-M determinants are firmly believed to originate from the chromosome of 
species o f the Kluyvera genus (Zhao and Hu, 2012), which belong to the family 
Enterobacteriaceae and have been isolated from soil, water, sewage, food and human 
clinical specimens (Farmer et a l, 1981). This is based on amino acid identities of up 
to 100% of certain CTX-M genes to chromosomal cefotaximase genes of strains of K. 
ascorbata, K. georgiana and K. cryocrescens as well as the sequence of the 
surrounding regions co-transferred by the insertion sequence (Zhao and Hu, 2012). 
Although many insertion sequences have been found alongside CTX-M genes, the 
most common ISs responsible for their mobilisation have been found to be l^Ecpl 
(Figure 1.2) and ISCR7. As well as providing a means of mobilisation, they also 
ensure transcription by providing an upstream promoter (Zhao and Hu, 2012).
1.3.3 CTX-M lactamases activity and clinical options
Unlike the TEM and SHV enzymes, whieh evolved from penicillinases into ESBLSs 
through the occurrence of point mutations, enzymes belonging to the CTX-M family 
are intrinsic ESBLs showing substrate preference for cefotaxime and ceftriaxone over 
ceftazidime (Rossolini et a l, 2008). The presence of a smaller binding site within 
CTX-M enzymes as compared to that of TEM and SHV enzymes explains why 
ceftazidime, with its bulky R2 side chain is not a good substrate for most CTX-M 
enzymes (Chen et a l, 2005). Nevertheless, as little as a single amino acid substitution 
within the active site (Asp240Gly) has been found to confer catalytic activity against 
ceftazidime, as is the ease with CTX-M-15 (Poirel et a l, 2002) and CTX-M-16 
(Bonnet et a l, 2001), which derived from CTX-M-3 and CTX-M-9 respectively. As 
for inhibition of the CTX-M enzymes, they again differ from TEM and SHV enzymes 
in that they are generally better inhibited by tazobactam than clavulanic acid or 
sulbactam (Bradford, 2001) with some exceptions, as is the case for Toho-1 (Chen et 
a l, 2005).
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Figure 1.2: Organisation oïlSEcpl
I Sfcpl bloCTX-M orf447
H
Typical genetic platform group 1 CTX-M genes with ISEcpl upstream of the CTX-M 
gene and orf447 downstream. Adapted from Zhao and Hu (2012).
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1.4 Plasmids
Plasmids are non-essential extra-chromosomal DNA that replicate autonomously as a 
component of the cell’s genome ranging in size from 1 to 100s ofkbs (Novick, 1987). 
Plasmids are ubiquitous, having been found across a wide range of bacterial species 
and they often code for traits beneficial to the harbouring cell, such as antibiotic 
resistance, toxic compound degradation and virulence determinants (Couturier et a l, 
1988). They are important agents of HOT due to their capacity to self-mobilise or be 
mobilised by other plasmids (Smillie et a l, 2010) and the fact that they often carry 
transposons and insertion sequences (Couturier et a l, 1988), and because many can 
be hosted by very broad range of bacteria (Smillie et a l, 2010). As well as carrying 
accessory genes, plasmids are composed of a backbone containing essential genes 
involved in their maintenance. Replication systems initiate plasmid replication and 
control copy number whilst partitioning systems ensure segregation of plasmids to 
daughter cells (Novick, 1987). In addition to these, addiction systems, also known as 
toxin/antitoxin systems or Post-Segregational Killing (PSKs), prevent plasmid free 
segregants from surviving, thus further stabilising plasmid carriage within 
populations (Zielenkiewicz and Ceglowski, 2001).
1.4.1 Plasmid classification methods
Incompatibility is the inability of two plasmids to be propagated stably in the same 
cell line and it is a manifestation o f plasmid relatedness caused by two plasmids 
sharing common elements involved in replication and/or equipartitioning (Novick, 
1987). One early system for the classification of plasmids into families or 
incompatibility groups consisted of introducing the test plasmid into a strain carrying 
a plasmid already assigned to a family. If the resident plasmid was eliminated from 
the progeny the test plasmid would then be assigned to the same incompatibility 
group (Datta and Hedges, 1971). This technique is technically cumbersome needing 
to be repeated against multiple plasmids belonging to different incompatibility groups 
(Couturier 7^/., 1988).
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Plasmids regulate their own replication so that copy number is stable. To do this they 
control replication through a negative feedback loop. Based on these replication 
control systems, a replicon typing method that used hybridization of probes specific 
to each of 19 replicons was developed. Although this method had its merits, mostly 
that multiple mating experiments were no longer required, there were also drawbacks, 
namely the problem of cross-hybridization amongst phylogenetically related yet 
compatible plasmids such as those belonging to the I superfamily (Incl, IncK, 
IncB/O) (Couturier et a l, 1988).
In order to simplify the experimental workflow involved in plasmid classification, 
PCR based approaches have been devised more recently. One such system was 
devised for the detection of broad host range plasmids belonging to IncN, IncP, IncQ 
and IncW families (Gotz et a l, 1996). A more comprehensive approach was later 
developed that targeted 18 major plasmid families in the Enterobacteriaceae (Carattoli 
et a l, 2005).
Due to the high prevalence of some of these plasmid families, as is the case for the 
IncF and Incl in the Enterobacteriaceae (Carattoli, 2009), it is often desired to further 
characterise these plasmids in order to reveal epidemiological relationships. A 
method often employed for this purpose is the comparison of the restriction fi-agment 
patterns of plasmids, known as Restriction Endonuclease Analysis (REA) or 
restriction fi-agment length polymorphism (RFLP) when it is followed by 
hybridization to a specific DNA or RNA probe (Tenover et a l, 1997). Restriction 
fragment pattern has been used extensively to reveal the relatedness o f resistance 
plasmids (Batchelor et a l, 2005, Novais et a l, 2007, Bertrand et a l, 2006). 
Restriction fragment analysis is relatively cheap (Tenover et a l, 1997) and can be 
used even when no incompatibility group has been assigned, for example when 
plasmids are non-typable. However restriction fragment patterns are not easily 
comparable across labs (Villa et a l, 2010). With the increasing availability o f 
complete plasmid DNA sequences, methods analogous to multi locus sequence typing 
for plasmid families have been devised (pMLST). They involve the selection o f 
backbone genes that are conserved across a family but which show enough diversity 
to provide discriminatory power and according to the alleles present in a plasmid, a
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sequence type (ST) is then assigned. So far pMLST typing schemes have been 
devised for the Incll group (Garcia-Fernandez et ah, 2008), the IncHIl group (Phan 
et a l, 2009), the IncF group (Garcla-Femandez et a l, 2011) and the incN group 
(Garcia-Fernandez et a l, 2011).
1.4.2 Plasmid families: the Incl complex with focus on Incll
There are currently 27 plasmids families recognised among Enterobacteriaceae 
(Carattoli, 2009), ranging from the broad host range plasmid families IncA/C and 
IncP to the highly prevalent I complex that is, however, restricted to the 
Enterobacteriaceae (Couturier et a l, 1988). The I complex is made up of 
phylogenetically related plasmid families including Incll, Indy, IncK, IncB/O and 
IncZ (Praszkier and Pittard, 2005). Plasmids belonging to these groups have in 
common the expression of thick and thin piluses, which as well as being involved in 
conjugation are also considered virulence factors (Sampei et a l, 2010). Another 
common feature is the presence of a multiple inversion system within the thin pilus 
operon that mediates rearrangements within the pilus tip, resulting in variation of 
binding specificity (Zechner et a l, 2000). Furthermore, the replication control o f 
plasmids belonging to the I complex is achieved via an antisense mechanism, 
whereby a small non-coding RNA binds the mRNA of the replication initiation 
protein, therefore inhibiting its translation (Praszkier and Pittard, 2005). As briefly 
mentioned before, another fimction often encoded by plasmids is that of plasmid 
stability, often achieved in the way o f addiction systems, also known as Post- 
Segregational Killing (PSK). One such system often found on I complex plasmids is 
pndCIA (Chilley and Wilkins, 1995). The pndA/C module is a toxin/antitoxin system 
that prevents plasmid loss by killing plasmid free segregants (Nielsen and Gerdes, 
1995). From the I complex, the Incll group specifically will be the focus from 
hereon, as this was the main plasmid type found in the farm pertaining to these 
studies.
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1.4.3 The association of CTX-M-1 with Incll plasmids
Incll plasmids are highly prevalent amongst resistant Enterobacteriaceae strains, as 
confirmed by a review including over 1000 typed plasmids conferring resistance to 
clinically significant antibiotics (Carattoli, 2009). Interestingly, Johnson et al (2007) 
found that the prevalence of Incll plasmids among E. coli strains was 17.4% for 
isolates from apparently healthy chickens and 6.9% for healthy antibiotic free 
humans, and even higher for E. coli strains associated with diseased individuals 
(Johnson et a l, 2007). Furthermore, Incll plasmids range widely in the types of 
resistance genes they carry, such as p-lactamase genes CMY-2, CTX-M-1,-9,-14, 
SHV-12, TEM-1,-52 and VIM-1 to name but a few (Carattoli, 2009).
As for CTX-M-1, it has been suggested that its association with Incll plasmids is 
partly responsible for driving their recent increase in prevalence throughout Europe 
(Carattoli, 2009). Reports of human and animal IncH-CTX-M-I plasmids from E. 
coli and S. enterica strains are common place in France (Marcadé et a l, 2009, Girlich 
et a l, 2007, Cloeckaert et a l, 2010, Madec et a l, 2011). Of note is that in one survey 
10% of healthy poultry were found to carry E. coli stains harbouring IncH-CTX-M-I 
plasmids. Worryingly, as it might indicate an instance of a zoonotic transmission 
event, in a later study o f isolates o f S. enterica carrying Incll-CTX-M-1 plasmids it 
was shown that plasmids of human and animal origin were related as demonstrated by 
Incll pMLST (Cloeckaert et a l, 2010). Additionally, S. enterica strains isolated from 
livestock and food from Germany have also been shown to harbour IncH-CTX-M-I 
plasmids (Rodriguez et a l, 2009). In the Netherlands, a similar picture is found, with 
an earlier study finding both E. coli and S. enterica strains from poultry harbouring 
IncH-CTX-M-1 plasmids (Dierikx et a l, 2010). A further study of plasmids from E. 
coli originating from patients, retail chicken and poultry using IncH pMLST 
demonstrated the relatedness o f the plasmids (Leverstein-van Hall et al., 2011).
1.4.4 Impact of plasmids on carrier strains
The role of plasmids as agents of HGT and their dissemination of antibiotic resistance 
is undisputed. When it comes to the fitness impact of plasmid carriage, it is clear that
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in the presence of a selective pressure, i.e. in the presence of an antibiotic, harbouring 
a plasmid conferring resistance will confer the organism an advantage (Slater et al,
2008). Nevertheless, from an evolutionary perspective an important question arises, 
that is, in the absence of that specific condition, is the association o f plasmid and host 
still beneficial to both parties? With the CTX-M genes in general, understanding the 
fitness implication of resistance plasmid carriage might help shed light on their 
‘explosive’ rise to prominence.
1.4.5 Phenotypic characterisation of plasmids
Multiple studies have addressed the question of what is the impact that plasmid 
carriage has on the harbouring strain in the absence of selective pressure. Many 
studies using a laboratory host strain that was naïve to the test plasmid have shown 
that indeed plasmid carriage reduced the host’s competitive fitness, which resulted in 
the plasmid carrying organism being outgrown by an otherwise isogenic plasmid free 
competitor (Lee and Edlin, 1985, Lenski and Bouma, 1987, Subbiah et a l, 2011). A 
number of factors have been shown to be the cause of this impairment, in some cases 
it was the expression o f the antibiotic resistance itself (Lee and Edlin, 1985, Bouma 
and Lenski, 1988), whereas at other times the cause was related to the additional 
metabolic cost associated with the replication and expression of the additional 
plasmid DNA (Bentley and Kompala, 1990). However, in contrast with these 
findings, a number of studies have also shown that, although initially, plasmid 
carriage imposed a net cost to the fitness of the harbouring strain, this cost could be 
ameliorated, or even reversed, after a period of co-evolution of the strain and plasmid. 
In some instances genetic changes had occurred on the chromosome of the strain that 
allowed it to better cope with the burden of the plasmid (Lenski et a l, 1994), in 
others the changes were shown to occur on the plasmid itself (Dionisio et a l, 2005) 
or even on both (Dahlberg and Chao, 2003). Even more remarkable is sul2 coding 
plasmid p9I23, which was shown to increase the fitness of both its natural host and 
that of a naïve host strain, without the need for an adaptation period (Enne et a l, 
2004) and aacQ) IV coding plasmids pUK200I and pUK2002 which were also able 
to increase the competitive fitness of a naïve host (Yates et a l, 2006).
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Other aspects of the phenotypic impact o f plasmids have also been investigated, such 
as their impact upon the strain’s virulence and biofilm formation. Incll related STEC 
virulence plasmid pO113 was partly responsible for the adhesion phenotype to Hep-2 
cells (Paton et a l, 2001) and for the haemagglutination of guinea pig erythrocytes 
(Srimanote et a l, 2002). In a separate study, IncH plasmid pSERBI o f C l096 was 
shown to account for 75% of the adhesion phenotype of atypical Enteroagregative E. 
coli (Dudley et a l, 2006). Studies of F-like virulence plasmids o f OI57:H7 strains 
similarly showed that the removal of the plasmid diminished the strains’ adherence to 
Caco-2 cells (Tatsuno et a l, 2001) as well as diminishing colonisation in cattle (Lim 
et a l, 2010a). Formation of biofilms plays an important role in environmental 
persistence and antimicrobial resistance and for that reason the contribution of 
plasmids to this characteristic has also been investigated. Both pOI57 (Lim et a l, 
2010b) and pSERBl (Dudley et a l, 2006) were shown to enhance the bio film 
formation in their host strains. Furthermore, a systematic study of 29 plasmids from 
15 incompatibility groups found that 9 of those plasmids, belonging to 6 different Inc 
groups conferred their lab host, a non-bio film former itself, the ability to form 
bio films. Interestingly, when the bacteria carrying the remaining plasmids, including 
Incll plasmids R64 and pIPl 12, were co-cultured with a plasmid free strain, bio film 
formation was seen, due to transiently de-repressed pilus synthesis (Ghigo, 2002).
1.4.6 Strategies for plasmid removal
One of the main reasons behind attempts to cure, or remove, plasmids has been to 
revert a clinically significant strain to a susceptible or a non-virulent phenotype. 
Another reason for plasmid curing, and more relevant to the studies presented later in 
this thesis, is to obtain information on the phenotype associated with plasmid 
carriage. An often used approach to plasmid curing involves inducing a general stress 
response in the host bacterium. A number of chemical compounds have been 
successful for this purpose, such DNA intercalating agents, certain antibiotics and 
sodium dodecyl sulphate (SDS). Altered growth conditions, such as subculturing at 
high temperature, have also been shown to induce plasmid loss. These approaches, 
however, also increase the chance of mutation within the chromosomal DNA, which 
is a confounding factor when interpreting any resulting phenotype (Bahl et a l, 2009).
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Multiple molecular biology approaches that avoid the risk of chromosomal mutation 
have been developed. Transposon based approaches have been used, such as the Tn5 
based method which involves the introduction of a suicide gene into the target 
plasmid (Stojiljkovic et a l, 1991), or a TnlO based approach which exploits 
linearization of the plasmid upon insertion which leads to plasmid loss (Imre et al,
2006).
Another approach to plasmid curing has been exploiting the characteristic of plasmid 
incompatibility and displacing the target plasmid with unstable miniplasmids 
containing the same replicon as that of the target plasmid, as was done for p0157 
(Tatsuno et a l, 2001) and RI and RP4 (Dahlberg and Chao, 2003). This approach 
involved transformation with the incoming plasmid and selection with antibiotic 
resistance followed by subculturing of the transformants on antibiotic free medium 
until susceptible colonies are found.
More sophisticated versions o f this approach involve the use of a purpose built 
unstable vector containing multiple genes targeting the maintenance of the target 
plasmid, namely its replication, partitioning and addiction systems, such as pCurel 
and pCure2. As well as these aforementioned genes aimed at causing plasmid 
displacement, a negative selection marker was included in the vector to facilitate the 
recovery of vector free colonies (Hale et a l, 2010).
1.5 Project background, hypotheses and aims
1.5.1 Project background
The overarching aim behind this project was to partly elucidate the reasons for the 
major increase in prevalence of CTX-M determinant by exploring the question of 
whether plasmid carriage confers selective advantage to the harbouring strain beyond 
that provided by antimicrobial resistance. The Enterobacteriaceae strains for the 
studies presented here originated from an Animal Health and Veterinary Laboratories 
Agency (AHVLA) investigation carried out in October 2009 at pig farm where, in
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September 2009, the first isolation of CTX-M harbouring Salmonella strains from 
food production animals in the UK had taken place.
1.5.2 Testable hypotheses
The ESBL harbouring isolates recovered from a single pig farm in the UK are highly 
similar indicating clonal expansion of a single resistant organism. If this first testable 
hypothesis is shown not to be the case then it is the spread of a single plasmid type 
that is responsible for the ESBL phenotype amongst outbreak strains.
A hypothesis arising from either outcome o f the above testable hypotheses is that 
those isolates carrying the ESBL appear to have spread on farm suggesting that the 
outbreak plasmid confers to its harbouring strains, beyond antibiotic resistance, a 
selective advantage that explains its success.
1.5.3 Alms
In order to tackle these testable hypotheses, a number o f approaches will be used and 
these comprise a series of linked aims that are:
• To characterise those bacteria that carry ESBLs from the outbreak farm in 
particular by characterising the genetic determinants conferring the ESBL 
phenotype, with special attention to plasmidic or chromosomal carriage o f the 
ESBL encoding determinants.
• Assuming plasmid carriage, to sequence and annotate representative plasmids 
from the outbreak farm.
• To develop an incompatibility based plasmid curing method that avoids the 
use of mutagens and multiple passaging to be used for the removal of the 
resistance plasmid from the outbreak strains and unrelated strains harbouring 
similar plasmids.
• To assess the effect that carriage of the outbreak plasmid has on the phenotype 
of the harbouring strains.
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Chapter 2 : Materials and methods
2.1 Bacterial strains and growth conditions
The outbreak strains investigated as part of this project were isolated by the AHVLA 
from a pig farm during an investigation looking for the presence of ESBL 
Enterobacteriaceae. Transformants and transconjugants were generated by 
introducing the outbreak CTX-M coding plasmids by either conjugation or 
electroporation into lab strains. Additionally, a series of strains harbouring DNA 
vectors were generated as part of the development of an incompatibility based curing 
vector. The strains used in this study were cultured on Luria Bertani (LB) agar 
supplemented with antibiotics as appropriate and incubated aerobically overnight at 
37°C. For broth cultures, 3ml o f LB broth supplemented with antibiotics as 
appropriate were incubated aerobically at 37°C with shaking at 220RPM. When 
culturing outbreak strains (B3779-B3850) or lab strains harbouring CTX-M coding 
plasmids the medium was supplemented with 2 pg/ml of cefotaxime. For strains 
harbouring derivatives o f subcloning vector pCR-Blunt the medium was 
supplemented with SOpg/ml of kanamycin. For strains harbouring pAKE604A or its 
derivatives the medium was supplemented with 50pg/ml of kanamycin or lOOpg/ml 
of ampicillin. For long term storage, 1ml of overnight broth culture was centrifuged at 
13000RPM in a benchtop centrifuge for 5min and the pellet resuspended in 1ml of 
Heart Infiision Broth (HIB) supplemented with 30% glycerol and stored at -80°C.
2.2 Culture media and buffers
The media and buffers described in this section were prepared by the AHVLA 
Biological Products Unit.
2.2.1 LB broth and agar
To make LB broth lOg of tryptone, lOg of sodium chloride and 5g of yeast were 
added to IL of distilled water and mixed by swirling. The pH was adjusted to 7.5 by 
addition o f IM sodium hydroxide or IM hydrochloric acid as required. The mix was 
aliquoted in the required volumes and autoclaved at 12UC for 15min. When plates
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were required 15g of agar was added following pH adjustment and the mixture boiled 
to dissolve the agar. After autoclaving the agar was aseptically poured into plates. 
When antibiotic supplementation was required filtered sterilised stock solutions were 
added to the broth before use or to the agar immediately prior to pouring.
2.2.2 ChromAgar CTX
Chromoagar CTX was used for the differential identification and selection of CTX-M 
harbouring bacteria. On this agar E. coli colonies grow blue, other faecal coliforms 
grow red and other Gram negative bacteria grow colourless. To prepare this agar 
32.8g of ChromAgar ECC (ChromAgar, EF320) were added to IL of sterile distilled 
water and mixed by heating and swirling. 2ml of resuspended ChromAgar CTX 
(CX062) supplement were added to the molten agar and aseptically poured into 
plates.
2.2.3 Phosphate Buffered saline (PBS)
To prepare PBS two salt solutions were prepared. Solution A was prepared by adding 
5.9g of disodium hydrogen phosphate 2 H2O and 4.3g of sodium chloride were added 
to IL of distilled water. Solution B was prepared by adding 4.5g o f potassium 
dihydrogen orthophosphate and 4.3g of sodium chloride to IL of distilled water. To 
make pH7.2 PBS 780ml of solution A were mixed with 220ml o f solution B, 
aliquoted as required and autoclaved at 121°C for 15 minutes.
2.2.4 Heart Infusion Broth (HIB) + 30% glycerol
For long term storage of strains at -80°C HIB supplemented with 30% glycerol was 
prepared by adding 37g of HIB powder (Oxoid, CM1032) to 300 ml o f glycerol and 
700ml o f distilled water. After mixing by agitation the broth was aliquoted as 
required and autoclaved at 121 ®C for 15 minutes.
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2.2.5 Rambach
Rambach agar was used for the differential isolation o f bacteria owing to its 
chromogenic properties. On this agar Salmonella colonies grow crimson, E. coli 
colonies grow green/black and K. pneumoniae colonies grow dark blue/purple. To 
prepare this medium 1 sachet of powder mix and 1 vial o f liquid nutrient mix (Merck, 
1.07500.0002) were aseptically added to IL of sterile distilled water and mixed by 
heating and swirling, then poured into plates. When antibiotic supplementation was 
required filtered sterilised stock solutions were added to the agar immediately prior to 
pouring.
2.2.6 Davis minimal medium (DM)
To prepare Davis minimal medium 7g of potassium phosphate (dibasic trihydrate), 2g 
of potassium phospohate (monobasic anhydrous), Ig of ammonium sulphate and 0.5g 
of sodium citrate were added to IL of distilled water and autoclaved 121 for 15 
minutes. After autoclaving the salt solution was supplemented by aseptically adding 
125pi of filtered sterilised 10% glucose solution, 500pl of filtered sterilised 10% 
magnesium sulphate solution and 500pl filtered sterilised 0.2% thiamine solution.
2.3 Bacterial identification by API20E
The API20E is a system for the identification of Enterobacteriaceae on the basis o f a 
series of biochemical tests produced by the company bioMérieux (20100). It consists 
of a strip which has 20 cupules filled with freeze dried reagents that test for the 
presence of enzymes, the production of certain metabolites and the ability to use a 
number of substances as carbon sources. The cupules were inoculated with bacteria as 
recommended by the manufacturer and incubated at 37°C for 20-24hrs. The 
Biomerieux website was used to obtain a match for the profiles 
(http://www.biomerieuxdiagnostics.com/servlet/srt/bio/clinicaldiagnostics/dynPage7d 
oc= CNL_PRD_CPL_G_PRD_CLN_11).
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2.4 Bacterial identification by MALDl-TOF Biotyping
Matrix-assisted laser desorption ionisation time of flight (MALDI-TOF) is a type of 
mass spectrometry in which a biological sample covered with an organic matrix is 
vaporised with a laser, followed by the application of a high voltage current to 
accelerate the ionised molecules. The accelerated molecules (proteins, peptides) will 
travel a known distance towards a detector which measures the size dependant travel 
time. As the proteins and peptides of a sample are separated by their mass, a 
‘molecular fingerprint’ for a particular organism can be obtained. For biotyping the 
fingerprint obtained is compared against Bruker’s extensive library of profiles of 
strains in order to provide identification down to the species level, together with a 
score on how reliable the ID is (http://www.bdal.de/navi/meta/home.html). The 
protocol provided by Bruker was used for the extraction from cells, the matrix 
preparation and the spotting the sample on the plate. Bruker’s software FlexControl 
was used to obtain a profile which was then analysed by the software MALDI 
Bio typer to provide an identity.
2.5 Preparation of DNA lysates for PCR reaction
For polymerase chain reactions (PCR), unless otherwise stated, template DNA was 
prepared by suspending a 5pl loop full of bacterial growth, either from plates or 
harvested from broth cultures by centrifugation, and resuspended in 500pl o f nuclease 
free water (Fromega, PI 193) followed by incubation at IOO°C for 5min.
2.6 CTX-M grouping PCR
In order to group the CTX-M enzymes, real time polymerase chain reaction (RT- 
PCR) was performed in a LightCycler 2.0 system using a LightCycler Fast Start DNA 
masterSYBR green I kit (Roche Diagnostics 03003230001) as previously described 
(Horton et a l, 2011). The primers used were CTX-M universal primers (Table 2.1). 
Each reaction contained 18pl of LightCycler Fast Start DNA masterSYBR green I, 
3mM MgCl], to which 2pl of lysate was added as a DNA source to make a final 
volume of 20pl. The PCR conditions consisted of a
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denaturing cycle at 95°C for lOmin followed by 30 amplification cycles at 95°C for 
lOsec, 65°C for 5sec and 72°C for 20sec. A melting cycle was performed and the 
increase in fluorescence in the products over time was measured to obtain a melting 
curve profile. The melting curves of the test samples were compared against those of 
controls for CTX-M groups 1, 2 and 9 and those matching one o f them were assigned 
a group.
2.7 Disk diffusion sensitivity testing
To obtain resistance profiles of the outbreak strains and the transformants the disc 
diffusion method was carried out as described by the British Society for 
Antimicrobial Chemotherapy (BSAC) (http://www.bsac.org.uk/Susceptibility+ 
Testing/ Standardized+Disc+Susceptibility+Testing+Method). Isosensitest agar 
plates air dried in a biosafety cabinet were inoculated as prescribed in the method and 
discs containing a known amount of antibiotic were placed on them. After 18hrs of 
incubation at 37°C the areas of growth inhibition around the disc were measured with 
a hand ruler and interpreted according to cut off values as specified in Table 2.2. The 
values were taken fi*om the BSAC manual, for those antibiotics which were specified. 
In the case of antibiotics for which no values were specified by the BSAC manual the 
values listed here were those used routinely by the AHVLA Department of 
Bacteriology.
2.8 Identibac's AMR-ve 05 DNA microarray
AMR-ve™ array tubes (http://www.identibac.com/identibac_amr.php) were used to 
screen all isolates for the presence of 54 antimicrobial resistance genes commonly 
present in Gram negative bacteria. The procedure followed was that recommended by 
the manufacturer. The strains were grown for 16hrs at 37°C on LB agar supplemented 
with cefotaxime (2pg/ml). A lOpl loop full o f bacteria was suspended in 0.4ml lysis 
buffer (O.IM Tris HCl, 0.005% Tween 20, Proteinase K) and heated for 2hrs at 60°C 
with vortexing every 30min. This was followed by 15min heating at 95°C. This lysate 
(6.55pl) was then used for the concomitant linear amplification and biotin labelling 
using the primers provided by Identibac. The labelled products were then hybridised
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Table 2.2: Sensitivity testing cut off points
Cut off points (0 in mm)
Antimicrobial
Code and 
amount (pg) Resistant Intermediate Susceptible Source
Nalidixic acid (Oxoid) N A 3 0 < 1 7 N /A > 1 8 BSAC J
Tetracy cline(Oxoid) TE 10 < 1 3 N/A > 14 AlIVLA
Neomycin (Oxoid) N 10 < 1 3 N/A > 1 4 AHVLA
Ampicillin (Oxoid) AMP 10 < 1 4 N/A > 15 BSAC
Fur^oiidone (Mast Group) PR 15 < 1 3 N/A > 1 4 AHVLA
Sulphamethoxazole/ Trimethoprim (Oxoid) SXT 25 < 15 N/A > 1 6 BSAC
Chloramphenicol (Oxoid) C 3 0 < 2 0 N/A > 21 BSAC
Amikacin (Oxoid) A K 30 < 1 5 16-18 > 19 BSAC
Gentamicin (Oxoid) CN 10 < 1 6 17-19 > 2 0 BSAC
Streptomycin (Oxoid) S 10 < 1 2 N/A > 13 AHVLA
Compound sulphonamides (Oxoid) S3 300 < 1 3 N/A > 1 4 AHVLA
Cefotaxime (Oxoid) CTX 30 < 2 3 24-29 > 3 0 BSAC
Apramycin (C%qid) APR 15 < 1 3 N/A > 1 4 AHVLA
Ciprofloxacin (Oxoid) CIP 1 < 1 6 17-19 > 2 0 BSAC
Cut off points used for the interpretation of disk diffusion sensitivity testing. 
0 : diameter of the zone of inhibition in mm.
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to the arrays and the signal intensity o f each o f three replicate spots per gene analysed 
with the software IconoClust (Identibac). The cut off points used were, as previously 
validated (Batchelor et a l, 2008), >0.4 signal intensity was considered a positive 
result, between 0.3 and 0.4 was considered ambiguous and <0.3 was considered 
negative. The gene chosen for normalisation was ubiquitous gene ihfA (integration 
host factor). For those probes for which an ambiguous result was obtained validation 
by PCR was carried out as previously described (Batchelor et a l, 2008).
2.9 Pulsed field gel electrophoresis with Xbal
In order to identify the phylogenetic relationships within each species of outbreak 
strains analysis o f the macrorestriction profiles of the genomic DNA of strains was 
performed by Xba\ pulsed field gel electrophoresis (PFGE) as described by the 
PulseNet network (Ribot et a l, 2006). To prepare chromosomal DNA overnight 
bacterial growth ft-om agar plates was resuspended in the cell suspension buffer 
(lOOmM Tris, lOOmM EDTA, pH8) to within 3.9-4.S OD610 on a Densimat 
(Biomerieux). lOpl of 20mg/ml proteinase K was added to 200pl of the cell 
suspension followed by addition of molten 1% SeaKem Gold agarose (1% SeaKem 
Gold agarose (Lonza 50152), lOmM Tris, ImM, EDTA, 1% SDS, pH8). The 
resulting cell-agarose suspension was immediately cast into 3 plug moulds and set at 
4°C for 5min. To lyse the cells the plugs from each strain were placed in 50ml Falcon 
tubes containing 5ml o f lysing buffer (50mM Tris, 50mM EDTA, pH8, 1% Sarcosyl) 
and 25ul of 20mg/ml proteinase K and incubated in shaking water bath at 54°C for 
2hrs. After this step the lysing solution was discarded and the plugs washed twice in 
50°C HPLC water for 15min in a shaking incubator, followed by an additional four 
washes in 50°C TE buffer (lOmMtris, ImM EDTA, pH8). For the digestion of the 
immobilised chromosomal DNA a third of plug was transferred to a labelled 
Eppendorf tube containing 200pl o f the restriction enzyme mixture (173pl nuclease 
free water. Buffer D, 5pi Xbal, 2ul of lOmg/ml BSA) and incubated for 2hrs at 37°C. 
After digestion the DNA fragments were separated by electrophoresis in 1% SeaKem 
Gold Agrose prepared in 0.5X Extended Range TBE (Bio-Rad 161-0741) using 
CHEF-DR® III Pulsed Field, for the E. coli thiourea was included in the 
electrophoresis buffer at a concentration of 50uM to limit DNA degradation.
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Electrophoresis conditions for the E. coli and K. pneumoniae strains were 14°C at 6 
V/cm for 19.5hrs with switch times ranging from 2.2 to 54.2s of linear ramping. 
Electrophoresis conditions for the S. enterica strains were 14°C at 6 V/cm for 19hrs 
with switch times ranging from 2.2 to 63.8s of linear ramping. To perform 
phylogenetic analysis of restriction profiles, TIFF files were analysed with 
BioNumerics software (v.6.6; Applied Maths, Belgium). Strains showing >90% 
similarity were classified as genetically related and assigned into clusters.
2.10 Plasmid profiling
Plasmid profiling was performed in order to determine the number of plasmids 
carried by each strain and their approximate size (Kado and Liu, 1981). To purify 
plasmid DNA 1ml of a 16hr culture was centrifiiged at 13000RPM for 5min and the 
pellet lysed in 3% SDS, 0.6% TRIS, 30mM NaOH solution at 55°C for 35min. After 
incubation 400pl of Phenol:Chloroform:Isoamyl Alcohol (Sigma-Aldrich P2069) was 
added, the tube vortexed then spun at 13000rpm for lOmin. The top aqueous layer 
was carefully removed and stored at -20°C.
To obtain a profile the purified plasmid DNA was mixed with an appropriate amount 
of 6x loading dye (Promega G1881) and run in a 0.8% agarose (Sigma-Aldrich 
A9539) TBE (89mM Tris base, 89mM Boric acid, 2 mM EDTA) gel at 150V for 
5.5hrs with cooled (19°C) recirculating buffer. As reference supercoiled DNA ladder 
(Sigma-Aldrich D5292), reference strain 39R861 (which carries plasmids of 148kb, 
63,4kb, 36kb and 6.9kb) and reference strain 20R764 (plasmid-free) were also run 
alongside the test samples. After 30min staining in Ipg/ml ethidium bromide solution 
and 30min de-staining a picture of the gel was taken under ultraviolet (UV) light.
2.11 HiSpeed Plasmid Midi Kit
Wild type plasmid DNA to be used for transformation or restriction fragment length 
polymorphism was extracted using HiSpeed Plasmid Midi Kit (Qiagen 12643) 
according to manufacturer’s instructions. Plasmid DNA was extracted from 150ml of 
overnight cultures in LB broth supplemented with the appropriate antibiotic and
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eluted in 1ml of nuclease free water (Promega PI 193). For RFLP analysis o f CTX-M 
plasmids the same procedure was carried out up to the step before using the 
QiaPrecipitator. From there an ethanol precipitation was carried out. The reason for 
the modification was to obtain DNA at a higher concentration.
2.12 Ethanol precipitation of DNA
With the purpose of cleaning and/or concentrating DNA it was precipitated by the 
addition 0.1 volumes of sodium acetate (pH4.6) and 2.2 volumes of 100% ethanol. 
The precipitation mixture was incubated at -20°C for 30 min and then centrifuged at 
13000rpm, 4°C, for 30 minutes in a bench top micro frige. The supernatant was 
discarded and the pellet washed with ice cold 70% ethanol, air dried for 15min and 
resuspended in an appropriate volume of water according to the final concentration 
required.
2.13 Transformation by electroporation
To introduce a plasmid into a strain a mixture of lp l  of plasmid DNA extracted using 
HiSpeed Plasmid Midi Kit and 25pl of competent cells were added to the bottom of a 
chilled 1mm electroporating cuvette and electroporated at 2.0 kV, 200D, and 25pF in 
a Bio-Rad Gene Puiser Electroporator. This was followed by Ihr incubation at 37°C 
in 0.6ml o f SOC medium (Invitrogen 15544-034). As a negative control one 
transformation was carried out with Ipl of nuclease free water instead of DNA. Neat 
and dilutions of the recuperated cells were plated on LB agar plates supplemented 
with the appropriate antibiotic to select for transformants. Individual colonies from 
each transformation were re-streaked then cultured in antibiotic containing LB before 
being tested by PCR and plasmid profiling.
2.14 Polymerase Chain Reaction (PCR)
Polymerase chain reaction (PCR) is a molecular biology technique used for the 
detection and amplification of a specific DNA sequence. Synthetic oligonucleotides 
complementary to the ends of the region to be amplified are included in the reaction.
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which are elongated by the polymerase enzyme also present. All amplifications were 
carried out using PCR System 9600 cycler machine (Applied Biosystems, 
Warrington, UK).
HotStarTaq Master Mix (Qiagen, 203445) was used for all PCR reactions according 
to the manufacturer’s recommendations. Briefly, an initial dénaturation step to 
activate the polymerase was carried out (15min at 95°C), followed by 25 cycles of 
94°C for 30s to denature dsDNA, annealing temperature as described for each primer 
pair for 30s, an extension step at 72°C for Imin/kb plus a final extension step at 72°C 
for 10 min.
As a source of DNA template lul o f lysate, broth culture or a colony suspended in 
H2O was used.
2.15 Agarose gel electrophoresis
In DNA gel electrophoresis, DNA samples are loaded into an agarose gel made in a 
buffering solution and a voltage applied. As DNA is negatively charged it will 
migrate towards the positive electrode in a size dependant manner. This enables 
separation of DNA fragment according to size to enable identification and, if 
necessary, downstream purification.
Generally PCR products or digested plasmids were run in 1-1.5% (w/v) agarose gels 
made in IxTBE buffer (tris 89mM, boric acid 89mM, 2mM EDTA). A molecular 
marker was run alongside samples to determine band sizes. Unless otherwise 
specified the marker used was Ikb DNA ladder (Promega). The gel was placed in a 
SubCell GT tank (BioRad) and submerged in IxTBE buffer. An appropriate amount 
of 6x loading dye (Promega G 1881) was added to samples and ladder before loading 
into the wells. Electrophoresis was carried out at lOOV for Ihr then the gels were 
stained in an ethidium bromide solution (Ipg/ml) for 30 min then an image of the gel 
under UV light captured using GeneSnap. In those cases where DNA was to be 
extracted from the gel for downstream processes, the agarose gels were made and run
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with IXTAE (40mM Tris, 20mM acetic acid, and ImM EDTA) buffer, to avoid the 
inhibitor effects of TBE.
2.16 Proofreading PCR
For applications were fidelity was required, such as the case o f sequencing of 
amplified products or cloning of amplified products, a proof reading polymerase was 
used. Phusion® High-Fidelity PCR Master Mix (New England Bio labs Ltd, M0531S) 
was used according to manufacturer’s instructions. Briefly, an initial dénaturation 
step was carried out (30sec at 98°C), followed by 25 cycles of 98°C for 10s to 
denature dsDNA, annealing temperature as described for each primer pair for 20s, an 
extension step at 72°C for 30sec per kb plus a final extension step at 72°C for 10 min.
2.17 Sequencing of amplified products
Following amplification by the proofreading PCR protocol the amplified products 
were checked by gel electrophoresis for the presence of a single band of the 
appropriate size. The remaining amplicon and a sample of the primers at a 
concentration IpM were sent to the AHVLA Central Sequencing Unit for clean-up 
and Sanger sequencing. In the case of sequencing of an insert following ligation into 
a vector, the plasmid was extracted using a QIAprep Spin Miniprep Kit and sent with 
the appropriate primers at a concentration of 0.8pM for sequencing as above.
2.18 PCR-based Replicon Typing (PBRT)
The plasmid typing scheme previously described (Carattoli et a l, 2005) was used to 
determine the replicon type of the transferred plasmids. This system consists of 5 
multiplex and 3 simplex reactions which identify the 18 most common replicon types 
within the Enterobacteriaceae. The products of each PCR were loaded on 1.5% 
agarose TBE gels and run at lOOV. For the multiplex PCR’s a separate reaction was 
carried out for each of the controls, then the amplicons were combined and loaded 
into a single lane in the gel for ease of visualization.
39
2.19 Assays of conjugation by liquid mating
Conjugation studies were performed to assess whether a plasmid is able to mediate its 
own transfer. For conjugation studies a donor bacterium (harbours the plasmid to be 
tested for conjugative transfer) and a recipient bacterium (a strain resistant to an 
antibiotic to which the donor is sensitive) are co-incubated in a liquid medium. The 
conjugation mixture is then plated on double selective agar containing the antibiotic 
that the recipient bacterium is sensitive to, as well as the antibiotic to which the 
plasmid o f interest confers resistance to, thus selecting for recipient bacteria which 
have acquired the plasmid of interest. The donor strains used were selected from 
among the outbreak strains. As well as the wild type strains, NEB 10-beta transformed 
with plasmid obtained from the corresponding wild type strains were also used as 
donors to demonstrate that the plasmid itself and not some other determinant present 
in the wild type strain was sufficient for mediating conjugative transfer. Two strains 
were chosen as recipient depending on the species o f the donor. S. typhimurium 26R 
rif+ was chosen as the recipient for E. coli and K. pneumoniae donors. E. coli 20R764 
rift- was chosen as the recipient for the S. enterica donors. Rambach, a chromogenic 
agar that distinguishes between the species of donor and recipient, was used to aid in 
the differentiation of real tranconjugants from spontaneous mutants of the donor 
strains. Briefly, 0.1ml of donor overnight culture and 0.3 ml o f recipient overnight 
culture (both grown in the absence of antibiotics) were added to 3ml of LB broth and 
incubated statically at 37”C for 1 or 5hrs. Serial dilutions of the conjugation mixture 
were made into PBS and dilutions -1 and -2 plated on Rambach agar (lOOug/ml Rif, 
2ug/ml CTX) then the plates were incubated overnight at 37®C. Single colonies of the 
appropriate colour from the double selective plate were screened for carriage of 
plasmid by plasmid profiling and plasmid gene carriage by PCR.
2.20 Restriction Fragment Length Polymorphism (RFLP) of 
plasmids
To identify phylogenetical relationships amongst the outbreak CTX-M plasmids 
isolated from these studies comparison of their Restriction Fragment Length 
Polymorphism was carried out. For this technique 3pg of plasmid DNA extracted
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using HiSpeed Plasmid Midi Kit were digested for 4hrs at 37°C in either EcoRl 
restriction mixture (nuclease free water to make up volume to 30pl, 3p Buffer H, Ipl 
EcoRl, 0.3pl of lOmg/ml BSA) or Bglll restriction mixture (nuclease free water to 
make up volume to 30pk 3pi Buffer D, Ipl Bglil, 0.3pl of lOmg/ml BSA). The 
digested DNA was separated in 0.8% agarose IXTBE gel at 16V for 20hrs and 
stained in ethidium bromide as already described.
2.21 Large Construct Kit
Wild type plasmid DNA to be sent for 454-pyrosequencing was extracted using the 
Large Construct Kit (QIAGen 12462) according to manufacturer’s instructions. This 
kit was chosen over the HiSpeed Midi Kit as it is indicated for the recovery of low 
copy number large DNA molecules (up to 250kb), produces high yield of DNA and 
minimises contamination by chromosomal DNA. Plasmid DNA was extracted from 
500ml of overnight cultures in LB broth supplemented with the appropriate antibiotic 
and eluted in 1ml o f nuclease free water. Extraction of pIFM3804 was carried out by 
M. Stokes (AHVLA) and M. AbuOun (AHVLA).
2.22 Plasmid sequencing and annotation
Plasmid DNA sequencing and assembly was performed by the AHVLA Central 
Sequencing Unit using a Roche 454 GS FLX and assembled using the Newbler 2.3 
software. Six to eight contigs were obtained for each plasmid. Primers were designed 
that synthesized outwards from the contigs obtained for plasmid pIFM3804 and a 
combinatorial PCR approach carried out. Once the primer pairs that produced 
amplicons had been identified, the PCRs were repeated using the Proofreading PCR 
method and sent to the AHVLA central sequencing unit for Sanger sequencing. The 
contigs obtained by 454 sequencing and the gaps sequenced by Sanger sequencing 
were assembled using contig assembly software SeqMan Pro (DNASTAR, 
Lasergene). For plasmids pIFM3791 and pIFM3844, the contigs obtained from 454 
sequencing were aligned using pIFM3804 as a reference and the gaps remaining 
closed by proofreading PCR and Sanger sequencing.
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Online automated annotation pipeline RAST (Aziz et a l, 2008) was used for 
preliminary annotation o f pIFM3804. The genebank formatted file thus obtained was 
loaded on annotation software SeqBuilder (DNASTAR, Lasergene,) and the 
aminoacid sequence of the genes identified by RAST manually blasted against the 
NCBI database (BLAST?) and renamed with more meaningful labels when 
appropriate. Additionally, in order to identify genes potentially missing from the 
RAST annotation, genes present in CoUb-p9 where searched within the sequenced of 
pIFM3804 using NCBI Blast2Seq and, if present, annotated accordingly. As a graphic 
representation of the annotated sequence a map was built using SeqBuilder displaying 
genes and resistance islands colour coded according to function.
2.23 Comparative analyses of plasmid sequences
To compare the sequence of pIFM3804 to other plasmids from the NCBI database 
two approaches were followed. The first involved the comparison of concatenates of 
the pMLST genes as previously described (Aanensen and Spratt, 2005). For this 
purpose a concatenate of the pMLST genes o f each of the plamids to be compared 
was generated and the sequences aligned using the ClustalW facility within 
MegAlign (DNASTAR, Lasergene) and a phylogenetic tree generated based on 
number of nucleotide substitutions also generated with MegAlign. The second 
approach compared the whole DNA sequence of the plasmid and it involved building 
a distance tree of the plasmids using Tree View Widget of BLAST (NCBI) using the 
tree method Fast Minimum Evolution.
2.24 Transformation by heat shock
5ul of plasmid DNA (up to 50ng) of ligation mixture or plasmid Miniprep were added 
to lOOul of chemically competent NEB 5-alpha E. coli (New England BioLabs Ltd 
C2987I). The cells were incubated on ice for 30 min, heat shocked at 42°C for 45 sec, 
then placed back on ice for a further 2 min. The shocked cells were then recuperated 
by adding 0.9ml of SOC medium and incubated at 37°C, 250rpm for Ihr thereby 
allowing expression of antibiotic resistance before plating on selective medium. 
Finally lOOul of the recuperated cells and lOOul of a 1:10 dilution of the recuperated
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cells were plated on LB agar plates containing the appropriate antibiotic and 
incubated overnight at 37®C. Colonies present on the selective plates were then 
screened for the presence of the appropriate plasmid by PCR and plasmid restriction 
analysis.
2.25 MinElute PCR Purification Kit
In order to remove inhibitors of downstream reactions DNA products were cleaned up 
using MinElute PCR purification Kit according to manufacturer’s instructions.
2.26 Ligation of blunt PCR products to pre-cut vector pCR-Blunt
Following proofreading PCR with the appropriate primers and confirmation of 
specific amplification by gel electrophoresis Ipl of pCR-Blunt vector and Ipl of the 
amplified product were added to Ipl lOX ligation buffer, Ipl of T4 ligase and 6 pl of 
nuclease free water. The ligation mixture was incubated at 16°C for Ihr and later used 
for transformation as appropriate.
2.27 QIAprep Spin Miniprep Kit
Vector DNA for restriction analysis, transformation and sequencing was extracted 
using QIAprep Spin Miniprep Kit (Qiagen 27104) according to manufacturer’s 
instructions. Plasmid DNA was extracted from 5ml overnight cultures in LB broth 
supplemented with the appropriate antibiotic and eluted in 50pl of nuclease free water 
(Promega) and stored at -20°C.
2.28 Restriction of cloning vectors
Restriction of cloning vectors with commercial endonucleases was carried out for 
opening of the accepting vector, preparation of the incoming insert or for 
confirmation of insertion after recovery. For digest the restriction mixture (See Tables 
2.3 to 2.8) was incubated at 37°C for 2hrs. All the restriction enzymes used were
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Table 2.3: Restriction digest mixture for Xbal-BamHl double digest
Xba\-BamH\ digest Per reaction 
DNA lug
Xba\ 0.5|xl
BamHl 0.5^1
Multiple Cloning Buffer 2pl
BSÀ Ô.2pl
Nuclease free water Make up to 20pl
Table 2.4: Restriction digest mixture forBglll-Xbal double digest
BgHl-Xbal digest Per reaction
DNA lug
Bglll . 0.5pl ^
Xbal 0.5pl
Buffer D . . ,
BSA 0.2pl
Nuclease free water Make up to 20pl
Table 2.5: Restriction digest mixture for Xbal single digest
X bal digest_________ Per reaction
DNA............ ......... Ipg
Xbal O.Spl
Buffer b  2pl
BSA 0.2pl
Nuclease free water Make up to 20pl
Table 2.6: Restriction digest mixture for EcoRl single digest
EcoRl digest________Per reaction
DNA Ipg
EcoRl 0.5pl
Buffer H 2pl
BSA 0.2pl
Nuclease free water Make up to 20pl
Table 2.7: Restriction digest mixture forXhol single digest
Xhol digest_________Per reaction
DNA Ipg
Xhol 0.5|xi
Buffer D 2pl
BSA 0.2pl
Nuclease free water Make up to 20|xl
Table 2.8: Restriction digest mixture forXbal-Xhol single digest
Xbal-Xhol digest Per reaction
DNA Ipg
Xbal 0.5pl
■Xhol 0.5pl
Buffer D 2nl
BSA 0.2pl
Nuclease free water Make up to 20pl
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purchased from Promega and their catalogue numbers were Xbal (R6181), BamHl 
(R6021), Bglll (R6081), Xhol (R6161) and EcoRl (R6011).
2.29 Qiaquick Gel Extraction Kit
Purification o f DNA fragments separated by gel electrophoresis such as PCR 
products or digested plasmids was carried out using QIAquick Gel Extraction Kit 
(QIAgen 28704). The procedure involved separating DNA by gel electrophoresis as 
already described and cutting the band containing the DNA fragment of interest out 
of the gel using a scalpel whilst exposing the gel to UV light. The DNA was then 
purified according to manufacturer’s instructions.
2.30 Ligation of insert and vector with sticky ends
Following restriction digest and gel band purification of inserts and vectors they were 
added on a stoichiometric ratio of 1:6 to Ipl lOX ligation buffer, Ipl of T4 ligase and 
made up to lOpl with nuclease free water. The ligation mixture was incubated at 16°C 
for Ihr and later used for transformation as appropriate.
2.31 Dephosphorylation hy Thermo Sensitive Alkaline 
Phosphatase
To prevent self-ligation of vectors digested with a single restriction enzyme, removal 
of 5’ phosphate groups of linearized plasmids was carried out with Thermo Sensitive 
Alkaline phosphatase (TSAP) (Promega). Following restriction digest Ipl o f TSAP 
was added to the digestion mixture and incubated at 37°C for 15 minutes. The DNA 
was cleaned up using MinElute PCR Purification Kit before proceeding to ligation in 
order to remove the enzymes and other potential inhibitors.
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2.32 Determination of minimum inhibitory concentration (MIC)
To determine the minimum inhibitory concentration (MIC) of amikacin the broth 
mierodilution method was followed. Briefly, each row of a 96 well plate was set up to 
contain lOOpl of LB supplemented with Amikacin at concentrations of 256, 128, 64, 
32, 16, 8 , 4, 2,1, 0.5, 0.25 and 0.12pg/ml (double the concentration to be tested). To 
prepare the bacterial inoeulates overnight eultures o f the test and control bacteria 
(NCTC 10418) were added to LB to a density of approximately 2x10^ CFU/ml and 
for each strain lOOpl of the inoculate added to each of the wells along a row. The 
plates were inoculated overnight at 37°C and then checked for visible bacterial 
growth. The experiment was repeated three times and the MIC was defined as the 
modal value of the lowest concentration of amikacin that inhibited visible growth.
2.33 Preparation of electrocompetent cells
To make wildtype bacteria electrocompetent a 1.5ml of an overnight culture was used 
to inoculate 150ml of pre-warmed LB and grown at 37°C and 250RPM to an OD600 
of between 0.4 and 0.6. The bacteria were chilled for lOmin in ice/water bath and 
harvested by centrifugation at 2500g for 20 min at 4°C in a Sorvall centrifuge. The 
pellet was resuspended into 75ml of 4°C 10% glycerol and harvested by 
centrifugation as above. The pellet was then resuspended in 37.5ml o f 4®C 10% 
glycerol and transferred to a 50 ml falcon tube and the bacteria harvested by 
centrifugation at 2500g for 20 min at 4°C in a bench top centrifuge. The pellet was 
resuspended in 3ml o f 4°C 10% glycerol and transferred to a 15ml falcon tube and 
harvested as above. The final pellet was resuspended in 300pl of 4°C 10% glycerol 
and 50pl used immediately for electroporation whilst the remainder was aliquoted in 
pre-chilled eppendorf tubes and stored at -80°C for later use.
2.34 Introduction of plasmids hy filter mating
In order to introduce plasmids pIFM3791, pIFM3804 and pIFM3844 into strains 
CL32 and S348/11 filter matings using strains T9 la, T04a and T44a as donors and 
each of the above strains as recipients were set up. For this experiment the pellet of
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1ml o f overnight culture of each strain was resuspended in 1ml sterile PBS and SOpl 
of the donor and 150pl of the recipient strain mixed in an eppendorf tube. A 
polycarbonate 0.2pm filter was placed on the centre of a dried LB agar plate and 
overlaid with the donor/recipient mix and the plate incubated at 37°C for 24hrs. After 
incubation, the filter was removed fi-om the plate and transferred to a 50ml falcon for 
washing with 10ml of sterile PBS. The bacteria were harvested by centrifugation and 
the new pellet resuspended in 2ml PBS. In order to select for transformants lOOpl of 
the bacteria resuspended in PBS as well as lOOpl of a 1/10 dilution of the 
resuspended bacteria were plated on Rambach agar plates supplemented with 
lOpg/ml of tetracycline and 2pg/ml of cefotaxime. Colonies of the appropriate colour 
(red for the S. enterica strains, purple for the K. pneumoniae strains) were re-streaked 
and checked for the presence of the incoming plasmid by CTX-M universal PCR and 
plasmid profiling.
2.35 Competitive growth studies
To explore the competitive fitness burden imposed by plasmid carriage competition 
experiments were carried out as previously described (Lenski et ah, 1994). To 
prepare the strains for the competition experiments they were streaked on LB agar 
plates (supplemented with 2 pg/ml o f cefotaxime for the plasmid bearing strains) and 
ineubated at 37°C overnight. A single colony was used to inoculate 3ml of LB 
(supplemented with 2 pg/ml of cefotaxime for the plasmid bearing strains) and 
incubated overnight at 37°C, 200rpm. The overnight broth cultures were then 
separately used to inoculate 5ml of Davis Minimal with a dilution factor of 10"^  and 
incubated at 37®C, 200rpm for 24hrs. To start the competitions lOOpl of eaeh o f the 
separately grown DM cultures to be competed against each other were mixed in an 
eppendorf tube and 50pl of the mixture used to inoculate 5ml of DM. A sample o f the 
competition mixture at time 0 was serially diluted and plated on LB agar and LB agar 
supplemented with 2 pg/ml o f cefotaxime to obtain counts of total bacteria (plasmid 
free + plasmid bearing) and of resistant bacteria (plasmid bearing bacteria) 
respectively. The competition culture was then incubated at 37°C 200rpm for 24 
hours and sampling was repeated as above. 50pl of the 24hrs cultured competition 
mixture was transferred to 5ml of DM. This procedure was continued for 6  days. To
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calculate the selection rate the natural log of the ratio of plasmid bearing : plasmid 
free for each day was plotted for each competition. The selection rate was taken as the 
slope of the equation defining the line o f best fit as caleulated in Exeel. Thus, a 
negative slope indicated that plasmid bearing bacteria were being outcompeted by 
plasmid free bacteria, whilst a positive slope indicated that plasmid bearing baeteria 
were outeompeting the plasmid free bacteria. Each competition was repeated four 
times therefore providing four values for the selection rate for statistical analysis. 
Two tailed t-tests were carried out to determine whether the mean selection rate for 
each pair of strains competed was significantly different from 0 .
To assess the amount of conjugation occurring between the plasmid bearing and 
plasmid free bacteria in the conditions of the competition experiment 1 day 
competitions were set up as above with the modifieation of using a rif+ mutant as the 
plasmid free competitor. To generate the rif+ mutants of CL32 and S348/11 
approximately 10  ^ bacteria were plated in triplieate on LB agar supplemented with 
lOOpg/ml of rifampicin and incubated for 16hrs at 37°C. The resulting colonies were 
re-streaked on LB agar supplemented with lOOpg/ml of rifampicin to confirm 
resistance. After one day o f competition a sample was diluted and plated on LB agar 
(total counts) and LB agar supplemented with 2pg/ml of cefotaxime and lOOpg/ml of 
rifampicin (counts oftransconjugants).
2.36 Bacterial growth kinetics in LB
Analysis of growth kinetics in LB of strains B3791 and S348/lltheir derivatives was 
carried out using a FLUOstar. To prepare the bacterial inocula overnight cultures 
were diluted in sterile LB to an approximate cell density of 2x10^. 200pl o f sterile LB 
was added to three wells of a clear 96-well plate for blank subtraction and 200pl of 
each inocula also added in triplicate. OD600 was automatieally determined and 
recorded at 15min intervals over 24h at 37°C (with 5 seconds shaking before each 
reading) for later analysis and the experiment repeated three times. In order to 
compare the strains three features of the kinetic curves were determined: area under 
curve (AUC), growth rate (GRate) and maximum growth (MaxG). The AUG was 
determined by approximately solving the integral of the kinetie curve following the
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trapezoidal rule in Excel. To mathematically determine the GRate the equation o f the 
line o f best fit between OD600=0.1 and OD600=0.2 was calculated with Excel. The 
equation of the line o f best fit was solved with values y0 =0 .1  and yf=0 .2  and the 
growth rate caleulated as follows: (xf-xO)/(yf-yO). For the MaxG, the highest value 
achieved by the strain was used for analysis.
2.37 Culture enumeration of association/invasion of Salmonella 
4,5,12,1:- S348/11 and its derivatives to 1PEC-J2 and HT29-16E 
monolayers
In order to assess the effect of plasmid carriage on the virulence Salmonella 4,5,12,1:- 
association/invasion assays o f monolayers of two mammalian cell lines were carried 
out. The porcine intestinal epithelial cell line IPEC-J2 was grown in Ham’s 
F12/DMEM supplemented with 5% foetal bovine serum (FBS, Sigma-Aldrich 
F9665), 2mM glutamine (Invitrogen 25039924), 5mg/L insulin, 5mg/L transferrin, 
5pg/L selenium (as ITS, Sigma-Aldrich 11884), ImM sodium pyruvate (Invitrogen 
11360039), lOmg/L gentamicin (Sigma-Aldrich G 1272) and 0.5mg/L amphotericin B 
(Sigma-Aldrich A2942) and maintained in an atmosphere of 5% CO2 at 37°C with 
100% humidity. For the assays 2 day old cells approximately 100% confluent grown 
in 24 well plates were used. The human colonic cell line HT29-16E was grown in 
DMEM (Sigma-Aldrich D5546) supplemented with 10% FBS, lOmg/L gentamicin 
and 0.5mg/L amphotericin B and maintained in an atmosphere of 5% CO2 at 37°C 
with 100% humidity. For the assays 5 day old cells approximately 100% confluent 
grown in 24 well plates were used. On the day of the assay the culture medium was 
removed from the wells and the cells washed twice with Hansk’s balanced salts 
solution (HBSS, Sigma-Aldrich H9269) to remove residual antibiotics. The bacterial 
inocula were resuspended in Ham’s F12/DMEM (when infecting IPEC-J2 
monolayers) or DMEM (when infecting HT29-16E) and delivered in volumes of 1ml 
at a density of 3.5x10^ CFU/ml per well. Each strain was added to three wells into 
each of two plates. The plates were then incubated for 2hr in an atmosphere o f 5% 
CO2 at 37°C with 100% humidity. After incubation the baeterial inocula were
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removed and the wells washed three times with HBSS. One plate was used for the 
enumeration o f associated bacteria. After washing, the cells were disrupted by 
addition of 1% triton-X 100 (in PBS) and mechanieal stirring followed by serial 
dilution and plating on LB agar (ineubated overnight, 37®C). The seeond plate was 
used for enumeration of intracellular bacteria (invasion). After washing, the 
monolayers were overlayed with Ham’s F12/DMBM supplemented with 150mg/L 
colistin (Sigma-Aldrich C4461) or DMEM supplemented with 150mg/L colistin, 
according to the cell line as above, and incubated for 90min in an atmosphere of 5% 
CO] at 37°C with 100% humidity. The antibiotic containing medium was removed 
and the wells washed three times with HBSS. After washing, the cells were disrupted 
by addition of PBS supplemented with 1% triton 100-X and meehanical stirring 
followed by serial dilution and plating on LB agar (incubated overnight, 37°C).
2.38 Laser scanning confocal microscopy studies of infection by 
Salmonella 4,5,12,i:- S348/11 and its derivatives to IPEC-J2 
monolayers
In order to verify intracellular presence of bacteria (strain S348/11 and its derivatives) 
within the IPEC-J2 cells, the infected cells were imaged by laser scanning confocal 
microscopy as follows. The porcine intestinal epithelial cell line IPEC-J2 was grown 
in RPMI (Sigma-Aldrich R8758), supplemented with 5% foetal bovine serum (FBS), 
2mM glutamine (Invitrogen 25039924), 5mg/L insulin, 5mg/L transferrin, 5pg/L 
selenium (as ITS, Sigma-Aldrich 11884), ImM sodium pyruvate (Invitrogen 
11360039), lOmg/L gentamicin (Sigma-Aldrich G 1272) and 0.5mg/L amphotericin B 
(Sigma-Aldrich A2942) and maintained in an atmosphere of 5% CO] at 37°C with 
96% humidity. For the infeetion assays 2 day old cells approximately 100% confluent 
grown on coverslips within 24 well plates were used. On the day o f the assay the 
culture medium was removed from the wells and the cells washed twice with 1ml of 
RPMI to remove residual antibiotics. For each strain 1x10^ bacteria resuspended in 
1ml of RPMI were added to a well and the plate incubated in an atmosphere of 5% 
C02 at 37°C with 96% humidity for Ihr. After incubation the inocula were removed 
and the wells washed two times with 1ml of PBS. To fix the preparations, 1ml of
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100% methanol was added to each well and the plate was incubated at -20°C for 
20min. 1ml of blocking solution (PBS supplemented with 5% FBS) was added to 
each well and the plate incubated for 30min at 37°C. Following blocking, the wells 
were washed with 1ml o f PBS and incubated in the presenee of monoclonal antibody 
mouse anti-Sodium Potassium ATPase (Abeam AB7671) with a final concentration 
of lOpg/ml for 30min at 3>TC. The wells were washed three times with PBS for 5min 
and incubated in the presence of polyclonal antibody Alexa Fluor 594 goat anti- 
Mouse IgG (Invitrogen A-11005) at 20pg/ml, lOpl o f FITC labeled anti-Salmonella 
somatic antigen 0:4,5 rabbit serum (Bio-Rad 59021) and DAPI (Molecular Probes 
D1306) at 5pg/ml for 30min at 37°C. Following three washes with 1ml PBS the 
coverslips were removed from the wells and mounted on microscope slides using 
Prolong Gold Antifade mounting reagent (Molecular probes catalogue no P 36935) 
for visualization and analysis on confocal microscope (Leica SPS AOBS spectral). 
For this experiment the infection and labelling of the slides was carried out by Dr I. 
Moreno (Instituto de Salud Carlos III, Madrid).
2.39 Culture enumeration of association of K. pneumoniae
B3791 and its derivatives to IPEC-J2 monolayers
In order to assess the effect of plasmid carriage on the virulence K. pneumoniae strain 
B3791 association assays of monolayers of mammalian cells were earried out. The 
porcine intestinal epithelial cell line IPEC-J2 was grown in Ham’s F12/DMEM 
supplemented with 5% foetal bovine serum (FBS, Sigma-Aldrich F9665), 2mM 
glutamine (Invitrogen 25039924), 5mg/L insulin, 5mg/L transferring, 5pg/L selenium 
(as ITS, Sigma-Aldrich 11884), ImM sodium pyruvate (Invitrogen 11360039), 
lOmg/L gentamicin (Sigma-Aldrich G1272) and 0.5mg/L amphotericin B (Sigma- 
Aldrich A2942) and maintained in an atmosphere of 5% C02 at 37®C with 100% 
humidity. For the assays 2 day old cells approximately 100% confluent grown in 24 
well plates were used. On the day of the assay the culture medium was removed from 
the wells and the cells washed twice with Hansk’s balanced salts solution (HBSS, 
Sigma-Aldrich H9269) to remove residual antibioties. The bacterial inocula were 
resuspended in Ham’s F12/DMEM supplemented with 2% mannose and delivered in
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volumes of 1ml at density o f 10  ^CFU/ml per well in triplieate. The plates were then 
incubated for Ihr in an atmosphere of 5% CO] at 37°C with 100% humidity. After 
incubation the bacterial inocula were removed and the wells washed three times with 
HBSS. After washing, the cells were disrupted by addition of 1% Triton-X 100 (in 
PBS) with mechanical stirring followed by serial dilution and plating on LB agar 
(incubated overnight, 37°C).
2.40 Crystal violet assays of biofilm formation
To quantify the effect of plasmid carriage on the formation of biofilm crystal violet 
assays of biofilm formation were performed at 25 and 37°C. For S. enterica strain 
S348/11 and its derivatives 3ml of LB-NoSalt were inoculated with each strain and 
incubated overnight at 25°C or 37°C statically. For K. pneumoniae strain B3791 and 
its derivatives 3ml of LB were inoculated with each strain and incubated overnight at 
25°C or 37°C statically. The overnight cultures were diluted to 00570=0.2 with 
sterile LB (with or without salt as appropriate). 96 well plates were prepared by 
adding lOOpl of sterile LB (with or without salt as appropriate) and three wells 
inoculated per strain by adding 30pl of the diluted cultures. To use as blanks 30pl of 
LB (with or without salt as appropriate) were added to three wells instead of culture. 
The inoculated plates were incubated statically at 25°C or 37°C for 24hrs. After 
incubation the culture was discarded and the wells washed 3 times with 130pl o f PBS 
and let to air dry. To stain the biofilm 130pl of 1% crystal violet was added to the 
wells and the plate incubated at room temperature for 30min. The crystal violet 
solution was then discarded and the wells washed 4 times with distilled water. To 
solubilise the bound crystal violet 130pl of ethanol/acetone (70/30 v/v) was added to 
the wells and after lOmin the OD570 determined using a micro-plate 
spectrophotometer. The experiments were carried out three times for eaeh strain and 
temperature.
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2.41 Studies of bacterial metabolism by Biolog Phenotype 
Microarray
Briefly, baeterial strains were cultured for 16hrs at 37°C on LB agar plates 
supplemented with antibiotics as appropriate. The eells were pieked from the agar 
plates with a sterile cotton swab and resuspended in 10 ml of M9-base (ImM KCl, 
0.25mM Na]S0 4 , 2mM NaH2P04, lOOmM Na]CL, MgCL] 0.05mM, O.lmM CaCh) 
and the cell density was adjusted to 85% transmittance (T) on a Biolog turbidimeter. 
The cell suspensions were then diluted 1:100 in M9-base supplemented with a 
nitrogen source (5mM NH4CI) for PMl and PM2, and in M9-based supplemented 
with a carbon source (20 mM disodium suceinate and 0.2 mM ferric citrate) for PM3. 
Bio log Redox Dye Mix A, which contains a redox dye used to measure cell 
respiration, was also added as recommended by the manufacturer. 2 0 0 pl of these cell 
suspensions were added to each well in PM plates, which were incubated statically at 
37°C in an OmniLog instrument. Substrate utilization was measured via the reduction 
of the tétrazolium dye forming a purple formazan at 15-min intervals for 24hrs. Each 
experiment was performed three times per strain. Data analysis was carried out by Dr 
E. Laing (Surrey University) in R and it involved calculation of the area under the 
curve (AUC), lag phase, maximum growth (MaxV) and maximum growth rate (Rate) 
followed by statistical analysis using 1-way ANOVA and Tukey HSD.
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Chapter 3 : Characterisation of CTX-M resistant strains 
isolated from an outbreak at a pig farm
3.1 Introduction and study background
3.1.1 Introduction and alms
CTX-M is an Extended Spectrum ^-Lactamase (ESBL) that belongs to the larger 
group of ESBLs, so named because this group of enzymes confers resistance to most 
penicillins and monobactams as well as the clinically important cephalosporins 
(Gniadkowski, 2001). Although only a rarity for over a decade after their diseovery in 
the late 1980s (Bonnet, 2004), CTX-M ESBLs have now become the most prevalent 
type of ESBL enzyme isolated (Lewis et a l, 2007, Bonnet, 2004, Livermore et ah, 
2007).
CTX-M carrying organisms were originally isolated fi-om clinieal settings, (Coque et 
a l, 2002, Boyd et a l, 2004, Batchelor et a l, 2005) however, detection of CTX-M 
bearing community isolates soon became increasingly common (Pitout et a l, 2005, 
Livermore et a l, 2007). Now, the CTX-M problem also features in veterinary isolates 
(Aarestrup et a l, 2006, Hopkins et a l, 2006), particularly worrying in the case o f 
food production animals. Furthermore, the use of antimicrobial agents in food 
animals selects for antimicrobial resistant bacteria, creating reservoirs, and also 
increasing the risk of zoonotic transmission (Piddock, 1996).
The aim of this study was to characterise CTX-M producing Enterobacteriaceae 
strains isolated fi-om a commercial pig farm by characterising the genetic 
determinants conferring the ESBL phenotype, with special attention to plasmidic or 
chromosomal carriage of the ESBL encoding determinants. The study was designed 
to test the hypothesis that the resistanee present in this farm was caused by clonal 
expansion of a progenitor resistant bacterium and also to investigate the prevalence 
and potential association of CTX-M genes with other resistance determinants.
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3.1.2 Antibiotic treatment in the outbreak farm
A number of different antibiotics were used to treat the affected piglets prior to and 
consequently to an outbreak of diarrhoeal disease. Prior to the diarrhoeal problem, the 
piglets had been treated with florfenieol, a chloramphenieol derivative, for 1 0  days 
starting at arrival to the nursery unit to treat a respiratory condition. Following the 
treatment course of florfenieol, the piglets were subsequently treated with tilmicosin, 
a macrolide, for 10 days. Three to four weeks after arrival at the nursery on 
presentation of diarrhoea, a one week course of amoxicillin, a P-lactam, was 
administered to control the diarrhoeal disease which subsequently cleared up. As the 
respiratory problem had not resolved, four weeks after the amoxieillin course, the 
piglets were treated for two weeks with suIfadiazine-trimethoprim, folate pathway 
inhibitors, then for a week with chlortetracycline hydrochloride.
Additionally, eight months before this incident, there was an outbreak of greasy pig 
disease in one of the breeding units that provides this nursery with weaned piglets. 
Ceftioftir, a veterinary approved third generation cephalosporin, was used for the 
treatment of those affected piglets. Nevertheless, none of the piglets treated with 
ceftioftir were sent to this nursery.
3.1.3 Study strains background
An AHVLA study of the outbreak farm was prompted following diarrhoeal disease in 
piglets. Pig dysentery was suspected, but the causative organism, Brachyspira 
hyodysenteriae, was not isolated from the carcases of three deceased piglets. 
However, ESBL Salmonella of serotypes 4,5,12,i:- and Bovismorbificans were 
present. The isolation of ESBL Salmonella at post-mortem examination prompted a 
further sampling visit from which the strains used for this study were obtained. 
During the farm investigation carried out by the AHVLA, faecal samples were taken 
from the pigs as well as lambs and cattle also reared on site. Environmental sampling 
was also carried out, with samples obtained from slurry, wild bird droppings and rat 
droppings. The strain collection representing this outbreak consisted of colonies of a
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mixture of colours isolated on Chromagar CTX, a selective chromogenic agar which 
selects for ESBL Enterobacteriaceae.
3.2 Results
3.2.1 Species identification
In order to obtain aecurate identification of the strains taken from the outbreak both 
API20-E and MALDI-TOF biotyping were carried out (see Sections 2.3 and 2.4). The 
strains were found, by both methods, to be Escherichia coli (n=40). Salmonella 
enterica (n=19) and Klebsiella pneumoniae (n=6 ).
3.2.2 Presence of CTX-M in the outbreak strains
To simultaneously confirm the presence and establish the group of the ESBL present 
in isolates isolated on Chromagar CTX, the CTX-M grouping PCR was carried out 
(see Section 2.5). It was found that 63 of the strains harboured a Group 1 CTX-M 
gene and two of the strains (both E. coli) harboured a Group 9 gene (data not shown).
3.2.3 Antimicrobial resistance among isolates
The antimicrobial resistance profile of the outbreak isolates was obtained by disk 
diffiision sensitivity testing (see Seetion 2.7). A panel of 14 antibiotics including 
compounds belonging to eight antimicrobial resistance families was used. All o f the 
strains were found to be resistant to ampicillin and cefotaxime as would be expected 
by the use of Chromagar CTX for initial isolation. None were resistant to either 
furazolidone or amikacin and one strain was classed as demonstrating intermediate 
resistance to ciprofloxaein; however, for this summary it was counted as resistant. 
Resistance to compound sulphonamides, tetracycline, sulfamethoxazole trimethoprim 
and chloramphenicol was highly prevalent at 96.9%, 86.2%, 83.1% and 80% 
respectively. The prevalenee o f resistance for the remaining antibiotics tested was 
streptomycin (44.6%), apramycin (32.3%), gentamicin (32.3%), neomycin (10.8%),
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ciprofloxacin (4.6%) and nalidixic acid (4.6%). The data was represented using 
bio informatics software Bionumerics version 6 .6  in Figure 3.1. In total, 16 different 
antimicrobial resistance profiles were found amongst the strains. For ease of 
presentation the resistances will be presented by their three letter abbreviation. The 
most common resistance profile was Tet (tetraeycline). Amp (ampicillin), SxT 
(sulfamethoxazole/trimethoprim), Cml (chloramphenicol), Sul (sulphonamides), Ctx 
(cefotaxime), displayed by 23 E. coli strains. The second most common profile was 
Tet, Amp, SxT, Gen (gentamicin), Str (streptomycin), Sul, Ctx, Apr (apramycin), 
displayed by 10 5'. enterica strains. The third most common profile was Tet, Amp, 
SxT, Gen, Str, Sul, Ctx, Apr, this was one of only two profiles displayed by strains 
belonging to different species (two E. coli and five S. enterica). The fourth most 
common profile was Tet, Neo (neomycin). Amp, SxT, Cml, Str, Sul, Ctx, displayed 
by five K. pneumoniae strains. Overall, the E. coli strains showed the most diversity 
in resistanee profiles, with 40 strains distributed across 12 of the resistanee profiles. 
The S. enterica strains showed slightly less diversity, with 20 strains distributed 
across 4 profiles. The K. pneumoniae strains showed the least diversity, with 5 out of 
6  strains displaying identical resistance profiles.
3.2.4 Antimicrobial resistance genotype among outbreak strains
To further elucidate the antimierobial resistance makeup of the outbreak strains, 
genotypic testing was carried out using Identibac’s AMR-ve 05 DNA microarrays 
(see Section 2.8). This array detects 52 groups of antimicrobial resistance genes and 2 
integrase genes commonly found in Gram negative bacteria. Individual probes on the 
array were designed to allow detection of multiple variants of the same resistance 
gene, by targeting conserved sequence regions (Batchelor et a l, 2008). As sueh the 
probes do not discriminate highly homologous variants of the same gene. For 
example, the probes for blaxEM and blasnv will pick up both ESBL and non-ESBL 
variants, thus not allowing the ESBL phenotype to be predicted. In the case of the 
aminoglycosides, again, multiple genes will be detected by the same probe because as 
little as one amino acid substitution can change substrate preferenee, thus not 
allowing accurate prediction of the aminoglycoside resistance phenotype. However,
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Figure 3.1: AMR profiles of the outbreak strains
Peî5i«i ctMïdâtiijn
M
Strain Sjrtcio Source Sourcenpe
E57S4 £  pyievmcniae 1 Pis
B3S07 11 pnsumcnkiâ 6 Pis
B3S03 K  pneujnoniae 1 Pii
B3SK K py:eiaficrJs2E 3 Pis
B3215 1 Pii
B3787 £  coii 5 Pis
B3S41 E. coii 1 Pis
B3751 £  prbELmonias 5 Pii
B3S4S S. erHcrica 15 Pis
B3779 E. coii 1 Pis
B37S1 E. coii 2
B37S2 E. coii 1 Pis
B37SB E. coii 5 Pig
B37S3 E. coii 1 Pis
E37S5 E. coii 3 Pis
B320C E. coii 6 Pig
B3S01 E. coii S' Slum-
B3S02 E. coii 5 Pis
B3S05 E. coii 3 Pig
B3312 E. coii 2 LaZib
B3217 E. coii 1 Pis
B3S1B E. coii I Pis
B3S24 E. coii 11 BW
B3B30 E. coii 3 Bird
B3S31 E. coii 13 Slum'
B3S33 E. coii 15 Pis'
B3S35 E. coii S Pig
B3235 E. coii IS Pis
B3S37 E. coii 3 Pig
B3S3S E. coii 4 Pis
B3B3S E. coii 4 Pis
B3342 E. coii 15 Pig
B37g7 E. coii 3 Wild bird
B3S25 E. coii 12 Est
B3B27 E. coii 3 Bird
B3S28 E. coii 7 Slum
B3792 S. enierka 1 Pig
B32M E. coii 2 L s^
B3S43 S. enîerica 14 Pis
B3230 S. cnîcrica 3 Pii
B3232 E. coii 14 Pis
B3B34 E. coii 1 Pig
B3S23 E. coii 10 Pis
B3S25 E. coii 10 Pig
B37gj E. coii 2 Pis
B3S40 E. coii 15 Pii
B37S5 E. coii 1 Pig
B37&5 S. enserica 7 Slum-
B33C4 E. coii 4 Pig
B3810 S. tnîerica 4 Pis
B3314 S. erjirica 3 Pii
B3S44 S. £rJ£rica 6 Pig
B3245 S. enterica 14 Pig
B3723 S. enterica 1 Pig
B37B4 S. enterica 3 Pig
B37B5 S. enterica 4 Pis
B37G'3 S. enterica 5 Pig
E37gS E. coii 3 Wild bird
B3B11 S. enterica 3 Pis
B3B13 S. enterica 4 Pig
B3S43 S. enterica 5 Pis
B3S45 S. enterica 5 Pig
B3B47 S. enterica 3 Pis
B37SO E. coii 2 Lar&
B37BG E. coii 5 Cattle— I
Antimicrobial resistance profiles of the outbreak strains clustered using Bionumerics 
version 6 .6 . NAL: Nalidixic acid, TET: tetracycline, NEO: neomycin, AMP: 
ampicillin, FRZ: furazolidone, SXT: sulfamethoxazole/trimethoprim, CML:
chloramphenicol, AMK: amikacin, GEN: gentamicin, STR: streptomycin, SUL: 
sulphonamides, CTX: cefotaxime, APR: apramycin, CIP: ciprofloxacin.
■  = Resistant, ■  = Intermediate, O  = Susceptible.
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the anticipation was that the genotype determined would confirm and correlate with 
the phenotype already determined.
Overall, positive results for at least one strain were obtained for 26 different probes. 
These 26 probes detected genes conferring resistance to seven different antimicrobial 
families namely p-lactams, sulphonamides, aminoglycosides, trimethoprim, 
phenicols, tetracyclines and macrolides, as well as two probes detecting integrase 
genes. It is worth noting that the antimicrobial treatment regime on the farm 
concerned included agents from six of these antimicrobial families, the only 
exception being the aminoglycosides.
As expected, 100% of the strains were found to carry a è/acrx-A/gene. Additional P- 
lactamase genes present among the strains were blajEM, which was present in 83% of 
the E. coli strains (n=33/40) and 84% of the S. enterica strains (n=16/19). The K. 
pneumoniae strains, on the other hand, were all found to harbour a blasnv gene. 
Sulphonamide resistance gene carriage was also high amongst the outbreak strains 
(91% carried at least one gene), with probes for suU, sul2 and sul3 positive for 42%, 
74% and 26% of the strains, with only four E. coli strains and two S. enterica strains 
that did not carry any sulphonamide resistance genes. Slightly lower, but nevertheless 
still highly prevalent at 8 8 %, was the presence of aminoglycoside resistance 
determinants. Only five E. coli and three S. enterica strains were found not to carry 
any aminoglycoside resistance genes. The aminoglycoside resistance genes detected 
amongst the outbreak strains were aadAl, aadA2, strA and strB, and their prevalence 
was, respectively 77%, 34%, 11% and 45%. The next most commonly found type of 
resistance gene was trimethoprim resistance, with 84% of the strains carrying at least 
one resistance gene. A total of seven E. coli strains and four S. enterica strains did not 
carry any trimethoprim resistance genes. The trimethoprim probes found to be 
positive were dfrl2, dfrAl, dfrA14, dfrAlV, dfrAl and dfrV respectively at 42%, 28%, 
8 %, 3%, 9% and 2%. Genes for resistance to the phenicols were present in 82% of the 
strains, with eight E. coli and four S. enterica strains not carrying either resistance 
gene. In this case, the genes were floR  and cmlA which were present in 80% and 40% 
of the strains, respectively. Tetracycline resistance genes were present in 72% of the 
outbreak strains. Of the strains not carrying any tetracycline resistance genes 11 were
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E. coli and 8  were S. enterica. Additionally, two macrolide resistance genes were also 
detected among the strains with very low prevalence. The probe for gene ercB was 
found to be positive in one E. coli strain and the probe for gene ermB was found to be 
positive for four E. coli and one S. enterica strain. In order to visualise the data more 
clearly, the bioinformatics software Bionumerics version 6 .6  was used to cluster the 
strains according to gene carriage followed by the creation of Minimum Spanning 
Trees. This showed that, overall, antimicrobial gene carriage clustered approximately 
with bacterial species (Figure 3.2A). The type of source of the strains, such as what 
animal they came from or whether they were slurry samples, on the other hand, did 
not seem to have a bearing on the antimicrobial gene makeup of the strains (Figure 
3.2B). It was noted that, similarly to the case seen for the antimicrobial resistance 
phenotype, the diversity in antimicrobial genotype profile diversity was different 
when comparing bacterial species. The E. coli strains were found to have the most 
diverse profiles, with the lowest for gene carriage being 1 , the median 1 0 , and the 
highest 13. The S. enterica strains were slightly less diverse, with the lowest for gene 
carriage being 3, the median 9 and the highest 12. The K. pneumoniae were the least 
diverse, with the lowest and median for gene carriage being 9 and the highest II.
3.2.5 Comparison of resistance phenotype and genotype of the 
outbreak strains
In order to compare the phenotypic antimicrobial resistance data with the genotypic 
antimicrobial resistance data the results were split into groups of related compounds. 
In the case of p-laetamase genes all the strains carried at least one resistance gene, 
blacTx-M with some of the strains carrying in addition either blajEM or blasnv^ As 
1 0 0 % of the strains were resistant to both of the p-lactams tested the agreement 
between the phenotype and the genotype was also 100%. For the sulphonamides there 
were some minor disagreements between the array and the phenotypic data. Of the 
strains carrying a resistance gene all o f them displayed a resistant phenotype (91%). 
On the other hand, the strains that did not carry a sulphonamide resistance gene 
recognised by the array were split between some that did not show resistance (3%)
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Figure 3.2: AMR genotype elusters contrasting bacterial and animal species
A
B
E. coli
K. pneumoniae 
S. enterica
Pigs
■ Cattle
■ Lambs
■ Sluny
■ Birds
■ Rats
Minimum Spanning tree according to AMR genotype profiles created using 
Bionumerics version 6 .6 . Each circle represents a profile, with those profiles shared 
by more than one strain divided into segments. Branch length corresponds to 
differences, with shorter branches representing fewer changes and longer branches 
representing more changes. A) Here the segments have been coloured according to 
the iso late's species showing that bacterial species clusters with resistance genotype. 
B) Here the segments have been coloured according to the type of source were the 
isolate originates showing that animal species does not cluster resistance genotype.
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and those that did (6 %). For trimethoprim, the array and phenotypic data were 100% 
in agreement. For the phenicols, gene carriage and phenotype agreed in for all but one 
strain which although it carried floR  it was found to be susceptible to 
chloramphenicol. The tetracycline resistance phenotype and genotype were partially 
in agreement, however, for 14% of the strains, whilst no tetracycline resistance gene 
was detected, a resistant phenotype was observed. It is recognised that the genes for 
tetracycline resistance are very diverse with at least 26 known gene types. It is 
possible that the array did not carry the relevant probes. For the aminoglycosides, 
high levels of apparent disagreement between resistance phenotype and genotype 
were found, with 38% of the strains carrying at least one aminoglycoside resistance 
gene whilst not displaying resistance to any of the five aminoglycosides included in 
the phenotypic testing. As for tetracyclines, there were probably deficiencies in gene 
coverage on the array.
3.2.6 Genotypic typing by pulsed field gel electrophoresis
The clonal relationships within each species were investigated by pulsed field gel 
electrophoresis (PFGE) with Xba\ (see Section 2.9) and differences in the macro 
restriction profiles were interpreted according to the criteria established by Tenover 
(Tenover et a l, 1995). Considerable diversity in macro restriction profiles was found 
among E. coli strains. Only two clusters of highly related strains were found (see E. 
coli clusters 1 and 2 in Figure 3.3). In the case of K. pneumoniae all six o f the strains 
were highly related with three bands difference or less (Figure 3.4). Within the S. 
enterica there were two unrelated clusters (Figure 3.5). Within both clusters the 
strains were highly related with up to three band differences in cluster 1 and no band 
differences in cluster 2 .
3.2.7 Comparison of AMR genotype and PFGE clusterings
The clustering generated by PFGE was compared to the AMR genotype profiles. It 
was found that, although, overall, there was a general amount of agreement, many 
exceptions were found, showing that identical PFGE profile did not always correlate
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Figure 3.3: Xba\ PFGE of outbreak E. coli strains
Dice (Opt: 1.50%) (Toi 1.5%-1.5%) 
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Xba\ Pulsed Field Gel Electrophoresis of E. coli strains clustered according to 
similarity using Bionumerics version 6 .6 . Two clusters (>4 strains) of highly related 
strains can be seen (cut point >90% similarity).
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Figure 3.4: Xba\ PFGE of outbreak Æ pneumoniae strains
Dice(Opt;1.50%) (Toi 1.5%-1.5%) 
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Xba\ Pulsed Field Gel Electrophoresis of K. pneumoniae strains clustered according 
to similarity using Bionumerics version 6 .6 . All the outbreak strains are highly 
related, with two pulsotypes shared by more than one strain.
Figure 3.5: Xbal PFGE of outbreak S. entrica strains
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Xba\ Pulsed Field Gel Electrophoresis of S. enterica strains clustered according to 
similarity using Bionumerics version 6 .6 . The strains group into two distinct groups. 
Cluster 1 consists of 16 highly related strains split among three pulsotypes. Cluster 
two consists of three strains displaying undistinguishable profiles.
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with identical resistance gene carriage. For the E. coli strains isolated in this study, 
PFGE clusters 1 and 2 approximately correlated with those clusters generated from 
the analysis o f AMR gene carriage (Figure 3.6). However, there were examples of 
strains that were undistinguishable by PFGE whilst analysis of AMR genotype found 
multiple differences. The most notable example was that represented by strains 
B3795, B3824 and B3826. Whilst there was only one difference in gene carriage 
between strains B3795 and B3826, when comparing strain B3824 to the other two, 
B3795 and B3826, there were respectively six and five differences.
In the case o f the K. pneumoniae strains, it was found that three strains sharing one 
pulsotype (B3794, B3809 and B3819) also showed identical AMR genotypic profile, 
whilst two strains sharing a second pulsotype (B3807 and B3808) differed in the 
carriage of one antimicrobial resistance gene.
With the S. enterica strains two different pictures were found. On the one hand were 
the strains belonging to S. enterica PFGE cluster 2 (B3792, B3848 and B3850), 
which as well as displaying indistinguishable PFGE profiles were identical in terms 
of their AMR gene carriage. On the other hand, the larger S. enterica PFGE cluster 
consisted of a mixture o f strains that were identical on both counts and strains that 
were not. The most notable pair of strains was B3810 and B3844, which although 
indistinguishable by PFGE, differed on AMR gene carriage on five genes.
3.2.8 Analysis of plasmid carriage amongst outbreak strains
As CTX-M genes are generally carried by plasmids, the plasmid content of each 
strain was investigated by plasmid profiling by gel electrophoresis (see Section 2.10). 
Representative gels for selected strains within each species can be seen in Figures 3.7,
3.8 and 3.9. All o f the strains were found to carry at least one plasmid. Considerable 
diversity was found among the E. coli strains in terms of the number o f plasmids 
carried, from one to eight plasmids, as well as their sizes, ranging in from ~3 to 
>148kb (Figure 3.7). The K. pneumoniae strains all carried two large plasmids 
(~100kb and >148kb, respectively) with two of the strains carrying an additional
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Figure 3.6: Comparison of AMR genotype and PFGE clusterings
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AMR genotype profiles clustered using Bionumerics version 6 .6 . For comparison 
with PFGE genotyping, specific strains have been coloured. Strains boxed red belong 
to E. coli PFGE cluster 1. Strains boxed in green belong to E. coli PFGE cluster 2. 
Strains boxed in purple are K. pneumoniae of identical pulsotype. Strains boxed in 
blue belong to S. enterica PFGE cluster 2. Strains boxed orange belong to S. enterica 
PFGE cluster 1.
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Figure 3.7: Plasmid profiling of representative E. coli strains
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Plasmid profiling gel electrophoresis of ten representative E. coli strains. The ladder 
is Sigma Supercoiled DNA Ladder. 39R861 is a reference strain carrying four 
plasmids of known sizes as labelled. All the test strains carry at least two plasmids 
(B3805) and up to eight plasmids (B3802).
Figure 3.8: Plasmid profiling of representative K. pneumoniae strains
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Plasmid profiling DNA gel electrophoresis of five of the K. pneumoniae strains. 
20R764 is a reference plasmid-ffee E. coli for identification of the chromosomal 
DNA band. 39R861 is a reference strain carrying four plasmids of known sizes as 
labelled.
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plasmid and one strain carrying an additional three plasmids, the smallest of which 
was ~3.5kb (Figure 3.8). In the case o f 5". enterica, all strains were found to harbour a 
plasmid o f -lOOkb with just one strain harbouring an additional plasmid of 
approximately ~3.5kb (Figure 3.9).
3.2.9 Strain Selection for further characterisation
Nine strains were chosen from within the collection for further characterisation. The 
main criterion used when selecting the strains was to obtain strains representing all of 
the clusters identified by species, PFGE and AMR. As the most numerous and diverse 
group, five E. coli strains were chosen in total. Strains B3780 and B3789 were chosen 
as they were the outliers in terms of their resistance phenotype and genotype. They 
only demonstrated resistance to p-lactams, and carried a single resistance gene, 
furthermore, unlike all the other strains tested the CTX-M gene carried belonged to 
group 9. Strain B3782 was chosen to represent E. coli PFGE Cluster 1, B3800 to 
represent PFGE Cluster 2 and strain B3804 was chosen as it did not belong to either 
cluster. From the K. pneumoniae strains B3791 was chosen as a representative as it 
shared its AMR genotypic profile with three other strains but unlike them it also 
showed resistance to the fluoroquinolones. From the S. enterica strains three were 
chosen in total as representatives. Two strains were chosen from the S. enterica PFGE 
Cluster 1, B3810 and B3844, as they were the most differing in their AMR genotypic 
profiles. A fiirther S. enterica strain was chosen from PFGE Cluster 2, strain B3792, 
which was undistinguishable from the other two strains in its cluster by all the 
characterisation carried out. The strains were genotyped by MLST (Table 3.1). The K. 
pneumoniae strain, B3791, was found to be ST type 14. All the E. coli genotyped by 
MLST were found to belong to unrelated novel ST types. As for the S. enterica, 
genotyping by MLST confirmed the relationships amongst the strains already 
established by PFGE, with strains B3810 and B3844 belonging to the same novel ST 
type ST1681 and strain B3792 belonging to unrelated ST type ST142. Additionally 
two of the S. enterica strains were also serotyped. Strain B3792 belonged to serotype 
Bovismorbificans and strain B3844 belonged to serotype 4,5,12:i:-.
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Figure 3.9: Plasmid profiling of representative S. enterica strains
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Plasmid profiling DNA gel electrophoresis of ten of the S. enterica strains. 20R764 is 
a reference plasmid-free E. coli for identification of the chromosomal DNA band. 
39R861 is a reference strain carrying four plasmids of known sizes as labelled. All 
the strains were found to carry one plasmid running between 63.4 and 148 kb. 
Additionally, one strain (B3850) carried an extra plasmid running between the 3 and 
4kb bands.
Table 3.1: Additional characterisation of strains selected for further plasmid 
analysis
Strain Species CTX-M group MLST type Serotype
B3780 E.coli CTX-M-9 ST3397 Not determined
B3782 E. coli CTX-M-1 ST1721 Not determined
B3789 E. coli CTX-M-9 ST3398 Not determined
B3800 E. coli CTX-M-1 ST3396 Not determined
B3804 E. coli CTX-M-1 ST3394 Not determined
B3791 K. pneumoniae CTX-M-1 ST14 Not determined
B3792 S. enterica CTX-M-1 ST142 Bovismorbificans
B3810 S. enterica CTX-M-1 ST1681 Not determined
B3844 S. enterica CTX-M-1 ST1681 4,5,12:i:-
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3.2.10 Introduction of the selected CTX-M plasmids into E. coli lab 
strain NEB 10-beta
In order to find out whether the CTX-M genes were carried by plasmids, plasmid 
DNA from the selected strains was introduced into a common background lab strain, 
E. coli NEB 10-beta (NEB C3019I). For this purpose, plasmid DNA from strains 
B3780, B3782, B3789, B3791, B3800, B3800, B3810 and B3844 was extracted using 
Qiagen’s HiSpeed Plasmid Midi Kit (see Section 2.11). The extracted plasmid DNA 
was used to transform NEB 10-beta Electrocompetent E. coli by electroporation (see 
Section 2.13) and transformants were selected for by plating on LB agar 
supplemented with 2pg/ml of cefotaxime. Two well isolated colonies from each 
transformation were re-streaked on LB agar supplemented with 2 pg/ml of cefotaxime 
before being cultured at 37°C for 16hrs in 5ml of LB broth supplemented with 2 
p,g/ml of cefotaxime. The resulting cultures were used to make glycerol stocks and 
stored at -80°C. To confirm that the transformants were carrying a CTX-M plasmid 
the isolates were tested by PCR (see Section 2.14) using CTX-M universal primers 
(Table 2.1). This PCR was positive for the transformants o f strains carrying a CTX-M 
gene belonging to group 1 (those transformed with DNA from B3782, B3791, B3800, 
B3810 and B3844) but negative for the transformants of strains carrying a CTX-M 
gene belonging to group 9 (those transformed with DNA from B3780 and B3789). 
These latter strains were tested with CTX-M group 9 specific primers and were all 
found to be positive. Additionally, plasmid carriage in the transformants was also 
confirmed by running plasmid profiling gels. It was found that all the transformants 
of the CTX-M group 1 strains carried a plasmid of undistinguishable size running 
between the I48kb and 63.4kb reference plasmid bands (Figure 3.10). The 
transformants of the CTX-M group 9 all carried a plasmid of undistinguishable size 
running between the 63.4kb and the 36kb reference plasmid bands (Figure 3.11). A 
fiirther transformant strain that was chosen for plasmid studies which was made from 
B3804 as above by M. AbuOun and M. Stokes however, as a background strain they 
chose to use Invitrogen’s DHIOB (Invitrogen 11319-019). This strain, named T04a, 
was also found a carry a single plasmid running between the 148kb and 63.4kb 
reference plasmid bands and to be positive for carriage of CTX-M gene by PCR using 
CTX-M universal primers.
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Figure 3.10: Plasmid profiling of CTX-M Group 1 transformants
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Plasmid profiling gel electrophoresis of transformants of six selected CTX-M group 1 
producing outbreak strains. The ladder is Sigma Supercoiled DNA Ladder. 39R861 is 
a reference strain carrying four plasmids of known sizes as labelled. 20R764 is a 
plasmid-free reference strain included to highlight the chromosomal contamination 
band. All the transformants were found to carry a single plasmid of undistinguishable 
size running between the 148kb and 63.4kb reference plasmid bands.
Figure 3.11: Plasmid profiling of CTX-M Group 9 transformants
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Plasmid profiling gel electrophoresis of transformants of two selected CTX-M group 
9 producing outbreak strains. The ladder is Sigma Supercoiled DNA Ladder. 39R861 
is a reference strain carrying four plasmids of known sizes as labelled. All the 
transformants were found to carry single plasmid of undistinguishable size running 
between the 63.4kb and 36kb reference plasmid bands.
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3.3 Discussion
Previously described outbreaks of CTX-M resistance were found to be clonal (Pitout 
et ah, 2005) and, thus, the main question addressed by the work undertaken in this 
chapter was whether the CTX-M outbreak on this pig farm was an instance of clonal 
expansion o f resistant organisms. It was found that the CTX-M positive strains in the 
collection consisted of three different species of Enterobacteriaceae, which is 
inconsistent with a clonal spread of a single resistant progenitor strain. When 
analysing the strains belonging to the different species this concept is further 
reinforced. The E. coli strains were highly diverse in their PFGE profiles and the S. 
enterica fell into two unrelated groups. However, due to their similarity in PFGE 
profiles, the K. pneumoniae isolates are highly similar and are likely to have recently 
originated from a single ancestral strain. However, this data would not rule out spread 
of a common single resistance gene across this population especially as non-clonal 
spread of CTX-M resistance is not uncommon either (Coque et a l, 2002). However, 
the data clearly showed different CTX-M types within the strains studied with for 
example the E. coli isolates carrying either CTX-M group 1 genes (38 strains) or 
CTX-M group 9 genes (2 strains). The CTX-M group 1 genes were however 
prevalent in the study group and could perhaps relate to the conjugative spread of a 
harbouring plasmid.
Another interesting finding was the fact that genes conferring resistance to all six of 
the antimicrobial families administered to the affected pigs were found amongst the 
outbreak strains, suggesting that the treatment possibly played a major role in the 
selection of antimicrobial resistance amongst the outbreak strains. This also ties in 
with the fact that many strains that were undistinguishable by PFGE displayed 
distinct antimicrobial resistance profiles, suggesting strong selective pressure causing 
the strains to acquire resistance genes. However, since antibiotic selective pressure 
was not consistently applied overtime and with different antibiotic treatment regimes, 
it is possible that greater diversity was created by subsequent loss o f resistance upon 
removal of the selective pressure.
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Identification o f Salmonella strains with serotype 4,5,12:i;-, a monophasic variant of 
serovar Typhimurium is currently increasing throughout Europe, often with 
association to consumption of pig products (Hopkins et ah, 2010). A study of 
monophasic strains originating from England and Wales during 2010 identified the 
most common resistance pattern as ampicillin, streptomycin, sulphonamides and 
tetracycline (Hopkins et a l, 2012). It is of concern that in this farm outbreak, all the 
S. enterica strains belonging to PFGE cluster 1, as well as being resistant to the four 
agents listed, were all resistant to further antimicrobial compounds. In particular 
16/16 strains were also resistant to trimethoprim and cefotaxime, 15/16 were resistant 
to gentamicin and 5/16 were resistant to chloramphenicol. The presence of a CTX-M 
gene in a strain of this serotype is an unusual finding, which, although previously 
reported for a strain originating from a patient in the United States (Sjolund-Karlsson 
et a l, 2011) is in fact the first such report for a UK strain. As pigs have been 
identified as a reservoir for Salmonella 4,5,12:i:- (Hopkins et a l, 2010) the presence 
of a CTX-M gene in these strains poses the potential consequence o f further limiting 
clinicians’ options when treating complicated infections should these strains enter the 
food chain and cause human infection. This is even more the case for patients for 
whom the use of fluoroquinolones, a common alternative to the third generation 
cephalosporins, is contraindicated.
The strains obtained at the time of sampling originated from both the affected 
animals, in this case the piglets, but also other animals and the environment, thus 
providing a good snapshot of the resistance amongst Enterobacteriaceae in the farm. 
However a limitation of the study was that as all the strains originated from a single 
time point, therefore no inferences on the evolution o f resistance at the farm could be 
made.
Another point that deserved further investigation was the characterisation of the 
plasmid strains. Having found that in this case the spread of a resistant clone is not 
the reason behind the presence of the CTX-M-1 gene in this outbreak, it would be 
interesting to find out whether the plasmids isolated from the selected strains are 
clonal themselves, which will be further investigated in the next chapter.
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Chapter 4:
Molecular characterisation of the 
plasmids conferring resistance to 
cefotaxime to the outbreak strains
Chapter 4 : Molecular characterisation of the plasmids 
conferring resistance to cefotaxime to the outbreak 
strains
4.1 Introduction and aims
The characterisation o f 65 CTX-M producing Enterobacteriaceae strains originating 
from a pig production unit was described in Chapter 3. Identification o f three 
different species o f resistant Enterobacteriaceae, and the genetic variability within 
both the E. coli and S. enterica strains, led to the dismissal of the original hypothesis 
that ‘this outbreak consisted of a clonal expansion of a resistant organism.’ Therefore, 
the aim of the research presented in this chapter was to characterise the CTX-M 
harbouring plasmids present in the nine selected strains from Chapter 3, including 
sequencing and annotation of representative plasmids. The reasons for the selection of 
the 9 plasmids chosen for further characterisation were explained at length on section 
3.2.9 but briefly the strains were chosen in order to represent each of the species 
studied, the major clusters within E. coli and S. eneterica and two outliers harbouring 
CTX-M genes belonging to group 9. The revised hypothesis for this work was that ‘a 
common successful plasmid was present throughout the outbreak strains, thus 
constituting an example of clonal spread of a resistance plasmid’.
4.2 Results
4.2.1 Antimicrobial resistance profile of transformants strains
The first objective was to describe the antibiotic resistance phenotype associated with 
the cefotaxime resistant transformants (see Chapter 3) and this was determined by 
disk diffusion sensitivity testing. A panel o f 14 antibiotics including compounds 
belonging to eight antimicrobial resistance families was used. The transformants of 
the CTX-M group 9 strains, T80a and T89a, were found to be resistant to two p- 
lactam agents, ampicillin and cefotaxime. The transformants of the CTX-M group 1 
strains possessed two distinct phenotypic profiles. Strains T82a and T92a had 
acquired resistance to ampicillin, cefotaxime and compound sulphonamides. Strains
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T9 la, TOOa, T04a and T44a had acquired resistance to ampicillin, cefotaxime, 
compound sulphonamides and chloramphenicol (Table 4.1).
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Table 4.1: Antimicrobial resistances transferred by the outbreak plasmids
Parent (species) Strain CTX-M Group AMP CML SUL CTX
B3780 (E coli) T80a 9 R S S R
B3782 (E coli) T82a 1 R s R R
B3789 (E coli) T89a 9 R s S R
B3791 {K. pneumoniae) T91a 1 R R R R
B3792 {S. enterica) T92a 1 R S R R
B3800 (E coli) TOOa 1 R R R R
B3804 (E coli) T04a 1 R R R R
B3810 {S. enterica) TlOa 1 R R R R
B3844 (E enterica) T44a R R R R
Antimicrobial resistances acquired along with plasmid by tranformant strains AMP: 
ampicillin, CML: chloramphenicol, SUL: compound sulfonamides, CTX: cefotaxime
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4.2.2 Antimicrobial resistance genotype of transformant strains
Having established the phenotype of the strains, the next step was to verify the 
findings genetically and to define the specific genes encoding the resistances. To find 
out the type of the CTX-M gene present in the plasmids, DNA of the transformant 
strains was used as a template for amplification with the CTX-M group 1 sequencing 
primers (strains T82a, T9 la, T92a, TOOa, T04a, TlOa and T44a) or CTX-M group 9 
sequencing primers (strains T80a and T89a) (Table 2.2). The amplified products were 
sequenced and it was found that the CTX-M group 1 transformants carried CTX-M-1 
whilst the CTX-M group 9 carried CTX-M-14. In order to identify the resistance 
genes that were being co-transferred by the plasmids the transformant strains were 
tested using a microarray approach (Identibac AMR-ve 05 DNA microarray: see 
section 2.8). As expected from the antimicrobial resistance results, no resistance 
genes besides CTX-M were found on strains T80a and T89a. All the CTX-M group 1 
transformants were found to harbour sul2 whilst those that were resistant to 
chloramphenicol (T9la, TOOa, T04a and T44a) also harbouredyZoE.
4.2.3 Determination of the incompatibility group of the outbreak 
plasmids
To further classify the outbreak plasmids their incompatibility group was determined 
using PCR-based replicon typing as previously described (Carattoli et a l, 2005). This 
technique is able to detect the 18 most common incompatibility groups in 
Enterobacteriaceae. The plasmids in strains T80a and T89a were not typable by this 
technique. The CTX-M-1 bearing plasmids (T82a, T9 la, T92a, TOOa, T04a, TlOa, 
T44a) were all found to belong to incompatibility group Incll-y (Figure 4.1).
4.2.4 Conjugation Studies
To establish whether the plasmids were self-transmissible by conjugation, liquid 
mating experiments were performed using both parental (B3780, B3782, B3789, 
B3791, B3800, B3804, B3800, B3810 and B3844) and transformant strains (T80a,
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Figure 4.1: PBRT of transformants harbouring the outbreak CTX-M plasmids
750bp-
500bp-
250bp-
“IncHIl
-IncHI2
-Incll-y
Gel electrophoresis of PCR based replicon typing, Multiplex 1 (IncHll, lncH12 and 
Incll-y) amplified products. The ladder is Promega’s 1 kb Ladder. All the 
transformant strains carrying a CTX-M group 1 gene were found to be positive for the 
determinant of the Incll-y and negative or IncHIl and lncH12. Strains, T80a and 
T89a, both transformed with CTX-M group 9 plasmids were negative for all three 
replicons.
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T82a, T89a, T9 la, T92a, TOOa, T04a, TlOa, T44a) as donors (see Section 2.19). This 
was done to differentiate self-mobilisable and thus truly conjugative plasmids from 
mobilisable plasmids. Truly conjugative plasmids would be able to transfer from both 
the parent and the transformant strain. Mobilisable plasmids, given that the right 
helper plasmid is present on the parent strain, can be mobilised by the helper plasmid 
transfer machinery and should therefore only be transferable from the parent but not 
the transformant strain. As plasmid recipient strains, two different strains were used 
depending on the species of the donor. For matings where the donor strain was either 
a K. pneumoniae or an E. coli, a rifampicin resistant Salmonella Typhimurium strain 
S26R was used as plasmid recipient. For those matings where the donor strain was a 
S. enterica, a rifampicin resistant E. coli K12"^ was used as a plasmid recipient. The 
reasoning behind the strain choice was that, on the chromogenic agar chosen for the 
double selection (cefotaxime and rifampicin) of the transconjugants, the donors and 
recipients could be easily distinguished by colour, as E. coli colonies are black/dark 
green, K. pneumoniae colonies are dark purple/navy blue and S. enterica colonies are 
red. By differentiating the species o f the colonies, the experiment was able to control 
for the spontaneous mutation of donors, which for rifampicin occurs at a rate of ~10'^. 
Two rounds of conjugation experiments were carried out. On the first attempt, the 
strains were allowed to mate for Ihr before being plated on the double selection 
medium (Rambach supplemented with 2pg/ml of cefotaxime and lOOpg/ml o f 
rifampicin). Transconjugants were found for those conjugations that used strains 
B3810 and B3844 as plasmid donors. A second attempt was carried out with the 
difference that the mating time was extended to 5 hours. On this occasion 
transformants were found for all o f the strains tested. As the aim of this experiment 
was solely to confirm a conjugative phenotype, no data on transfer frequencies was 
obtained.
4.2.5 Restriction Fragment length Polymorphism of the outbreak 
plasmids
Plasmid DNA extracted from the transformant strains was digested using EcoRl or 
Bglll and run on 0.8% agarose TBE gels (see Section 2.20). Although there seemed to
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be some non-specific shearing of the DNA, judging by the amount o f background in 
the lanes, the examples shown in Figures 4.2 and 4.3 were the best obtained after 
attempting the experiment four times. For the Incll-y plasmids, the EcoRl produced 
multiple bands spread out along the gel. Although there were some band variations, 
clear similarities were seen amongst the Incll-y plasmids (Figure 4.2). Because of the 
poor quality o f the gels it was not possible to calculate the predicted size o f each 
plasmid and although similar ‘dominant’ bands were seen for seven of the plasmids, 
there was evidence of incomplete digestion negating the possibility to definitively 
compare the profiles. For the plasmids of T80a and T89a only three and two bands 
were found respectively when digesting the DNA with EcoRl (Figure 4.2). This was 
not enough to draw conclusions regarding their relatedness. For this reason, digests 
were also performed using Bglll, which produced slightly better results, with five 
identical bands present for both plasmids (Figure 4.3).
4.2.6 DNA sequencing of the outbreak plasmid
Three outbreak plasmids were chosen for full sequence analysis. pIFM3791 
originated fi*om K. pneumoniae strain B3791, pIFM3804 originated fi*om E. coli 
strain B3804 and pIFM3844 originated ft^ om Salmonella 4,5,12,i:- strain B3844. 
DNA fi*om the respective transformant strains was extracted using QIAGEN Large 
Construct Kit (see Section 2.21) and sent for sequencing to the AHVLA Central 
Sequencing Unit where they were sequenced using a shotgun library on a Roche 454 
GS FLX followed by de novo assembly using the Newbler 2.3 (see Section 2.22). 
Between 6 and 8 contigs were obtained for each plasmid. In order to close the gaps, 
primers were designed that would synthesize into the gaps for the first plasmid for 
which the sequence was obtained, pIFM3804. Combinatorial PCR was carried out 
and the PCR amplicons sequenced by the Sanger method. In order to close one gap of 
around 1.5kb, after the first round of sequencing, a second round of primers was 
needed. The strategy followed for the remaining two plasmids was slightly different. 
As previous experiments suggested high sequence similarity between these plasmids, 
the closed pIFM3804 was used as a reference to assist in the closing of the remaining 
two plasmids. It was found that all of the contigs produced for these two plasmids fit 
within the already closed pIFM3804, with most o f the gaps present in the same
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Figure 4.2: EcoRl RFLP of CTX-M Group 1 and Group 9 outbreak plasmids
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EcoRl RFLP gel electrophoresis of plasmid DNA isolated from transformant strains 
T80a to T44a. The ladder is Promega’s Ikb Ladder. Although some differences and 
some shearing may have occurred similar dominant bands are present in the plasmid 
DNA of CTX-M Group 1 transfomants suggesting that these plasmids are related.
Figure 4.3: Bglll RFLP of CTX-M Group 9 outbreak plasmids
y  y
Bglll RFLP gel electrophoresis of plasmid DNA isolated from transformant strains 
T80a and T89a. The ladder is Promega’s Ikb ladder. Identical banding pattern 
suggests that CTX-M Group 9 plasmids isolated from T80a and T89a are related.
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regions. For this reason, for the remaining two plasmids, directed PCR was carried 
out using only those primers that were known to close a gap in pIFM3804. The 
resulting amplified products were sequenced by the Sanger method. In those instances 
where gaps were present that had not been present in pIFM3804 new primers were 
designed. All three sequenced plasmids were circular molecules o f -104Kb with an 
average GC content of 50.7%. Comparison of the DNA sequences using BLASTN 
revealed that the three sequenced plasmids were almost identical amongst themselves 
except for 5 single nucleotide insertions (in pIFM3791 and pIFM3844 with respect to 
pIFM3804), a G to T substitution (in pIFM3844) and a single and double nucleotide 
deletion in pIFM3804 and pIFM3844 respectively (Table 4.2). Additionally, a 467bp 
inversion was found in plasmid pIFM3804 with respect to the other two plasmids.
4.2.7 Plasmid annotation results
Annotation of pIFM3804 (to access file visit https://www.dropbox.eom/s/wyq749djeg 
3g 1 gx/annotated%20pIMF3 804.sbd) predicted 151 protein coding genes, 2 frameshift 
mutated genes and 2 RNA genes (Figure 4.4). Most of the predicted genes were 
typical of IncII plasmids, as was expected since the plasmids were highly similar 
(89% query coverage, total score 1.627e+05) to well described Incl-I plasmid Collb- 
P9 (GenBank accession number AB021078.I). Large areas of homology to plasmid 
ColIb-P9 were present in the way of large opérons encoding the functions of 
replication, conjugative transfer and Type IV pilus assembly. It is within the pilV  
shuffion components that the 467bp inversion in pIFM3804 was found with respect to 
the other two plasmids sequenced, consistent with the action o f the downstream 
encoded recombinase gene, rci. Additionally there were both known and putative 
addiction systems, respectively pndA/C and yacABC. Besides plasmid housekeeping 
genes, two antimicrobial resistance regions were also identified. The first one, a 
7I18bp region that had inserted upstream o f yacABC (4175-11294), displayed 99% 
identity with 95% coverage to Acinetobacter baumanii ISCR2 (accession number 
FN293050.1). This region coded for two tranposase genes, resistance genes sul2 and 
floR, plus a number of other genes of known or putative function (Figure 4.5). The 
second resistance region was 3004bp long and it had inserted within shfB of the pilV 
shuffion. This region contained p-lactamase gene CTX-M-1 and its organisation was
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Table 4.2: Sequence differences in outbreak plasmids pIFM3791, pIFM3804 and 
pIFM3844
Position in pIFM3804
Sequence
Gene EffectPIFM3791 P1FM3804 plFM3844
! 6M8 G G A ISCR2
serine to phenylalanine 
in pIFM3844
10994 CG -G -- outside coding region NA
i 19884 G G ybaA
ffameshift (in plFM3791 
and pIFM3844) :
24941 A A hypothetical protein
frameshift (in pIFM3791 
and pIFM3844)
56570 A A hypothetical protein
frameshift (in pIFM3791 
and pIFM3844)
57253 T - T outside coding region NA
; 58328 T T exc
frameshift (m pIFM3791 
andpIFM3844)
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Figure 4.4: Genetic map of plasmid pIFM3804
RNAI repZ
So/p
5 0 0 0 0
1 1
The orange boxes represent the insertion regions. The arrows represent genes and 
have been coloured according to function as follows: green: plasmid DNA replication 
and maintenance; light blue: transposases; pink: genes with no proposed function; 
red: antimicrobial resistance determinants; grey: conjugative transfer locus; yellow: 
Type IV pilus.
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Figure 4.5: Genetic map of ISCi?2
sul2 gImM ISCR2 lysR floR virD2-like ISCR2
 ' 1—
6000 8000
p3804 (4000 to 11000 bps)
10000
Genetic map o f the resistance island I S c a r r y i n g  sul2 and floR  within plasmid 
pIFM3804.
Figure 4.6 Genetic map ofl^Ecpl
5'shfB tnpA of ISEcpi Thyp 
kiR of iSEcpI
blar trypB-Iike Z'shfB
85000 86000 87000
p3804 (84649 to 87903 bps)
Genetic map of the resistance island ISEcpl carrying blacrx-M-i within plasmid 
pIFM3804. In red is gene shfB, disrupted by insertion of the island.
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typical for ISEcpl, with ISEcpl transposase gene tnpA followed by a ISEcpl right 
inverted repeat, then b l a c T X - M - i ,  and, on the opposite strand, a conserved hypothetical 
protein, trypB-like (Figure 4.6). BLASTN searches revealed that this region was 
highly homologous (99% identical, query coverage of 95%) to previously described 
AM003904.1 OÏE. coli strain RB-01.
4.2.8 Comparison to previously described plasmids
The complete DNA sequence of plFM3804 was used to perform BLASTN searches 
in order to identify highly related plasmids for sequence comparisons. The four top 
hits for fiilly sequenced plasmids were chosen for further sequence comparisons, 
namely pSH146_87 (accession number JX445149.1), pSL476_91 (accession number 
CP001118.1), CoHb-P9 (accession number AB021078.1) and R64 (AP005147.1). 
Additionally, a further three Incll plasmids were chosen for sequence comparison 
which, although not as closely related as the plasmids listed above, they were 
included in this analysis as they were found to carry a CTX-M gene. They were, 
namely pEK204 (EU935740.1), pEC_Bactec (GU371927.1) and pESBL-EAll 
(CP003290.1).
In order to cluster the plasmids according to their backbone sequence, a concatenate 
of the Incll pMLST genes was created with the alleles present in each of the above 
plasmids (see Section 2.23). The pMLST genes are highly conserved backbone genes 
which display a low level of sequence variation. The concatenates thus produced 
were aligned using the ClustalW functionality present in DNASTAR Lasergene 
MegAlign (Figure 4.7). Based on the ClustalW alignment and nucleotide 
substitutions, the outbreak plasmid plFM3804 was found to be most closely related to 
plasmids R64 and pSL476_91. Additionally, it was found that the other three CTX-M 
harboured more nucleotide substitutions with respect to plFM3804 than any o f the 
other plasmids analysed.
An alternative clustering method was used that takes into account the whole plasmid 
nucleotide sequence (see Section 2.23). In this instance a distance tree of the plasmids
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Figure 4.7: Phylogenetic tree of Incll plasmids according to differences in 
pMLST genes
I pESBL-EAll 
I pEC-Bactec 
pEK204 
pSH146_87 
Collb-Pg 
plFM3804 
R64
pSL476_91
1 .7
Nucleotide Substitution per 100 residues
Phylogenetic tree constructed according to nucleotide substitution in the aligned 
sequences of the concatenated pMLST genes of the selected plasmid. The names of 
the CTX-M bearing plasmids have been coloured blue.
Figure 4.8: Phylogenetic tree of Incll plasmids based on whole DNA sequence
pEC_Bactec 
-pE SB L -E A ll
0 .0 0 2  F a s t  M i n i m u m  E v o lu t io n
-pEK204
 pSH 146_87
------------PIFM3804
|-p S L 4 7 6 _ 9 1  
I----------------R64
-Coll-BP9
Phylogenetic tree constructed based on whole plasmid sequence using NCBl 
BLASTN tree widget. The names of the CTX-M bearing plasmids have been 
coloured blue.
89
was built using NCBI BLAST’S tree widget using the tree method Fast Minimum 
Evolution (Figure 4.8). For this analysis slightly different results were obtained, with 
pIFM3804 most closely related to ColIb-P9 as well as R64 and pSL476. 
Nevertheless, the overall results were similar to those previously found, with 
pIFM3804 most closely related to the non-CTX-M plasmids chosen for the 
comparison.
When looking specifically at the CTX-M insertion and its surroundings a number of 
differences were noted between pIFM3804 and the three Incll plasmids carrying a 
CTX-M gene present in the NCBl database. Firstly, they carried a different CTX-M 
type to that carried by the plasmids o f the outbreak studied here. Whereas the 
plasmids sequenced in these studies were found to harbour CTX-M-1, pEK204 
harboured CTX-M-3 and pEC_Bactec and pESBL-EAll harboured CTX-M-15. 
Furthermore, in the other plasmids in the GenBank database the ISEcp7-CTX-M had 
inserted downstream from impB and within the vicinity of blaxEM-i whereas, for 
pIFM3804 the ISE'cpi-CTX-M was present within the shfB of the pilV shufflon and 
no was found.
4.2.9 CTX-M-1 genetic environment studies
A number of PCR primers were designed to investigate the genetic environment of 
the CTX-M-1 gene in the remaining Incll plasmids (pIFM3782, pIFM3792, 
plFM3800 and plFM3810). The sequence of plFM3791, plFM3804 and pIFM3844 
was used as the basis for primer design and consequently all three strains were 
included as controls in each of the experiments. For these PCRs both the parents and 
transformants were tested. The PCRs designated Envl, Env2 and Env3, used, 
respectively, primers Envl F W and EnvlRV, Env2FW and Env2RV and Env3FW and 
Env3RV (Table 2.1). Envl PCR was designed to detect the trypB-like gene of 
ISEcp7-CTX-M-1 and pilV, respectively, resulting in a 910bp amplicon spanning 
both the insertion and the plasmid backbone. Env2 PCR was designed to detect CTX- 
M-1 and trypB-like resulting in a 249bp amplicon within ISE'cp/-CTX-M-1 and 
downstream of CTX-M-1. Env3 PCR was designed to detect to tnpA and CTX-M-1 
resulting in a 425bp amplicon within lSEg?7-CTX-M-1 and upstream of CTX-M-1.
90
All the plasmids tested were positive for PCRs Envl, Env2 and Env3, including 
control plasmids plFM3791, plFM3804 and plFM3844 (Figures 4.9, 4.10 and 4.11). 
The fourth PCR, Env4a, used primers Env4FW and Env4RV (Table 2.1), designed to 
bind shfC’ and tnpA respectively, however, due to the inversion present on plFM3791 
and plFM3844 with respect to pIFM3804, a 617bp amplicon would be expected for 
plFM3804 and no amplicon for the other two sequenced plasmids. All the plasmids 
tested, including plFM3791 and pIFM3844, were positive for the Env4 PCR product, 
however the H2O and NEB 10-beta negative controls were not (Figure 4.12).
4.2.10 Presence of the outbreak plasmid in the remaining outbreak 
strains
A total of 63 of the outbreak strains studied in Chapter 3, including 7 of the strains 
selected for further plasmid characterisation in this chapter, had been found to carry a 
CTX-M gene belonging to group 1. To investigate whether the remaining 63 strains 
carried plasmids related to those characterised and sequenced in this chapter, fiirther 
PCR studies were carried out. The first round of PCR involved testing all of the 
outbreak strains except those carrying CTX-M group 9 genes (ie: B3780 and B3789) 
for the presence of the Incll-y incompatibility determinant using the PBRT primers 
IncIl-yFW and IncIl-yRV (Table 2.1) which amplify a 139bp region. All of the 
strains tested were found to be positive for this gene. For the second round o f PCR, 
primers from the CTX-M-1 genetic environment studies were used, specifically 
Env2FW and EnvlRV (Table 2.1). These primers were chosen as they produce a 
1290bp product which spans the insertion sequence and the plasmid backbone. Also, 
it was confirmed using Primer-BLAST that this PCR would not be positive against 
any other CTX-M group 1 and Incll plasmids already described (pEK204, 
pEC Bactec, pESBL-EAl 1) as the insertion site within the backbone of each plasmid 
was different to the one described in these studies. O f the strains tested, 61 were 
found to be positive and two strains were negative (B3798 and B3847).
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Figure 4.9: Envl PCR on selected outbreak strain and their transformants
OOObp 
750bp 
500bp 
250bp
DNA gel electrophoresis of the amplified products of Envl PCR on parents and 
transformant strains. As negative control both H20 and NEB 10-beta DNA were used.
Figure 4.10: Env2 PCR on selected outbreak strain and their transformants
OOObp 
750bp 
500bp 
250bp
DNA gel electrophoresis of the amplified products of Env2 PCR on parents and 
transformant strains. As negative control both H20 and NEB 10-beta DNA were used.
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Figure 4.11: Env3 PCR on selected outbreak strain and their transformants
1OOObp 
750bp 
500bp 
250bp
DNA gel electrophoresis of the amplified produets of Env3 PCR on parents and 
transformant strains. As negative control both H20 and NEB 10-beta DNA were used.
Figure 4.12: Env4 PCR on selected outbreak strain and their transformants
ro» CSI M i
#—4 OOObp 
#— 750bp 
*— 500bp 
«— 250bp
Figure 4.12: DNA gel electrophoresis of the amplified products of Env4 PCR on 
parents and transformant strains. As negative control both H20 and NEB 10-beta 
DNA were used.
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4.3 Discussion
The overall aim o f the work described in this chapter was to characterise the CTX-M 
harbouring plasmids present in a collection of Enterobacteriaceae strains isolated 
from a pig production unit. Amongst the 9 plasmids chosen for plasmid 
characterisation, for which the selection criteria were described in the previous 
chapter, two distinct plasmid types were found. The first plasmid type was made up 
of two CTX-M-14 plasmids carried by E. coli strains isolated, respectively, from 
cattle and lambs. These plasmids ran between the 63.4kb and 36kb plasmid reference 
bands and were not found either genotypically or phenotypically to carry any 
additional resistance besides CTX-M-14. Although the two plasmids within this 
group were not typable by PBRT, their similarity in size, resistance gene carriage and 
their Bglll RFLP profile provides evidence that these are likely to be a single plasmid 
type. Instances of CTX-M-14 harbouring plasmids which were not typable by PBRT 
have been observed in Australia (Zong et a l, 2008), France (Berçot et a l, 2008, 
Marcadé et a l, 2009), Spain (Diestra et a l, 2009), Thailand and the United Kingdom 
(Hopkins et a l, 2006). However, due to the lack of characterisation o f said plasmids, 
it is impossible to establish any potential relationship to the plasmids described in this 
study.
The second, more numerous, type of plasmid was present in seven of the strains 
chosen for plasmid characterization, which belonged to all three species isolated. 
These plasmids belonged to incompatibility group Incll, presented similar EcoRl 
restriction profiles and they were around lOOkb in length. As well as carrying CTX- 
M-1, these plasmids were found to carry sul2 and were variable for carriage of 
resistance gene florR, with 5 out of 7 plasmids positive for its carriage. As the isolates 
were made from a single farm visit, rather than a longitudinal study, it is not possible 
to comment further on the potential loss or acquisition o f the additional gene cassette. 
Also, as the quality o f the plasmid RFLP data was less than satisfactory, it was not 
possible to say for certain whether the plasmid backbone for each plasmid is highly 
similar. Hence, a sequencing approach was needed and, from within this group, three 
plasmids originating from an E. coli strain, a K. pneumoniae strain and a S. enterica 
strain, were chosen for full DNA sequence analysis. The sequenced plasmids were
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found to be identical except for six single or double nucleotide insertions, a SNP and 
a 436bp insertion within the pilV  shufflon. Sequence variations in the pilV  shufflon 
region were nevertheless to be anticipated, as it is a long known feature of Incl 
plasmids caused by the re-arrangement of this region mediated by Rci recombinase 
which selects the variable N-terminus portion o f the PilV adhesin (Komano et a l,
1987).
When comparing the sequence of the annotated plasmid plFM3804 to previously 
sequenced plasmids from the NCBl database, it was shown that the backbone o f this 
plasmid is most closely related to plasmids not harbouring CTX-M genes. Sequence 
analysis of the ISEcp7-CTX-M-1 resistance region have revealed its sequence to be 
highly homologous to that of ISEcpf-CTX-M-1 of E. coli RB-01 originating from a 
Parisian hospital (Eckert et a l, 2006). Additional analysis o f the insertion site within 
the plasmid backbone revealed that this ISEcpl had inserted at a different site within 
the plasmid backbone than that of previously sequenced CTX-M harbouring Incll 
plasmids. These data suggest that plFM3804 is a novel CTX-M harbouring plasmid 
that has arisen by the stepwise acquisition o f resistance islands 1SCR2 and ISEcpl by 
a CoUb-p9 like plasmid, rather than a plasmid evolved from previously described 
CTX-M harbouring plasmids pEK204, pEC Bactec or pESBL-EAl 1.
The PCR tests based on the derived sequence data were used to assay all strains and 
61 of the 63 were positive for these primer pairs. This is strong evidence for a high 
degree of similarity if not identity. However, the RFLP data, which as stated may not 
be of a high quality, and PCR data, collectively suggest close identity o f the 61 
plasmids but cannot preclude the possibility of minor differences either at the SNP 
level or acquisitions and losses as perhaps exemplified by the floR  region.
Regarding the differences in carriage o f floR  amongst the strains carrying the Incll 
plasmid, examination of the DNA sequence of this resistance region for the three 
sequenced plasmids revealed the presence o f well characterised transposition element 
ISCR2. BLASTN searches of the region spanning both resistance genes resulted in a 
match (99% identity over 95% of this region) against Acinetobacter baumanii 1SCR2 
element (FN293050.1) as well as shorter matches still containing both resistance
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genes against K. pneumoniae plasmid pKVHl (HF545434.1), E. coli plasmid 10660- 
1 (AF231986.2) and pHHV216 from an uncultured bacterium (FJ012880.1). 
Homologous recombination between multiple copies of 1SCR2 has been shown to 
lead to variance in resistance gene carriage for the Vibrio cholerae element SXT 
(Toleman et ah, 2006). If the same is happening for the strains in this collection, it 
would explain the variance in carriage of the floR  resistance determinant. Interesting 
further work would include sequencing studies o f the 1SŒ2 region within those 
plasmids lacking the floR  determinant.
Another aim of this work was to establish the prevalence of the CTX-M harbouring 
plasmid amongst the remaining 63 outbreak strains. As only two outbreak strains had 
been found to harbour a CTX-M Group 9 gene, no further work was carried out to 
investigate the presence of plFM3780 and plFM3789-like plasmids. On the other 
hand, PCR studies carried out on the CTX-M group 1 harbouring outbreak strains 
using primers that detect a plFM391, plFM3804 and plFM3844 unique region, 
suggested the presence of this plasmid type in at least 61 outbreak strains, including 
the 7 strains chosen for plasmid characterisation in this chapter. Interestingly, a 
further two strains which were negative for this PCR, were still positive for carriage 
of the Incll-y determinant and a CTX-M group 1 gene. Further studies should aim to 
determine the CTX-M type carried by these strains, whether it is associated with the 
Incll-y plasmid in these strains and the insertion site within the plasmid backbone.
Finally, an experiment to determine the conjugation status of the characterised 
plasmids was carried out as part of these studies. It is interesting to note that for the 
conjugations using Salmonella 4,5,12,i:- B3810 and B3844 conjugation was achieved 
after Ihr mating in a liquid environment whereas for all of the other strains 
conjugation had not been achieved by then. Unfortunately, as counts of 
donor/recipient/transformant were not carried out, rates of conjugation could not be 
quantified which would have allowed a comparison of conjugation efficiencies for the 
5hr mating experiment. An interesting experiment would be to use the three 
sequenced-plasmid strains as donors and attempt to introduce them, by conjugation, 
into strains of all three different species studied here, calculating the conjugation 
rates.
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The data presented here suggest that the prevalent plasmid type was mobile and may 
well have readily disseminated into multiple host bacterial backgrounds. It is 
tempting to speculate that the Salmonella background afforded a high degree of 
promiscuity, although the mechanism for this is unclear. It is more likely that the 
plasmid type described here, assuming a single type is what is being described, has a 
fixed rate and that it is the biology o f the recipient, including such factors as surface 
exclusion and restriction, that was responsible for the differences in apparent transfer 
rate. Important for the epidemiology of the CTX-M resistance gene and the revised 
testable hypothesis of this chapter is that the plasmid vector was mobile and therefore 
this will, under appropriate circumstances, permit clonal spread of the gene/plasmid 
through conjugation.
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Chapter 5:
Development of an Incll specific 
curing vector and generation of 
Incll plasmid cured derivatives
Chapter 5 : Development of an Incll specific curing 
vector and generation of Incll plasmid cured derivatives
5 .1  Introduction and aims
To address the question of what is the phenotypic impact of plasmid carriage upon the 
host bacterium, a key tool was the construction of plasmid cured derivatives of the 
outbreak strains. Additionally, it was also intended to construct complemented strains 
by re-introducing the original plasmid into the cured strains, as this would permit 
identification of any phenotypic effects caused by the plasmid removal process rather 
than absence of the plasmid.
On analysis of the full DNA sequence o f three outbreak plasmids (See Chapter 4) it 
was found that the same plasmid isolated from different species o f bacteria contained 
single nucleotide point mutations. To investigate whether these mutations were 
genetic adaptations to the host bacterium it was decided that, as well as creating 
complemented strains by introducing the original plasmid that was removed, cured 
strains complemented with the plasmids originating from the other two species 
studied would also be constructed.
Construction o f plasmid free, otherwise isogenic derivatives of the strain carrying the 
plasmid of interest is key in understanding the phenotype that plasmid carriage 
conveys. The process of eliminating a plasmid from its host strain is referred to as 
curing. A traditional method for plasmid curing involves the growth of the target 
strain in the presence sub-lethal concentrations of DNA intercalating agents. These, 
however, are known for their mutagenic effects (Ferguson and Denny, 2007). Another 
common way of achieving curing is the repeated passage o f the strain in non-selective 
medium, followed by replica plating on selective and non-selective medium with the 
aim of identifying colonies that have spontaneously lost the plasmid. Unfortunately, 
both of these approaches carry the risk of accumulation o f unwanted mutations in the 
strains, thus weakening any conclusion made from the analysis of such strains. 
Consequently, for these studies, plasmid incompatibility based curing was chosen 
instead. The basis for incompatibility curing is the observation that two plasmids
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bearing the same replicon cannot be stably maintained in a cell line (Couturier et a l,
1988). To this end, genes involved in the downregulation of replication o f plasmid are 
cloned into a suitable vector. Additional genes that can be included in a curing vector 
are the antitoxin counterparts in addiction systems in order to avoid the killing of 
plasmid free segregants (Hale et a l, 2010). Plasmid Incompatibility based curing has 
been successfully employed for curing of plasmids belonging to other replicons (Hale 
et a l, 2010), (Tatsuno et a l, 2001), but not for Incll plasmids.
The DNA sequence of outbreak plasmid pIFM3804 (this study) as well as that of 
other Incl I plasmids uploaded to NCBI were analysed in order to identify key 
replication and addiction genes to be included in the curing vector. The main 
component in control of copy number in Incll plasmids is the non-translated RNA 
gene RNAI. This RNA binds the mRNA transcript of the replication initiator repZ 
thus inhibiting its translation (Nikoletti et a l, 1988). Other genes considered for 
inclusion in the curing vector were the antitoxin from addiction system pndA/C and 
the stability system parB, also present in the outbreak plasmid.
An artificial cloning vector kindly provided by Dr C. Thomas (University o f 
Birmingham) (pAKE604A) was used in this work. pAKE604A is a modified version 
of pAKE604, which has been used previously for incompatibility based curing (Hale 
et a l, 2010). The only modification in pAKE604A with respect to pAKE604 is a 
different multiple cloning site (MCS) (Figure 5.1). Two features of pAKE604A make 
it particularly suitable for its use as a curing vector. The first one is that its replicon is 
not stable, that is that in the absence of selection, a proportion o f the population will 
spontaneously loose the vector, which enables recovery o f vector free clones after the 
curing of the target plasmid has been achieved. The second feature is the presence of 
counter selection gene sacB. The structural gene sacB originates from Bacillus 
subtilis, where it encodes for levansucrase. Levansucrase catalyses the synthesis of 
levans in the presence of sucrose, which are toxic to gram negative organisms (Gay et 
a l, 1985). This property enables the selection of those clones that have lost the curing 
vector.
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Figure 5.1: Genetic map of pAKE604A 
B g m
pAKE604A
7216 bps
lacZa
pMBl oriV
TTi
EcoRl BamHl 
Xbal
Diagram of DNA vector pAKE604A. oriT: transfer origin from RK2/RP4, allows 
mobilization from strain S17-1. pMBl oriV\ high copy number origin of replication. 
lacZa: allows blue/white selection in appropriate hosts. BglW, EcoRl, Xbal and
r  ^ r
BamHl: restriction sites, kan : kanamycin resistance, dimp : ampicillin resistance. 
sacB: counter selection gene from B. subtilis, encodes levansucrase.
101
5.2 Results
5.2.1 Introduction of pAKE604A into DH5 Alpha
pAKE604A DNA obtained from Dr C. Thomas (University of Birmingham) was 
transformed into E. coli DH5 Alpha Max Efficiency and transformants were selected 
by plating on LB agar supplemented with lOOpg/ml of ampicillin. Four well isolated 
colonies were re-streaked on LB agar supplemented with lOOpg/ml of ampicillin 
before being cultured at 37°C overnight in 5ml of LB broth supplemented with 
lOOpg/ml of ampicillin. The resulting cultures were used to make glycerol stocks and 
stored at -80°C. The isolates were named CL09 to CL12. For clarity purposes, a table 
listing the strains and plasmids constructed during the cloning process has been 
included in Appendix 1.
5.2.2 Subcloning of RAW/into pCR-Blunt
Primers were designed to amplify the RNAI gene along with its native promoter. The 
forward primer, RNAIFW (Table 2.1), was designed so that it introduced an Xbal site 
followed by a Xhol site to the 5’ o f the cloned RNAI gene. The reverse primer, 
RNAIRV (Table 2.1), was designed to introduce a BamHl site to the 3’ of the cloned 
RNAI gene. The amplified products were run on an agarose gel and a single clean 
product of the predicted size (155bp) was generated verifying success o f the PCR. As 
no non-specific amplification was detected, the remaining PCR product was cleaned 
using MinElute PCR Purification Kit (see Section 2.25) and ligated with pre­
linearized commercial vector pCR-Blunt following manufacturer’s recommendations 
(see Section 2.26). The ligation mixture was used to transform chemically competent 
E. coli DH5 Alpha Max Efficiency cells and transformants were selected by plating 
on LB agar supplemented with 50pg/ml o f kanamycin, as pCR-Blunt carries a 
kanamycin resistance gene (aph(3)-I). Four well isolated colonies were re-streaked 
on selective agar and subsequently cultured on LB broth supplemented with 50pg/ml 
of kanamycin. Plasmid DNA was extracted from the transformants using QIAprep 
Spin Miniprep kit (see Section 2.27). The extracted plasmid DNA was digested using 
Xbal and BamHl to confirm presence of the insert of the predicted size (see Section
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2.28). Extracted plasmid DNA was also sent for sequencing using insert flanking 
primers (M13FW and M13RV) to ensure no errors had been introduced by the 
polymerase during amplification. The resulting strains were named CLOl to CL04.
5.2.3 Cloning of RNAI into pAKE604A
To prepare RNAI for insertion into pAKE604A, strain CLOl was cultured at 37°C 
overnight in 5ml of LB broth supplemented with 50pg/ml of kanamycin and plasmid 
DNA was extracted using QIAprep Spin Miniprep kit. The extracted plasmid was 
digested with Xbal and BamHl and the band running below the 250bp marker cut out 
of the gel. QIAquick Gel Extraction Kit was used to purify the digested insert DNA 
out of the band (see Section 2.29). To prepare the vector pAKE604A it was digested 
with Xbal and BamHl and the fragments separated by gel electrophoresis. Alongside 
the double digested vector uncut plasmid DNA and single digests were also run on 
the same gel. This was done to enable identification of the appropriate band and to 
confirm that both restriction sites were functional. The digested vector was purified 
from the gel using QIAquick Gel Extraction Kit. The vector and insert were ligated 
(see Section 2.30) and used to transform E. coli DH5 Alpha Max Efficiency. 
Transformants were selected by plating on LB agar supplemented with lOOpg/ml o f 
ampicillin. Three single colonies were re-streaked on LB agar supplemented with 
lOOpg/ml of ampicillin before being cultured at 37°C overnight in 5ml of LB broth 
supplemented with lOOpg/ml of ampicillin. Insertion was verified by PCR using 
RNAI-FW and Pre-MCS primers and the same primers were also used for 
sequencing. The extracted plasmids were digested with Bglll and Xbal to confirm the 
predicted total size of the plasmid and, as expected, two bands of 4243bp and 31 lObp 
respectively were observed. Single restriction digests using Xbal, EcoRl and Xhol 
were also set up to confirm functionality o f the restriction sites. The resulting strains 
were named CL 19, CL20 and CL21. A map o f the resulting vector, pIFMI9 can be 
seen in Figure 5.2.
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Figure 5.2: Genetic map of pIFM19 
Bglll
am p^
pIFM19
7959 bps 2000^
5 0 0 0
3 0 0 0 o r lT R K l
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pMBl oriV
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— l J --------------
lacZa RAW/Prom 
interrupted
BamHl
I
RNAI lacZa
cont’d
Diagram of DNA vector pIFM19. RNAI (blue arrow) and a small upstream region 
containing its native promoter {RNAI Prom) have been introduced into pAKE604A 
between the Xba\ and BamHl sites. Additionally, an Xhol has been introduced for 
later cloning. All other genes as in figure 5.1. Magnified section not to scale.
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5.2.4 Subcloning of tbe aac6'-Ib gene into pCR-Blunt
As the outbreak strains were already resistant to kanamycin an alternative resistance 
marker was chosen for inclusion in the curing vector to enable ease of selection. It 
was decided not to remove the other selection markers present in the plasmid, as this 
would give the vector the potential to work against a wider range of strains, should it 
be needed in future. The amikacin resistance gene aac6’-Ib was chosen and cloned 
from a wild type plasmid isolated by C. Boinet (AHVLA) as part of her PhD studies 
and sequenced by M. AbuOun (AHVLA) and M. Stokes (AHVLA) as part of a CTX- 
M plasmid sequencing study (personal gift). In this case, both the forward and reverse 
primers, aac6’-IbFW and aac6’-IbFW (Table 2.1) were designed to amplify aac6'-Ib 
from the above plasmid, and so that they introduced EcoRl sites at either side of the 
cloned gene. These primers were used to amplify the aac6’-Ib gene and the PCR 
product was run on an agarose gel. A single clean product of the predicted size was 
generated verifying success of the PCR. As no non-specific amplification was 
detected, the remaining PCR product was cleaned using MinElute PCR Purification 
Kit and ligated with pre-cut commercial vector pCR-Blunt following the 
manufacturer’s recommendations. The ligation mixture was used to transform 
chemically competent E. coli DH5 Alpha Max Efficiency cells and transformants 
were selected by plating on LB agar supplemented with 50pg/ml o f kanamycin. 
Kanamycin was chosen for selection, rather than amikacin, due to the kanamycin 
resistance marker already present in the vector being well characterised and the 
concentration of kanamycin needed for selection already well established. Well 
isolated colonies were re-streaked on LB agar supplemented with 50pg/ml of 
kanamycin and subsequently cultured at 37°C overnight in 5ml of LB broth 
supplemented with 50|xg/ml of kanamycin. Primers flanking the insertion site 
(MI3FW and MI3RV) were used to confirm presence of the insert (expected ~800bp 
band) and also for sequence analysis. The resulting strains were named CL22, CL23, 
CL24, CL25 and CL26.
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5.2.5 Cloning of aac6'-Ib into pIFM19
To prepare aac6’-Ib for insertion into pIFM19 strain CL25 was cultured at 37°C 
overnight in 5ml o f LB broth supplemented with 50|xg/ml of kanamycin and plasmid 
was extracted using QIAprep Spin Miniprep kit. The extracted plasmid was digested 
with EcoRl and the insert DNA purified using QIAquick Gel Extraction Kit. To 
prepare vector pIFMI9, strain CL25 was cultured at 37°C overnight in 5ml o f LB 
broth supplemented with lOOpg/ml of ampicillin and its plasmid extracted by plasmid 
QIAprep Spin Miniprep kit. The plasmid was then digested with EcoRl and the 
appropriate band extracted from the gel using QIAquick Gel Extraction Kit. The 
digested, purified pIFMI9 DNA was dephosphorylated using Thermo Sensitive 
Alkaline Phosphatase (TSAP) in order to avoid self-ligation of the vector.
The purified insert and vector were ligated and transformed into chemically 
competent E. coli DH5 Alpha Max Efficiency. A map of the resulting plasmid can be 
seen in Figure 5.3. Transformants were selected by plating on LB agar supplemented 
with lOOpg/ml of ampicillin. Only one colony was found. This colony was re­
streaked on LB agar supplemented with lOOpg/ml of ampicillin and subsequently 
cultured at 37®C overnight in 5ml of LB broth supplemented with lOOpg/ml of 
ampicillin. As only one restriction site was used for cloning of this gene the insert 
could be inserted in either the correct orientation, and therefore downstream of the 
lacZa promoter, or in the wrong orientation, in which case it would not be expressed. 
A PCR was set up using aac6’-IbFW and Pre-MCS, which, if positive, would indicate 
the insert is present in the correct orientation. A second PCR was set up using aac6’- 
IbRV and Pre-MCS, which, if positive, would indicate the insert is present in the 
wrong orientation. The insert was present in the correct orientation as detected by 
PCR. Nevertheless, as confirmation, the resulting plasmid was sent for sequencing 
using the correct orientation PCR primers (EcoRI-aac6-IbFW and Pre-MCS). The 
resulting strain was named CL27 and its plasmid pIFM27.
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Figure 5.3: Genetic map of pIFM027
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Figure 5.3: Diagram of DNA vector pIFM27. aacô'Ib (blue arrow) has been 
introduced into pIFM19 at the EcoRl site placing it under the control of the lacZa 
promoter. All other genes as in figure 5.2. Magnified section not to scale.
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5.2.6 Determining the MIC for Amikacin of DH5 Alpha, CL27 and 
outbreak strains B3791, B3804 and B3844
To test the levels o f amikacin resistance that the cloned gene conferred to the strain 
amikacin MIC’s were carried out for DH5 Alpha and CL27 (see Section 2.32). As 
only disc diffusion data was available for the outbreak strains B3791, B3804 and 
B3844 regarding amikacin susceptibility, these strains were also tested (Table 5.1). 
As the aac6’-Ib gene was cloned under the control of the lacZ promoter already 
present in the vector, MIC determination was also carried on bacterial cells in which 
Aac6 expression had been induced with IPTG (lOOpM). The plasmid free DH5 Alpha 
baseline MIC was 0.5pg/ml. This increased 8 fold to 4pg/ml after introduction of the 
plasmid pIFM27. The results on IPTG induction were inconclusive, as out of the 
three times the experiment was carried out, the result was 4 on two occasions and 8 
on one occasion. As for the outbreak strains to be targeted for curing, they were all 
below the EUCAST MIC breakpoint for resistant strains of 8/16pg/ml. However 
strains B3804 and B3844 showed a relatively high MIC at 4pg/ml when compared to 
the resistance level of CL27.
5.2.7 Transformation of pIFM27 into target strains B3791, B3804 and 
B3844
Electro competent cells of B379I, B3804 and B3844 (see Section 2.33) were 
transformed via electroporation with pIFM27 DNA. The strains to be transformed 
displayed MICs to amikacin similar to that of the DH5 Alpha carrying pIFM27. For 
this reason transformants were selected by plating on LB agar plates containing 
amikacin at a range of concentrations. For strain B3791 selection plates containing 2 
and 4pg/ml of amikacin respectively were used. Colonies were only found on the 
2pg/ml plate. Forty colonies were inoculated into lOOpl of LB broth supplemented 
with 2pg/ml of amikacin. In the case o f strains B3804 and B3844, the selection plates 
used were supplemented with 8 and 16pg/ml of amikacin. Colonies were recovered 
on both concentrations. Only three colonies tested positive by PCR for the presence
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Table 5.1: Amikacin MICs of B3791, B3804, B3844, DH5 Alpha and CL27
Strains MIC (pg/ml)
B3791 1 '"'-J
B3804 4
B3844 4
DH5 Alpha 0.5
CL27 4
IPTG induced CL27 4*
Amikacin MIC results. B379I, B3804 and B3844 are the outbreak strains to be cured 
by introduction of pIFM27, which carries the amikacin resistance gene aac6’-Ib 
under the control of the lac promoter. DH5 Alpha is the lab strain used for the cloning 
of pIFM27, thus making strain CL27. IPTG induction of the aac6’-Ib gene was 
attempted to increase MIC. * This experiment was repeated three times, two times 
MIC results were 4ug/ml whilst once the result was 8ug/ml.
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of curing vector pIFM27, all three were B3791 transformants. The isolates were 
stored in HIB glycerol at -80°Cand named CL28, CL29 and CL30. Isolates CL28, 
CL29 and CL30 were found to be negative for carriage of a CTX-M gene by 
Universal CTX-M PGR as well as being unable to grow on LB agar supplemented 
with 2pg/ml cefotaxime plates.
A further attempt to transform B3804 and B3844 with pIFM27 was carried out using 
freshly made electrocompetent bacteria and plasmid DNA. The range of selective 
plates was increased to include LB agar plates supplemented with 32pg/ml of 
amikacin. Eighty eight B3804 colonies and 168 B3844 colonies were tested however 
no true transformants were found.
5.2.8 Isolation of vector free derivatives of strains CL28, CL29 and 
CL30
As the ultimate goal of the curing process was the creation o f isogenic mutants, the 
next necessary step was the removal of the curing vector. For this step, two 
characteristics of the curing vector were exploited. The first was the fact that the 
vector is unstable, that is that in the absence of selection vector free clones will arise. 
The second is the presence in the vector of sacB gene, which confers sucrose 
sensitivity. Strains CL28, CL29 and CL30 were cultured in antibiotic free LB, diluted 
to -lO'^CFU/ml and plated on LB agar and LB agar supplemented with 5% sucrose. 
For each strain nine colonies were re-streaked on sucrose agar, then cultured in LB 
and tested for the presence of the vector by using primers aac6-IbFW and Pre-MCS 
and none of them were found to be positive. Three colonies from each CL28, CL29 
and CL30 were stored in glycerol. The strains were named, respectively, CL31, CL32 
and CL33, CL34, CL35 and CL36 and CL37, CL38 and CL39. Xba\ PFGE was 
carried out on all the derivatives o f B3791 to confirm their identity (Figure 5.4). All 
the strains tested were shown to be derived from the original B3791 strain. However, 
some minor differences in the banding pattern were found. In the case of strains 
CL28, CL29 and their pIFM27 free derivatives, the difference is in the position of one
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Figure 5.4: Xbal PFGE of B3791 and its plasmid cured derivatives
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Pulsed field gel electrophoresis of Xba\ digested genomic DNA of K. pneumoniae 
strain B3791, its pIFM27 transformed derivatives CL28, CL29 and CL30. 
Additionally, CL28, CL29 and CL30 plFM27 free derivatives, CL30-CL39, are also 
displayed. Size reference strain S. Braenderup was run alongside. Circled blue is a 
band that in CL27, CL29 and their derivatives has migrated further than its B3791 
counterpart (circled red). In the case of CL37 this lower than expected band is also 
present (circled green) although this is not the case for its progenitor CL30 for which 
the band is no longer present.
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band, which is smaller for these strains than for the original strain B3791. In the case 
of strains CL30 and its derivatives the situation is slightly different. CL30 and its 
derivatives CL38 and CL39 have lost the band that in the other strains has become 
smaller. However, strain CL37 displays the same pattern as strains CL28 and CL29 
and their derivatives, with one difference in profile consisting of a band smaller than 
that of the original strain. Plasmid content of the CL28, CL31, CL32, CL29, CL34 
and CL35 was confirmed by plasmid profiling and it was found to be as expected 
(Figure 5.5). Strains CL28 and CL29 had lost a plasmid at -lOOkb and acquired a 
plasmid of~8kb. Strains CL31, CL32, CL34 and CL35 were no longer carrying either 
of these plasmids.
5.2.9 Cloning of pndB into pIFM27
Following failure to select for pIFM27 transformed B3804 and B3844 it was 
hypothesized that the antitoxin against the pndA/C system present in the outbreak 
plasmid may be needed in the curing vector in order to increase curing efficiency. 
pndB is an RNA gene which inhibits the activation of the addiction system pndA/C. 
Primers were designed to amplify this gene along with its native promoter whilst also 
introducing restriction sites either side of the amplified region. In this case the cloning 
approach was slightly modified because very low numbers of transformants had been 
found previously after the subcloning step. The forward primer, pndBFW (Table 2.1), 
was designed to introduce an Xbal site followed by an Agel site at the 5’ end of the 
cloned gene. Additionally, an extra random 6 bases were included at the 5’ end of the 
primer, thus enabling the digestion of PCR products for direct cloning into pIFM27 
(Figure 5.6). The reverse primer, pndBRV (Table 2.1), was designed to introduce 
Xhol restriction site to the 3’ of the cloned region. As was done for pndBFW an extra 
6 random bases were added to the 5’ of pndBRV. A PCR was setup using pndBFW 
and pndBRV and pIFM3804 DNA. The amplified product was cleaned up using 
MinElute PCR Purification Kit and digested using Xbal and Xhol. Following 
restriction digestion, the amplified DNA was cleaned using MinElute PCR 
Purification Kit in preparation for the ligation step. To prepare pIFM27 for the 
insertion of the above digested PCR products, strain CL27 was cultured at 37°C
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Figure 5.5: Plasmid profiling of B3791 and its cured derivatives
pIFM379t
k^IL au
148kb
63.4kb
36kb
6.9kb
Plasmid profiling DNA gel electrophoresis of B3791, its pIFM27 transformant 
derivatives CL28 and CL29, and their pIFM27 free derivatives CL31, CL32, CL34 
and CL35. 20R764 is a reference plasmid-free E. coli for identification of the 
chromosomal DNA band. 39R861 is a reference strains carrying four plasmids of 
known sizes as labelled. The red lines are the native plasmids of B3791 and its 
derivatives. The blue lines in CL28 and CL29 are the introduced plFM27 curing 
vector. In lanes CL28 to CL35 the native CTX-M Incll plFM3791 has been lost.
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Figure 5.6: Genetic map of pIFM040
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Figure 5.6: Diagram of DNA vector pIFM40. pndB (blue arrow) and its native 
promoter have been introduced into pIFM27 between restriction sites Xba\ and Xho\. 
All other genes as in figure 5.3. Magnified section not to scale.
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overnight in 5ml of LB broth supplemented with lOOpg/ml of ampicillin and plasmid 
DNA extracted using QIAprep Spin Miniprep kit. The extracted plasmid was digested 
with Xbal and Xhol and following restriction digestion o f the vector DNA it was also 
cleaned using the MinElute PCR Purification kit. The digested vector and insert were 
ligated and transformed into chemically competent E. coli DH5 Alpha Max 
Efficiency. Transformants were selected by plating on LB agar plates supplemented 
with lOOpg/ml of ampicillin. Five single colonies were re-streaked on LB agar 
supplemented with lOOpg/ml of ampicillin and subsequently cultured at 37°C 
overnight in 5ml of LB broth supplemented with lOOpg/ml of ampicillin. To confirm 
the presence of the insert the isolates were tested by PCR using the pndBFW and Pre- 
MCS primers and all 5 strains gave a product of 370bp. QIAprep Spin Miniprep Kit 
was used to extract plasmid DNA which was sent for sequencing using primers 
pndBFW and Pre-MCS. The resulting strains were stored as glycerol stocks and 
named CL40, CL41, CL42, CL43 and CL44.
5.2.10 Transformation of pIFM40 into target strains B3804 and 
B3844
Curing of strains B3804 and B3844 was reattempted by introducing the curing vector 
pIFM40 into them by electroporation. Transformants were selected by plating on LB 
agar plates supplemented with 8pg/ml of amikacin. Colonies were found for both 
transformations. A total of 72 B3804 colonies and 56 B3844 colonies were inoculated 
into lOOpl of LB broth supplemented with 8pg/ml of amikacin. After 4 hours the 
inoculated broths were tested by PCR for presence of pIFM27 using primers pndBFW 
and Pre-MCS, however all o f them tested negative for carriage of vector pIFM40. As 
it appeared that the plate MIC generated by the marker gene was not sufficiently 
different fi*om that of the innate resistance MIC shown by these recipient bacteria the 
chance of selecting the desired recombinants was extremely low. For this reason 
further attempts were abandoned.
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5.2.11 Validation of Incll curing vector on kanamycin sensitive lab 
strains
The repeated finding of pseudo-transformant colonies able to grow on amikacin 
supplemented LB agar when attempting to select for pIFM27 and pIFM40 suggested 
that the selective marker introduced did not generate an MIC value sufficiently 
different from that of the recipient bacteria to allow for adequate selection. To test 
whether the problem was only one of selection, curing was attempted on fully 
kanamycin sensitive lab strains that had been transformed with the outbreak plasmids. 
The strains used for this purpose, T9 la, T04a and T44a, were E. coli NEB 10-beta 
derivatives that carried outbreak plasmids pIFM3791, pIFM3804 and pIFM3844, 
respectively.
5.2.12 Transformation of pIFM27 Into T91a, T04a and T44a
T9 la, T04a and T44a were made electrocompetent and curing vector pIFM27 was 
transformed into them by electroporation. Transformant colonies were recovered on 
LB agar supplemented with 50pg/ml of kanamycin for all three strains. Two single 
colonies from each transformation were re-streaked on LB agar supplemented with 
50pg/ml of kanamycin and subsequently cultured at 37°C overnight in 5ml LB broth 
supplemented with 50pg/ml kanamycin. The resulting cultures were stored as 
glycerol stocks and tested for the presence of pIFM27 by PCR using primers aac6’- 
IbFW and Pre-MCS and with CTX-M group 1 primers (Table 2.1). The PCR tests 
were positive for the vector PCR and negative for the CTX-M group 1 primers. The 
resulting confirmed strains, named CL54 to CL59 (Appendix 2), were found to be 
positive for pIFM27 and negative for CTX-M gene, suggesting that pIFM27 had been 
successfully introduced and the native Incll-CTX-M-1 plasmids displaced.
5.2.13 Removal of curing vector from strains CL54-CL59
As previously done with strains CL28, CL29 and CL30, the last step of the curing 
process for strains CL54-CL59 was to remove curing vector pIFM27. For this
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purpose the strains were cultured in antibiotic free LB broth. The resulting cultures 
were diluted to -lO'^CFU/ml and plated on LB agar and LB agar supplemented with 
5% sucrose. Two single colonies from the sucrose plate for each strain were re­
streaked on sucrose supplemented agar and subsequently cultured at 37°C overnight 
in 5ml of LB broth. The resulting cultures were stored as glycerol stocks and tested 
for the presence of pIFM27 by PCR using primers aac6’-IbFW and Pre-MCS and 
with CTX-M group 1 primers. The resulting strains, named CL69-CL80 (Appendix 
3), were found to be negative for both pIFM27 and CTX-M gene, suggesting that 
pIFM27 had been successfully removed and that the strains were cured of their native 
Incll-CTX-M-1 plasmids. Additionally, plasmid profiling of these strains and their 
parent strains CL54-CL59 was carried out to confirm plasmid carriage (Figure 5.7). 
Strains CL54-CL58 were found to be carrying a plasmid of approximately 8kb, 
consistent with uptake of pIFM27 and no other plasmid, consistent with loss of their 
respective Incll plasmid. Strains CL69-CL80 no longer carried either plasmid.
5.2.14 Validation of IncI-1 curing vector with wild type strains of 
alternative origins
To investigate whether curing vector pIFM27 would be able to displace Incll 
plasmids not originating from the outbreak farm dealt with in these studies, wild type 
strains carrying Incll-CTX-M plasmids from other sources were obtained. Strains 
LREC215 and LREC447 were obtained as part of studies carried out by L. Randall 
(AHVLA). Strain LREC215 was a CTX-M Incll-y E. coli isolated from a broiler as 
part of a large survey of CTX-M in UK livestock (Horton et a l, 2011). Strain 
LREC447 was also a CTX-M Incll-y E. coli isolated from a broiler; however, in this 
case the strain was identified as an avian pathogenic E. coli (Randall et a l, 2012).To 
confirm the identity of the plasmids CTX-M group 1 and Incll-y replicon typing 
primers were used for PCR. Gel electrophoresis of both PCR tests showed that both 
tests were positive. These two strains were selected as they were found to be fully 
sensitive to kanamycin, thus avoiding the use of amikacin as a selective marker, 
which had previously proved ineffective.
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5.2.15 Transformation of pIFM27 into LREC215 and LREC446
Strains LREC215 and LREC446 were made electrocompetent and curing vector 
pIFM27 was transformed into them by electroporation. Transformant colonies were 
recovered on LB agar supplemented with 50pg/ml of kanamycin for all three strains. 
Two single colonies from each transformation were re-streaked on LB agar 
supplemented with 50pg/ml o f kanamycin and subsequently inoculated into LB broth 
supplemented with 50pg/ml. The resulting cultures were stored as glycerol stocks and 
tested for the presence of pIFM27 by PCR using primers aac6-IbFW and Pre-MCS 
and with CTX-M group 1 primers. The resulting strains, named CL61, CL62, CL65 
and CL66 (Appendix 4), were tested by PCR and they were found to be positive for 
the pIFM27 detecting PCR and negative for CTX-M group 1 PCR, suggesting that 
pIFM27 had been successfully introduced and the native Incll-CTX-M plasmids 
displaced.
5.2.16 Removal of curing vector from strains CL61, CL62, CL65, CL66
To remove curing vector pIFM27 strains CL61, CL62, CL65 and CL66 were cultured 
in antibiotic free LB. The resulting cultures were appropriately diluted and plated on 
LB agar supplemented with 5% sucrose. Two single colonies for each strain were re­
streaked on sucrose supplemented agar then cultured in LB broth. The resulting 
cultures were stored as glycerol stocks and tested for the presence of pIFM27 by PCR 
using primers aac6-IbFW and Pre-MCS and with CTX-M group 1 primers. The 
resulting strains, named CL81-CL88 (Appendix 5), were found to be negative for 
both PCRs, suggesting that pIFM27 had been successfiilly removed and that the 
strains were cured of their native Incll-CTX-M-1 plasmids. Additionally, plasmid 
profiling o f these strains and their parent strains was carried out to confirm plasmid 
carriage (Figure 5.8). Strains CL61, CL62, CL65 and CL66 had acquired an 8kb 
plasmid, presumptively pIFM27, and lost a plasmid of-lOOkb, presumptively their 
native Incll-CTX-M plasmid. Strains CL80-CL88 had subsequently lost the plasmid 
band of 8kb. Otherwise, the plasmid content of the strains was identical to that of 
their respective parents, LREC215 and LREC447. In the case of strain LREC215, 
aside from the changes described above, all of its derivatives still carried a large
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Figure 5.8: Plasmid profiling of LREC215, LREC447 and their respective cured
derivatives
fS fS cn 
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Plasmid profiling DNA gel electrophoresis of strains LREC215 and LREC446, their 
pIFM27 carrying derivatives CL61, CL62, CL65 and CL66 and their pIFM27 free 
derivatives CL81-CL88. 20R764 is a reference plasmid-free E. coli for identification 
of the chromosomal DNA band. 39R861 is a reference strain carrying four plasmids 
of known sizes as labelled. The red circles highlight the Incll-CTX-M plasmids. The 
blue circles highlight the curing plasmid plFM27. This gel demonstrates that on 
introduction of pIFM27 the native Incll-CTX-M plasmids are lost from the strains. 
Subsequently, after growth on non-selective agar and recovery on sucrose 
supplemented agar the curing plasmid pIFM27 is also lost.
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plasmid (>148kb) and two smaller ones (~7kb and ~4.5kb, respectively). As for strain 
LREC447, all o f its derivatives still carried a plasmid of ~148kb.
5.2.17 Confirmation of plasmid curing by further PCR studies
In order to investigate whether the plasmids in the cured strains had been removed or 
whether they may have integrated in the chromosome the presence o f a number of 
genes besides CTX-M was checked by PCR. For the strains cured of the outbreak 
plasmid (B3791 cured derivatives, T9 la  cured derivatives, T04-1 cured derivatives 
and T44-2 cured derivatives) the primers used were floRFW and floRRV, EnvlR and 
Env2FW, Incll-yFW and Incll-yRV and pndBFW and pndBRV (Table 2.1). For the 
strains unrelated to the outbreak, as no sequence data of their plasmids was available, 
only Incll-yFW and Incll-yRV and pndBFW and pndBRV were used. The strains 
were tested at both stages of curing (i.e., whilst still carrying pIFM27 and after its 
removal) and they all tested negative for the all the genes checked.
5.2.18 Salmonella strain S348/11
As no curing of the outbreak Salmonella strain B3844 was achieved, an alternative 
strain was chosen to carry out the phenotypic comparisons of plasmid carrying and 
plasmid free strains. A panel o f six cefotaxime susceptible Salmonella strains with 
antigenic formula 4,(5),12:i:- isolated from the outbreak farm were characterised as 
potential alternatives. Universal CTX-M PCR was carried out to verify the phenotype 
and all strains were found to be negative. The second criterion was that the strains did 
not harbour an Incll plasmid. The Incll-y PBRT primers were used, however two out 
of the six strains in the panel were positive and so removed from the panel. Further 
characterisation of the remaining strains included Xbal PFGE (Figure 5.9) and 
antimicrobial resistance profiling (Table 5.2). One of the strains was resistant to 
chloramphenicol. All the strains tested were resistant to compound sulphonamides. 
Strain S348/11 was chosen as it was it was susceptible to chloramphenicol and 
because of its similarity in PFGE pattern to the target outbreak strain B3844.
121
Figure 5.9: Xbal PFGE of CTX-M harbouring and CTX-M free Salmonella
4,5,12,1:- strains
IX S'
'N ##
A) Pulsed field gel electrophoresis of digested genomic DNA of CTX-M free S. 
4,5,12,i:- strains obtained from the affected farm. Size reference strain S. Braenderup 
was run alongside. B) Pulsed field gel electrophoresis ofXba\ digested genomic DNA 
of CTX-M bearing outbreak S. 4,5,12,i:- for comparison.
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5.2.19 Introduction of outbreak plasmids into CL32 and S348
The last step in constructing strains for plasmid phenotype comparisons was to 
introduce the outbreak plasmids into strains CL32 and S348/11. In the case of strain 
CL32 this would permit confirmation that any deviations in behaviour seen were 
indeed caused by the absence o f the plasmid and not an artefact of the curing process. 
Another question to be addressed was whether the small sequence variations observed 
amongst the three sequenced outbreak plasmids represented adaptations to the species 
where the plasmid originated from. For this reason plasmid bearing derivatives were 
made using all three sequenced plasmids (i.e.: one originating from a K. pneumoniae 
strain, one from an E. coli strain and one from a S. enterica strain) (Appendix 6). 
Solid surface mating conjugations were set up to introduce the plasmid into strains 
CL32 and 8348/11 (see Section 2.34). Transformant strains carrying the outbreak 
plasmids T9 la, T04a and T44a were chosen as donors. Transconjugants were selected 
by plating on Rambach agar supplemented with tetracycline at lOpg/ml, which selects 
for strains CL32 and S348/11, and cefotaxime at 2pg/ml, which selects for the 
incoming plasmid. Two colonies from each transconjugation for strain S348/11 were 
further analysed. The colonies were positive in PCR tests using the CTX-M universal 
primers (Table 2.1). Plasmid profiling was also carried out and presence of a plasmid 
of~100kb confirmed (Figure 5.10).
In the case of strain CL32, only one colony was found for each of the T9 la  and T04a 
conjugations and two colonies for the T44a conjugation. The colonies were all found 
to be positive by CTX-M universal PCR. Plasmid profiling was carried out on 
transconjugants of CL32. The strains had acquired plasmid of~100kb (Figure 5.11).
5.3 Discussion
The main hypothesis tested in the work in this chapter was whether targeting the 
replicon of Incll plasmids was an efficient way of obtaining plasmid cured 
derivatives whilst avoiding the use of mutagens and repeated passaging. This 
approach was successful in curing six out of eight strains, from three unrelated
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Figure 5.10: Plasmid profiling of S348/11 and its outbreak plasmid harbouring
transconjugants
148kb
63.4kb
6.9kb
Plasmid profiling DNA gel electrophoresis of strain S348/11 and its outbreak plasmid 
carrying derivatives. 20R764 is a reference plasmid free E. coli for identification of 
the chromosomal DNA band. 39R861 is a reference strain carrying four plasmids of 
known sizes as labelled. Strain S348/11 carries no plasmids as shown in this gel, its 
transconjugants have acquired a plasmid of around lOOkb, circled blue.
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Figure 5.11: Plasmid profiling of CL32 transconjugants complemented with the
outbreak plasmids
148kb
63.4kb
6.9kb
Plasmid profiling DNA gel electrophoresis of strain CL32 transconjugants. T91-3 
plasmid DNA has been included as a reference of the outbreak plasmid size (circled 
red). 20R764 is a reference plasmid free E. coli for identification of the chromosomal 
DNA band. 39R861 is a reference strain carrying four plasmids of known sizes as 
labelled. All transconjugants have acquired a plasmid of around lOOkb, circled blue.
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origins. Previous work on plasmids belonging to other incompatibility groups 
reported similar success, such as that using pCurel and pCure2 (Hale et a l, 2010), 
and the cloned replicon of p0157 (Tatsuno et a l, 2001). Although curing was not 
achieved for two of the outbreak strains targeted, the results suggest that the failure 
was due to poor selection rather than failure of the curing approach itself. 
Specifically, the curing of lab strains carrying the outbreak plasmids suggests that the 
problem was one o f selection, and not of specificity. Nevertheless, to further 
substantiate the claim that this method is an efficient way o f curing Incll plasmids a 
more suitable resistance marker should be found, followed by reattempting curing of 
the other outbreak strains. Indeed, given the promise shown in this and previous 
studies it would be useful to have curing plasmids that are constructed with a wide 
range of selectable markers. These need not be antibiotic resistance which, as we 
have seen in this study, may not provide sufficient selection, but other markers 
possibly catabolic. Additionally, the full potential of this curing strategy should be 
explored by attempting to cure strains of other species of Enterobacteriacea of their 
Incll plasmids.
An unexpected finding within this work was the change in PFGE profile that occurred 
for the cured derivatives of B3791. These small changes in banding pattern could be 
the result o f random mutations, such as the loss of a restriction site or a deletion or 
insertion (Tenover et a l, 1995). However, as all three cured clones displayed some 
difference in the banding pattern, it could be hypothesized that the change was caused 
by, or at least necessary for, the curing. Using these strains for phenotypic 
comparisons carries the risk that the differences observed could be caused by the 
chromosomal change rather than the loss o f plasmids. On the other hand, by also 
using plasmid complemented strains, rather than just the wildtype, when carrying out 
the comparison, any difference caused by the chromosomal mutation should be easily 
identified, as it would be present on both the plasmid free and plasmid complemented 
strain. Picking up on the possibility that chromosomal rearrangement may play a part 
in the curing process, it is known that plasmids can integrate into the chromosome, as 
has been shown to be the case for the virulence plasmids of enteroinvasive E. coli and 
Shigella flexneri (Zagaglia et a l, 1991) and pMTl of Yersiniapestis the (Protsenko et 
al., 1991). Indeed integration may be a strategy for plasmids to survive or may be a
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transient state that is resolved: whether this leads to the changes in PFGE is unknown. 
To assess specifically what had changed in the chromosome of the cured strain whole 
genome sequencing before and after curing could have been carried out.
Although no cured outbreak S. enterica strains were successfully made, an alternative 
plasmid-ft-ee strain with very similar characteristics to outbreak strain B3844 was 
obtained. As well as originating from the same farm as the outbreak strains, strain 
S348/11 displayed the same serotype and identical PFGE banding pattern. In terms of 
the antimicrobial resistance, it was very close to what a hypothetical cured version of 
B3844 would be expected to be. Specifically, it was sensitive to cefotaxime and 
chloramphenicol, which are carried by the outbreak plasmid. It is worth noting that all 
the strains tested as potential candidates, including the one eventually chosen, were 
resistant to sulphonamides. This, regardless of outbreak plasmid carriage, was 
expected, as it was shown in Chapter 3 that all the Salmonella 4,(5), 12:i:- from the 
outbreak farm carried, as well as the plasmid associated sul2, an additional 
sulphonamide resistance gene, sull. An interesting question arises as to whether this 
strain B3844 was the progenitor strain that had acquired the CTX-M plasmid or 
whether it was a naturally cured isolate. If the hypothesis suggested above that 
plasmid integrates and then resolves on loss, it might be possible to detect plasmid 
remnants or genetic scars on the chromosome where these events have taken place. 
This study would be intriguing and could be tackled by PCR, Southern blotting or 
more effectively whole genome sequencing however, this was beyond the time scale 
of this study.
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Chapter 6:
Phenotypic effect of plasmid 
carriage on S a l m o n e l l a  e n t e r i c a  
and K l e b s i e l l a  p n e u m o n i a e  strains
Chapter 6 : Phenotypic effect of plasmid carriage on 
Salmonella enterica and Klebsiella pneumoniae strains
6.1 Introduction and aims
The final aim of this project was to assess the effect that carriage of the outbreak 
plasmid has on the phenotype of the harbouring strains with a view to advancing 
understanding of the reasons for the high prevalence of Enterobacteriaceae plasmids 
harbouring CTX-M genes. To enable studies into the phenotypic outcome of carrying 
of a CTX-M Incl plasmid, other than resistance, an incompatibility based plasmid 
curing method was developed in order to displace it from its harbouring strain 
(Chapter 5). Whilst this approach was successful at curing K. pneumoniae strain 
B3791, producing Incll plasmid-free strain CL32, it was unsuccessful against two 
other species o f bacteria present at the outbreak farm. Thus Incll plasmid free strains 
were sought from the same farm that may either be the progenitor without the 
plasmid, or at least very similar, or a derivative that had lost the plasmid naturally. 
Salmonella 4,5,I2,i;- strain S348/11 was selected from a panel o f strains originating 
from the outbreak farm. In order to study the plasmids’ contribution to the phenotype 
of the harbouring strain, sequenced plasmids pIFM379I (originating from a K. 
pneumoniae strain), pIFM3804 (originating from an E. coli strain) and pIFM3844 
(originating from a S. enterica strain) were introduced into strains CL32 and S348/11. 
With these resources it was possible to tackle the aim of this chapter, namely, to 
identify the phenotypic effect that plasmid carriage has on the harbouring strains, 
testing the hypothesis that plasmid carriage is beneficial to the competitive ‘fitness’ of 
the harbouring strain thus explaining the high success of the plasmids. Additionally, 
by including strains complemented with a plasmid isolated from each o f three 
species, this might reveal whether the point mutations observed in the plasmid 
sequences’ represent adaptation specific to the species from which it was isolated. 
The first set of strains chosen for the phenotypic studies undertaken in this chapter 
comprised the wild type K. pneumoniae B3791, its Incll plasmid cured derivative 
CL32 and plasmid complemented strains CL32-pIFM3791, CL32-pIFM3804 and 
CL32-pIFM344. The second set of strains comprised the wildtype Salmonella
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4,5,12,1:- strain S348/11 and its plasmid harbouring derivatives S348-pIFM391a, 
S348-pIFM3791b, S348-pIFM3804a, S348-pIFM3844a.
6.2 Results
6.2.1 Effects of plasmid carriage on the competitive fitness of the 
hearing strain
To determine the impact that the outbreak CTX-M-1 plasmid has on the competitive 
fitness o f its carrying strain, competition studies were carried out following methods 
adapted from previously described experiments ((Lenski et al, 1994), (See section
2.35)). For this assay the plasmid free strain and an otherwise isogenic plasmid 
carrying strain were co-cultured and passaged for 6 days in Davis Minimal (DM) 
medium. Using selective (LB agar supplemented with 2pg/ml of cefotaxime) and 
non-selective solid medium (LB agar), daily counts of the total numbers of bacteria 
and the plasmid carrying organism were carried out. To calculate the number o f 
plasmid free bacteria the number of plasmid carrying bacteria was subtracted from the 
total number of bacteria. For the competition experiments conducted with Salmonella 
strain S348/11 and its derivatives (set 2), dilution and plating as described by Miles 
and Misra was performed (Miles et al., 1938). For the competition experiments 
carried out with Klebsiella strain CL32 and its plasmid carrying counterparts, the 
larger colonies present after overnight incubation did not allow the use o f the Miles 
and Misra method. Instead 50pl of the appropriate dilution was spread on each plate. 
To calculate the plasmid’s selection rate the loge ratio of plasmid free to plasmid 
carrying bacteria for each repeat was plotted and the slope of the line of best fit for 
each repeat taken as a measurement of the selection rate for that experiment. A 
positive slope would denote that plasmid free bacteria are out-competing the plasmid 
carrying counterparts and a negative slope would denote the opposite (see Figure 6.1 
for an example of a repeat where the plasmid free organisms are outcompeting
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Figure 6.1: Representative example of a competition experiment of strain CL32 
vs. B3791
0.5
-0 .5
-2 .5
-3 .5
30 1 2 54 6
Time (days)
The negative slope of the line of best fit denotes that B3791 is being outeompeted by 
CL32.
Table 6.1: Effect of plasmid carriage on the competitive fitness of strains B3791 
and S348/11
Plasmid less Plasmid Carrying Selection Rate P value
B3791 -0.29 0.08
CL32 CL32-pIFM3791 -0.19 0.009CL32-plFM3804 -0.22 0.011
CL32-pIFM3844 -0.27 0.006
S348/ll-pIFM3791a -0.97 0.034
S348/11 8348/11-pIFM3804a -0.01 0.954
8348/11-pIFM3844a 0.01 0.957
Competition experiment results (Selection Rate) and their statistical significance as 
assessed by a two tailed T test (P value). Highlighted in green are those results 
considered to be significantly different from no selection (P<0.05).
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plasmid carrying organisms). To find out whether the selection rates were different 
from 0, the results of the repeats were analysed using a two tailed T-test. In the case 
of the competition studies carried out using K. pneumoniae strain CL32 as the 
plasmid free competitor the selection rate was negative (i.e. the number o f plasmid 
carrying bacteria decreased throughout the experiment) in all cases indicating that 
plasmid carrying strains were outeompeted by the plasmid free competitor CL3332. 
The results were found to be significant (P<0.05) for all the competitions except when 
competing wild type strain B3791 against CL32 (Table 6.1).
In the case of the competition studies carried out using Salmonella strain S348/11 as 
the plasmid free competitor, the results were different according to the strain it was 
competed against. Plasmid bearing strain S348/11-pIFM3791a was found to be less 
fit than its plasmid free competitor S348/1I with a selection coefficient of -0.97 
(P=0.034). For the other two plasmid strains tested the selection coefficient was not 
significantly different from 0 (Table 6.1).
Additionally, in order to evaluate the contribution that conjugation was having on the 
numbers of resistant bacteria recovered in the first 24 hours of the competition 
experiment, each competition was repeated using rifampicin resistant versions of the 
plasmid free competitors CL32 and S348/11. Here, to obtain the counts of 
transconjugants, at the 24hr sampling point, in addition to counts on LB agar and LB 
agar supplemented with 2pg/ml of cefotaxime counts were also carried out by plating 
on LB agar supplemented with 2pg/ml of cefotaxime and lOOpg/ml o f rifampicin. For 
all these experiments transconjugants were detected, however, the number of 
transconjugants as a proportion of the number of bacteria growing on cefotaxime 
supplemented agar was very small (approximately two in every million for the 
CL32"^ competitions and two in every ten million for the 8348/11"^ competitions).
6.2.2 Effects of plasmid carriage on the growth of the hearing strain
To test whether plasmid carriage had an effect on the growth of the strains when 
cultured in laboratory medium (LB), growth curves were calculated by measuring 
OD600 at 15 minute intervals for 24hrs using a FLUOstar OPTIMA (8ee section
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2.36). The mean o f each measurement was plotted to generate growth curves for 
visual comparison. The statistieal analyses carried out were one way ANOVA 
followed by Tukey’s honestly significant difference (HSD) when appropriate.
For strain B3791 and its derivatives it was found that growth characteristics were 
similar amongst the strains. Specifically, the strains’ lag phase and exponential phase 
appeared similar when the growth curves were represented as described above 
(Figure 6.2). In order to identify small effects not obvious from examination of the 
growth curves the area under the curve (AUC) and maximum growth (MaxG) were 
calculated and compared across strains. Additionally, to compare the strains’ growth 
during early exponential phase, the growth rate from OD=0.1 to OD=0.2 was 
mathematically calculated. A trend line was obtained for each repeat and the values of 
x (i.e. time) were obtained using y (i.e. OD) values of 0.1 and 0.2. The growth rate 
(GRate) for each experiment was then calculated using the formula (yryo)Z(xrXo). For 
all three measures, although there were small differences, statistical analysis revealed 
that they were not significant (Appendix 7).
As differences in the competitive fitness of transconjugant S348/ll-pIFM379Ia had 
been observed in previous experiments that were not seen in the other plasmid 
bearing S348/1 l-pIFM3791 derivatives an additional transconjugant carrying 
pIFM3791 was also tested, namely S348/11-pIFM3791b. The reasoning for this 
inclusion was to enable the investigation of whether this difference in behaviour was 
indeed due to carriage of plasmid pIFM3791 or whether the differences were caused 
by possible damage to the host cell during or after mating. The growth profile of 
strain S348/I l-pIFM3791a was apparently different than that of the other four strains 
tested (8348/11, S348/ll-pIFM3791b, 8348/1 l-pIFM3804a and 8348/11-
plFM3844a) (8ee figure 6.3). The strains, ordered by slowest to fastest according to 
averaged GRate, were 8348/1 l-plFM379la, 8348/1 l-plFM3844a, 8348/11, 8348/11- 
plFM3804a and 8348/1 l-plFM379lb. The differences were found to be significant 
when comparing all other four strains to 8348/1 l-plFM379la (Appendix 8). 
According to averaged MaxG their strains were ordered in an a slightly different 
manner to GRate, however, strain 8348/1 l-plFM3791a achieved the lowest value, 
with averaged absorbance values of 0.64 for 8348/1 l-plFM379la, 0.78 for 8348/11,
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Figure 6.2: Growth kinetics studies of K. pneumoniae strain B3791 and its
derivatives
Gowth curves of B3791 and its derivatives
0.8
0.7
0.6
0.5
= 0.'
O0.3.
0.2
-  B3791
-  CL32
-  CL32-PIFM3791
-  CL32-PIFM3804
-  CL32-PIFM 3844a
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Strain B3791 and its derivatives were inoculated in LB and incubated at 37°C with 
shaking whilst the OD600 was automatically recorded by a plate reader.
Figure 6.3: Growth kinetics studies of Salmonella 4,5,12,i:- strain S348/11 its 
derivatives
Growth curves of S348/11 and its derivatives
0.8
0.7
0.6 /
0.5
0.4
°0 .3
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— S348/11
-  S348/11-plFM 3791a
-  S348/11-pi FM 3804a
— S348/11-plFM 3844a
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Strain S348/11 and its derivatives were inoculated in LB and incubated at 37 C with 
shaking whilst the OD600 was automatically recorded by a plate reader.
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0.80 for S348/ll-pIFM3804a and 0.81 for S348/ll-pIFM3791b and S348/11- 
pIFM3844a. These differences were again only found to be significant when 
comparing S348/1 l-pIFM3791a to the other strains (Appendix 9). The results for 
AUC also followed a similar pattern, with strain S3481 l/pIFM3791a achieving the 
lowest value, which was significantly different from all the other strains, including 
that of analogous transconjugant S348/1 l-pIFM3791b. Additionally, plasmid bearing 
transconjugants S348/1 l-pIFM3791b, S348/1 l-pIFM3804a and S348/1 l-pIFM3844 
all achieved higher values of AUC than progenitor strain S348/11, although in this 
case the difference only carried significance when comparing it against strain 
S348/1 l-pIFM3844a (Appendix 10).
6.2.3 Association and invasion assays of S348/11 and its plasmid 
carrying derivatives to HT29-16E and IPEC-J2 cells
Salmonella 4,5,12,i:- has been shown to be a monophasic variant of the food 
poisoning associated serotype Salmonella Typhimurium (Echeita et al., 2001). For E. 
coli it has been shown that plasmid carriage can increase bacterial adherence to other 
bacteria, cultured cells and inanimate surfaces (Dudley et al., 2006). In order to 
investigate the impact that plasmid carriage has on the virulence of Salmonella strain 
S348/11, association and invasion assays o f monolayers of two mammalian cell lines 
were performed (See section 2.37). The first cell line, a HT29-16E, is a mucus 
secreting human colonic cell line (Lesuffleur et al., 2006) and it was chosen due to 
the zoonotic potential o f Salmonella 4,5,12,i:- and because its mucus secretion 
properties makes it more physiologically relevant to Salmonella invasion than other 
non-mucus secreting cell lines. The second cell line chosen for these studies, IPEC- 
J2, is a non-transformed intestinal epithelial cell line that was isolated from a neonatal 
piglet jejunum (Schierack et al., 2006). It was chosen as the outbreak described in 
these studies occurred in pigs. Although it does not secrete mucus, it does produce a 
glycocalyx (Schierack et al., 2006).
As strain S348/11 and its derivatives were resistant to gentamicin, the antibiotic used 
in standard association/invasion assays, a colistin protection assay was adapted for
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these studies (Kusters et al, 1993). For these assays approximately 3.5x10^ bacteria 
were resuspended in antibiotic free cell culture medium (as appropriate according to 
the cell line) and added to each of three wells on each of two 24-well plates of 
confluent monolayers. After 2hrs incubation, the cells in one plate were washed, 
lysed and diluted for plate count enumeration to obtain numbers of associated bacteria 
(adhered + invaded). The second plate on the other hand was washed and overlayed 
with the appropriate cell culture medium supplemented with 150pg/ml of colistin. 
After 90 min o f incubation the monolayers were washed, lysed and diluted for plate 
count enumeration to obtain numbers of invaded bacteria.
For the experiments carried out using the human colonic cell line HT29-16E, as this 
experiment was carried out before any suspicions of potential damage to 
transconjugant S348/1 l-pIFM3791a, only strains S348/11, S348/1 l-pIFM3791a, 
S348/1 l-pIFM3804a and S348/1 l-pIFM3844a were tested. It was found that, for all 
strains excepting S348/1 l-pIFM3791a, bacteria were recovered in excess o f 
5xlO^CFU/well, with the original strain S348/11 presenting the highest value with 
bacteria recovered at 6.9x1 O^CFU/well. Strain S348/1 l-pIFM3791a presented 
association values approximately four-fold lower than the other strains tested, with 
bacteria recovered at 1.6xlO^CFU/well (Figure 6.4A). Nevertheless, statistical 
analysis (one way ANOVA, followed by Tukey’s HSD) revealed that the differences 
were only significant between the highest and lowest strains, namely S348/11 and 
S348/1 l-pIFM3791a (Appendix 11). The invasion results for this cell line followed a 
similar pattern to that described for the association experiments. Specifically, for 
three of the strains, S348/11, 8348/1 l-pIFM3804a and pIFM3844a, the average of 
bacteria recovered ranged from 7.5x10^ to 9.8x1 O^CFU/well. The average recovery of 
invaded bacteria for strain S348/11 -pIFM3791 a was, on the other hand approximately 
100 times lower than for the three strains mentioned above at 9.6x1 O^CFU/well 
(Figure 6.4B). However, none of the differences stated for invasion of HT29-16E 
carried any statistical significance (Appendix 12).
For the experiments carried out with IPEC-J2 monolayers, and as previously 
conducted for the growth kinetics experiments, the additional transconjugant 
harbouring pIFM3791 was included, namely S348/1 l-pIFM3791b. For the porcine
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Figure 6.4: Effect of plasmid carriage on the association and invasion of S348/11 
to monolayers of HT29-16E
A)
1(F^
S348/11HT29-16E Association S348/11HT29-16E Invasion
Mean values have been plotted with error bars representing standard deviation for 
each strain. A) Association to cultured monolayers of HT29-16E of S348/11 and its 
plasmid carrying derivatives. B) Invasion of cultured monolayers of HT29-16E of 
S348/11 and its plasmid carrying derivatives.
Figure 6.5: Effect of plasmid carriage on the association and invasion of S348/11 
to monolayers of IPEC-J2
A) S348/11IPEC-J2 Association B) S348/11IPEC-J2 Invasion
10^  KFi
y  y
Mean values have been plotted with error bars representing standard deviation for 
each strain. A) Association to cultured monolayers of IPEC-J2 of S348/11 and its 
plasmid carrying derivatives. B) Invasion of cultured monolayers of IPEC-J2 of 
S348/11 and its plasmid carrying derivatives.
138
cell line recovery of associated bacteria exceeded 2.9x1 O^CFU/well for all strains 
tested with the exception of strain S348/ll-pIFM3791a, for which the association 
value was over tenfold lower at 2.3x1 O^CFU/well (Figure 6.5A). Statistical analysis 
revealed that the association for S348/ll-pIFM3791a was significantly different to 
the association of strains S348/11, S348/1 l-pIFM3804a and S348/1 l-pIFM3844a. As 
for the additional transconjugant tested, S348/1 l-pIFM3791b the result was 
approximately tenfold higher than for strain S348/11 -pIFM3791a at 
2.1xlO^CFU/well, however, this result was not found to be significantly different 
from any of the other strains tested (Appendix 13). The invasion results again 
followed a similar pattern to that described for the association results. The invasion 
rates for strains S348, S348/1 l-pIFM3791b, S348/1 l-pIFM3804a and pIFM3844a 
ranged from 1.4xlO'^CFU/well to 1.7xlO'^CFU/well whereas for strain S348/11- 
pIFM3791a invasion was 100 times lower at 9.7x1 O^CFU/well. On the other hand, 
when this experiment was carried out using S348/ll-pIFM3791b, invasion values 
were 1.7xlO'^CFU/well (Figure 6.5B). However, statistical analysis revealed that the 
differences where only significant when comparing strain S348/1 l-pIFM3791a to 
strains S348/1 l-pIFM3791b (Appendix 14).
6.2.4 Laser scanning confocal microscopy studies of infection of IPEC- 
J2 cells by S348/11 and its plasmid carrying derivatives
In the association/invasion experiments described above for strain S348/II and its 
derivatives it was found that invasion of plasmid carrying derivative S348/11- 
pIFM3791a was unusually low, at approximately 100 times lower than all other 
strains tested (Section 6.2.3). However, when the experiments were carried out with a 
second transconjugant, S348/11 -pIFM3791b, the recovered bacteria for association 
and invasion was at levels comparable to those of the remaining strains, including 
plasmid free progenitor S348/11 (Section 6.2.3). To confirm that invasion was indeed 
occurring for this strain, as well as the remaining S. enterica strains tested in this 
chapter, qualitative studies o f invasion were carried out using laser scanning confocal 
microscopy (Figure 6.6) (See section 2.38). For this experiment 2x10^ bacteria were 
added per well to IPEC-J2 monolayers grown on cover slips. Following an infection
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Figure 6.6: Confocal microscopy studies of infection of IPEC-J2 cells by 8348/11 
and its plasmid carrying derivatives. On the right: images of individual z planes 
obtained by laser scanning confocal microscopy of infected IPEC-J2 monolayers, the 
cell membranes have been coloured red, the bacteria green and the nuclei blue. On the 
left: the corresponding fluorescence intensity profile along the highlighted line with 
the colours representing: red = membrane, green = bacteria and blue = nuclei.
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S348/ll-pIFM3791b
S348/11-PIFM3804
S348/11 prFM3791b 
Fluorescence intensité' profile
S348/11 pIFM3804 
Fluorescence intensity profile
S348/11-PIFM3844 S348/11 pIFM3844 
Fluorescence intensity profile
Figure 6.6: Confocal microscopy studies of infection of IPEC-J2 cells by S348/11 
and its plasmid carrying derivatives (Continued): On the right: images of 
individual z planes obtained by laser scanning confocal microscopy of infected IPEC- 
J2 monolayers, the cell membranes have been coloured red, the bacteria green and the 
nuclei blue. On the left: the corresponding fluorescence intensity profile along the 
highlighted line with the colours representing: red = membrane, green = bacteria and 
blue = nuclei.
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time of one hour the monolayers were washed and fixed with methanol. For 
membrane visualisation the fixed monolayers were incubated with a Mouse-a- 
ATPase Na+/K+ monoclonal antibody followed by incubation with Goat-a-Mouse 
IgG polyclonal antibody labelled with Alexa Fluor 594. For visualisation of the 
bacteria and the nuclei, respectively, the preparations were incubated with a FITC 
labelled KdihhiX-a-Salmonella polyclonal antibody and DAPI. The preparations were 
then visualised using a Leica SPS AOBS Spectral and the images recorded for later 
analysis. On the maximum projections bacteria could be seen clustered in association 
with the cultured cells for all the strains tested, however, it was not possible to 
distinguish whether individual bacteria where located extracellularly or 
intracellularly. For this purpose, superpositions o f all three channels on single z 
planes were examined. Bacteria were considered to be located intracellularly when 
the fluorescence intensity profile along a chosen line indicated the presence of 
membrane fluorescence, followed by bacterial fluorescence, then nucleus 
fluorescence and again membrane fluorescence. Two negative controls were also run, 
for which either only the bacteria or the cellular membranes were labelled. Using the 
procedure described above, intracellular bacteria were detected for strain S348/11 and 
all o f its derivatives, including strain S348/1 l-pIFM3791a.
6.2.5 Association of B3791 and its derivatives to IPEC-J2 cells
Association to intestinal epithelial cells is an important step prior to K. pneumoniae 
colonisation, with certain plasmid mediated adhesins playing a role in this process 
(Favrebonte et al, 1995). To characterise the contribution that plasmids pIFM3791, 
pIFM3804 and pIFM3844 have on the association phenotype of K. pneumoniae strain 
B3791 association studies were carried out using IPEC-J2 monolayers (See section 
2.39). This cell line was chosen over HT29-16E because the S348/11 
association/invasion assays resulted in more reproducible results and also due to the 
porcine origin of the outbreak strains. This assay was carried out on B3791, its Incll 
plasmid cured derivative CL32, and complemented strains CL32-pIFM3791, CL32- 
pIFM3804 and CL32-pIFM3844a. The association method was based on previously 
described studies (Favre-Bonte et al, 1999). For this assay approximately 10  ^bacteria 
resuspended in antibiotic free DMEM/Ham’s FI2 supplemented to 2% mannose were
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each added to three wells of a 24-well plate of confluent monolayers. After Ihr 
incubation the monolayers were washed, lysed and diluted for plate count 
enumeration to obtain rates of associated bacteria. The average numbers o f associated 
bacteria ranged fi*om 3 x 1 (CL32) to 4.3x10"  ^ (CL32-pIFM3844a) (Figure 6.7). 
Statistical analysis (one way ANOVA) revealed that these differences were not 
statistically significant (Appendix 15).
6.2.6 Effect of plasmid carriage on biofilm formation
Due to the role that biofilm formation plays in environmental persistence and 
antimicrobial resistance (Costerton et al., 1999, Hall-Stoodley et al., 2004), crystal 
violet assays of bio film formation were carried out for K. pneumoniae strain B3791 
and its derivatives and for S. enterica strain 8348/11 and its derivatives. The bio film 
forming abilities of the strains were assessed after 24 hours static growth at 25°C and 
at 37°C in either LB broth (no salt) for the 8348 and its derivatives or standard LB 
broth for B3791 and its derivatives (8ee section 2.40). In order to find if any of 
differences seen were statistically significant one way ANOVA was performed. For 
the experiments on strain 8348/11 and its derivatives, including additional 
transconjugant 8348/1 l-pIFM379lb, there were no statistically significant differences 
among the strains tested. Nevertheless, the overall trend for biofllm formation for 
strain 8348/11 and its derivatives was to form more biofllm at 25°C (Figure 6.8A) 
than at 37°C (Figure 6.8B), except for strain 8348/1 l-pIFM379la, for which the 
opposite was true (Appendix 16). For the experiments carried out with strain B3791 
and its derivatives similar results were obtained, with no significant differences in 
biofllm formation at either temperature. Here the overall trend was, again, higher 
biofllm formation at 25°C (Figure 6.9A) than at 37°C (Figure 6.9B), with no 
individual exceptions (Appendix 17).
6.2.7 Effect of plasmid carriage on the metabolism of K. pneumoniae 
B3791 as assessed by Phenotypic Microarray Biolog
In order to assess the effect that plasmid carriage has on the metabolism of the host
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Figure 6.6: Effect of plasmid carriage on the association of B3791 to monolayers 
ofIPEC-J2
10»
B3791EPEC-J2 Association
Bacterial suspensions of strain B3791 and its derivatives were added to monolayers of 
1PEC-J2 and incubated for two hours followed by culture enumeration of associated 
bacteria. The bars represent mean values and the error bars represent the standard 
deviation for each strain.
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Figure 6.7: Effect of plasmid carriage on biofilm forming abilities of Salmonella
4,5,12,i:- strain S348/11
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Biofllm formation of S348/11 and its derivatives was tested using a crystal violet
0 o
assay at 25 C (A) and 37 C (B). The values plotted are mean values and the error bars 
represent the standard deviation for each strain.
Figure 6.8: Effect of plasmid carriage on biofilm forming abilities of K. 
pneumoniae strain B3791
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Biofllm formation of B3791 and its derivatives was tested using a crystal violet assay 
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at 25 C (A) and 37 C (B). The values plotted are mean values and the error bars 
represent the standard deviation for each strain.
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strain, Phenotype Microarray Bio log investigations were carried out on wild type K. 
pneumoniae strain B3791, its Incll plasmid cured derivative CL32 and 
complemented strain CL32-pIFM3791. Strain B3791 and its derivatives were chosen 
for these tests over 8348/II and its derivatives as successful curing had been 
achieved for them. Using these strains two questions could be answered, first whether 
the plasmid carriage affected the metabolic properties of the strain, by comparing the 
behaviour of B3791 with that of CL32, and secondly, whether any of the differences 
seen were due to the curing process itself, by comparing the behaviour of B3791 to 
that of CL32-pIFM379I. The Bio log system consists of commercially available 96 
well plates containing freeze dried reagents that can be used to test a strain’s ability to 
respire under defined metabolic conditions. Plates PMl and PM2 were chosen as they 
test for the ability of the strain to respire using 190 different compounds as single 
carbon sources. Plate PM3 was used to test 95 different compounds as single nitrogen 
sources. Resuspension media based on the M9 formulation were prepared specifically 
for each type o f Bio log plate, thus the resuspension medium prepared for plates PMl 
and PM2 provided all necessary nutrients, except for a carbon source, whilst the 
resuspension medium prepared for plate PM3 provided all necessary nutrients, except 
for a nitrogen source. Additionally, a negative control well, to be used as a blank 
subtraction, was present in each of the plates. To compare the respiration of the 
strains in each well a number of features of each kinetic curve were calculated in R by 
Dr E. Laing (University o f 8urrey). The features studied were: the area under the 
curve (AUC), the maximum value achieved MaxV), and the maximum rate of change 
(Rate). One way ANOVA was used to identify differences between the three strains 
for each well and kinetic curve value; those highlighted as possibly being 
significantly different (ANOVA P-value < 0.05) were subjected to a Tukey’s H8D 
post-hoc test. 8trains that showed a significant difference were identified by a 
Tukey’s H8D P-value < 0.05.
For carbon plate PMl apparent respiration was found on the negative well for all 
repeats. However, no such problem was encountered within the negative well present 
in carbon plate PM2. As the same cell suspension was used for the inoculation of both 
plates for each strain on each repeat and as all the PMl plates used for these 
experiments belonged to a single batch, the conclusion was reached that there was a
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fault with the specific PMl batch used. As no blank subtraction could be carried out 
this data could not be analysed. Due to time constraints this experiment could not be 
repeated with a new batch of plates.
For carbon sources plate PM2 there were five compounds for which statistically 
significant differences in respiration amongst the strains tested were found (Figure 
6.10). In all instances all three strains were able to utilise the compounds however 
plasmid fi*ee strain CL32 was better able to utilise the compounds than the other two 
strains. The compounds for which significant differences were found (Tukey HSD P- 
value < 0.05) were L-glucose, L-sorbose, caproic acid, 4-hydroxy benzoic acid and 
putrescine. For L-glucose and L-sorbose strain CL32 was significantly different from 
the other two strains, which in turn were not significantly different from each other. 
For caproic acid, 4-hydroxy benzoic acid and putrescine, although CL32 was better 
able to utilise these compounds than the other two strains, the difference was only 
significant when comparing against the lowest o f the other two strains, which in some 
cases was WT strain B3791 and in some cases was plasmid complemented strain 
CL32-pIFM3791 (Table 6.2).
In the case o f nitrogen sources on plate PM3, there were seven compounds for which 
statistically significant differences in respiration amongst the strains tested were 
found (Figure 6.11). As was the case for PM2, although all three strains were able to 
utilise the compounds, plasmid free strain CL32 was better able to utilise the 
compounds than its plasmid bearing counterparts. For putrescine, y-amino-N-butyric 
acid and dipeptide Ala-Gly strain CL32 was significantly different from the other two 
strains, which in turn were not significantly different from each other. For L-alanine, 
L-proline and L-threonine although CL32 was better able to utilise these compound 
than the other two strains the difference was only significant when comparing against 
plasmid complemented strain CL32-pIFM3791. Finally, for dipeptide Ala-Thr 
significant differences were found for two different measures of growth, MaxV and 
AUC, however, the comparisons differed for each measure. Whilst the AUC for 
CL32 was significantly different from the other two strains which in turn were not 
different from each other, for MaxV all three comparisons revealed significant 
differences (Table 6.2).
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Figure 6.9: Effect of plasmid carriage on the ability of K. pneumoniae B3791 to
use different carbon sources as assessed by Biolog Phenotype Microarray
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Respiration with the compounds listed as the single source of carbon for WT strain 
B3791, cured derivative CL32 and complemented strain CL32-pIFM3791 as 
measured using plate PM2 of Bio log Phenotype Microarray.
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Figure 6.10: Effect of plasmid carriage on the ability of K. pneumoniae B3791 to
use different nitrogen sources as assessed by Phenotype Microarray Biolog
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Respiration with the compounds listed as the single source of nitrogen for WT strain 
B3791, cured derivative CL32 and complemented strain CL32-plFM3791 as 
measured using plate PM3 of Bio log Phenotype Micro array.
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6.3 Discussion
In this chapter, the aim was to identify the effect that carriage of the outbreak 
plasmids had, beyond that of antimicrobial resistance, on different aspects of the 
phenotype o f Æ pneumoniae strain B3791 and Salmonella 4,5,12,i:- S348/11 strain. 
As the full DNA sequence analysis did not suggest any potential areas of interest, a 
broad approach was taken and therefore chose to investigate the effect of plasmid 
carriage on growth, virulence, biofllm and metabolism, which may suggest the 
presence of hitherto unknown genes that confer an advantage to the host.
One of the aspects of the plasmids’ biology that was examined was the effect of their 
carriage on the growth and competitive growth of strains B3791 and S348/11. The 
general consensus is that plasmids tend to slow down the rate of growth of naïve host 
strains as has been shown in numerous studies (Lee and Edlin, 1985, Lebek, 1980, 
Enne et al., 2004). However, it has been shown that this hindrance can be ameliorated 
after a period of co-evolution between the plasmid and the strain (Bouma and Lenski, 
1988). Nevertheless, instances have been described of plasmids that are beneficial, 
not only to an accustomed strain, but also to naïve hosts, such as was found to be the 
case for apramycin resistance plasmids pUK2001 and pUK2002 (Yates et a l, 2006) 
(Yates et al, 2006)(Yates et al, 2006)(Yates et al, 2006)(Yates et a l, 2006)(Yates et 
al, 2006) and sulphonamide resistance plasmid p9123. In the studies described here 
the effect of plasmid carriage on plasmid accustomed K. pneumoniae strain B3791 
and on plasmid naïve Salmonella 4,5,12,1- strain S348/11 were tested. The 
competition experiments revealed that, when plasmid carrying strains were grown in 
direct competition with plasmid cured CL32, they were outcompeted by the plasmid 
cured strain over the course of the experiment, suggesting that for this strain, in the 
absence o f antibiotic selection, plasmid carriage represented a fitness burden. There is 
however the possibility that rather than the strains being affected by plasmid carriage 
it is actually the manipulations carried out on CL32 that have introduced a change in 
the strain that makes it fitter. However, this is unlikely as the effect was still present 
even when competing strain CL32 with complemented strains, which were derived 
fi’om CL32 itself. On the other hand, when the strains were grown as monocultures 
and the increase in turbidity monitored over time, no differences were found between
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the growth of wild type plasmid carrying strain B3791, its cured derivative CL32 or 
the plasmid complemented strains. For strain S348/11 a different picture emerges 
when looking at the effect of plasmid on the strain’s growth. The competition 
experiments suggested that carriage of pIFM3791 was detrimental for the harbouring 
strains, as S348/ll-pIFM3791a was outcompeted by its plasmid free counterpart, 
whilst carriage of pIFM3804 and pIFM3844 was neutral to the fitness o f the strain. 
However, for the growth profiling experiments an additional transconjugant 
harbouring the same plasmid was included and for this experiment, although 
S348/llpIFM3791a was again defective in its growth by every measure calculated, 
this difference was not seen for strain S348/ll-pIFM3791b. Furthermore, when 
looking at AUC, which measures growth along the whole kinetic curve, plasmid free 
strain S348/11 was less fit than all the remaining plasmid harbouring strains, although 
the comparison was only significant against strain S348/11 -pIFM3844a. This 
experiment suggests that carriage of the outbreak plasmids was, at the least, neutral 
and possibly slightly beneficial to the derivatives of S348/11 and that, in the case o f 
S348/ll-pIFM3791a, the differences in growth were due to some damage, such as 
mutation, occurring to the strain either during or after mating. Future work should 
explore whether the differences in competitive growth are still seen when conducting 
the experiments with transconjugant S348/11 -pIFM3791 b.
As for the ‘virulence’ phenotype, the plasmids did not seem to have an effect on the 
ability of strain B3791 to associate to cultured porcine epithelial cells. For strain 
S348/11, both association and invasion were tested. In comparison to the wild-type 
strain S348/11 and its other two plasmid carrying derivatives S348/II -pIFM3804 and 
S348/1 l-pIFM3844, strain S348/1 l-pIFM379Ia seemed to be less able to adhere and 
invade the cell lines tested (although not all o f the differences were significant). 
Nevertheless, the IPEC-J2 experiments carried out using an additional transconjugant 
carrying plasmid pIFM3791 (strain S348/I I-pIFM379Ib) showed adhesion and 
invasion levels comparable to those of strains S348/11, S348/11-pIFM3804 and 
S348/1 l-pIFM3844. Therefore, we concluded that, as seen for strain B3791, plasmid 
carriage did not have an effect on the ability of S348/11 to associate and invade and 
that the differences observed for S348/1 l-pIFM3791a were due to a spontaneously 
acquired mutation elsewhere in the genome of this particular clone. The carriage of
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Incll plasmids pSERBI (Dudley et al, 2006) and pOII3 has been previously shown 
to increase the hosts’ ability to adhere to cultured mammalian cells, due to de­
repressed type IV pilus and production of adhesin Saa respectively. However, there 
was no evidence for this being the case for the plasmids here studied. This could 
explain our findings of no phenotypic differences between plasmid free and plasmid 
carrying strains. Yet, we need to be cautious as so few cell lines were assayed and, 
therefore, we cannot conclude with absolute assurance that the plasmids do not affect 
this specific aspect of virulence. It would be interesting to undertake animal studies in 
which animals were dosed separately or in competitive index type experiments with 
plasmid free and plasmid bearing strains. Counts of the bacteria collected over time 
and from different host sites may be informative. For example, loss of plasmid may 
indicate the plasmid is a burden and selection for plasmid free isolates is made in 
vivo. The converse may be observed if higher numbers of plasmid bearing strains are 
found at certain loci in vivo. One could also investigate the impact of antibiotic 
treatment during infection too. All speculative, but worth considering especially as on 
the farm the evidence was that these strains were indeed associated with the hosts, 
having been isolated from their faeces.
The work presented here has shown carriage of plasmids pIFM3791, pIFM3804 and 
pIFM3844 did not have an influence on the ability of either B3791 or S348/11 to 
form biofilm when grown statically on polystyrene wells. These findings were in 
accordance with previous work showing that Incll plasmids pIP112 and R64 
similarly did not increase bio film formation of their host strain (Ghigo, 2002). On the 
other hand the type IV pilus of Incll plasmid pSERBl has been previously found to 
be involved in an increased ability of the host strain to form biofilms on abiotic 
surfaces. However, unlike the type IV pilus o f pIP112 and R64, the expression of 
Type IV pilus of pSERBI was de-repressed (Dudley et a l, 2006). If Type IV pilus 
formation is repressed in pIFM3791, pIFM3804 and pIFM3844, as is the norm for 
Incll plasmids, this could explain why their carriage did not increase the ability o f the 
strains to form biofilm. In hindsight it may have been informative to have undertaken 
RT-PCR analysis of gene expression during these assays to test whether expression of 
the pil locus was suppressed.
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To investigate whether there was a metabolic advantage in plasmid carriage, the 
ability of K. pneumoniae strain B3791 to respire using certain carbon and nitrogen 
sources was tested. It was observed that there were no compounds for which there 
were striking differences in respiration, such as no respiration for one strain versus 
respiration for another one. However, for the four carbon sources and five nitrogen 
sources for which significant differences were found, it was in fact the plasmid free 
derivative CL32 that respired more than the other two strains tested. This could be 
explained if expression of plasmid genes is diverging resources away from the 
transcription of metabolic pathways involved in the growth under nutrient limiting 
conditions. However, one compound for which differences were found, L-Glucose, 
stood out, as the ability to use it as a carbon source is extremely rare, with only two 
known species that carry opérons for its use, the first to be identified being a 
Burkholderia caryophylli strain (Sasajima and Sinskey, 1979) and the second one a 
Paracoccus species 43P (Shimizu et al., 2012). Therefore, to ensure the reliability o f 
these results, future work should include the validation of these results by carrying 
out experiments for those compounds for which differences were found, using in 
house prepared media, rather than Bio log plates. Additionally, it would be interesting 
to see the effect that this plasmid has on the metabolism of Salmonella 4,5,12,i:-, as 
the other tests, such as the competition studies, indicated that plasmid carriage is 
neutral and in some instances beneficial, as was the case for the growth kinetics of 
plasmid carrying strain S348/ll-pIFM3844.
All in all, the data presented here show that the effect that a plasmid has on its host is 
highly dependent on that host’s make up, as it was shown here that the naïve 
Salmonella 4,5,12:i- was better prepared to carry the outbreak plasmids than the 
plasmid co-evolved K. pneumoniae strain B3791. Additionally, the experiments here 
also show that whether an effect is detectable or not will depend on the exact aspect 
of fitness that is being measured. The implication of these findings for the reversal o f 
antimicrobial resistance is that even if there is a fitness cost for a certain strain of 
pathogenic bacteria, as long as there are others in its environment for which such cost 
does not exist, and given the mobility of conjugative plasmids, once the selection 
pressure is imposed by means of the antibiotic, the plasmid can spread again. For this 
reason, it would have been interesting to have carried out the experiments in this
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chapter with E. coli strains isolated from the farm. E. coli are often found to be 
harmless commensals, and if it was found that plasmid carriage is either beneficial or 
neutral for them, this could further lend weight to the idea that plasmids are 
maintained by certain strains and are then get taken up by other strains in times of 
need.
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Chapter 7:
Final discussion
Chapter 7 : Final discussion
Antibiotic resistance in bacterial pathogens is being reported at an ever-increasing 
rate (Livermore, 2007). Epidemic resistant clones have been shown to be responsible 
for outbreaks around the world, as is the case with CTX-M-15 producing E. coli clone 
ST131 025 :H4 (Peirano and Pitout, 2010). However, for members of the 
Enterobacteriaceae and many other bacterial families, the problem of resistance is 
exacerbated by the ready exchange of genetic material facilitated by conjugative 
plasmids (Frost et al., 2005). In the case o f the third generation cephalosporin, 
acquired p-lactamases belonging to the ESBL group are an extremely prevalent 
mechanism of resistance (Paterson and Bonomo, 2005).
The ESBL group is large and diverse, comprising of many families; some, such as the 
TEM, SHV, CTX-M and OXA, are highly prevalent and made up of multiple related 
enzymes, whereas others remain rare, with at most a handfiil o f variants, as is the case 
for the PER, VEB and BES (Paterson and Bonomo, 2005). Why some enzyme 
families become widespread and epidemic whilst others remain rare is in itself 
interesting and understanding this would perhaps better inform attempts to curb or 
reverse the spread of antibiotic resistance of those more prevalent classes. In the 
studies presented here the CTX-M family was chosen for two reasons, the first being 
their high prevalence and almost worldwide endemic status, having displaced the 
previous most prevalent ESBLs, those belonging to the TEM and SHV families. 
Secondly, they make an interesting case study because although they were first 
described in 1986 (Bonnet, 2004), only three years following the isolation o f the first 
ESBL, SHV-2 (Paterson and Bonomo, 2005), they remained relatively rare until the 
2Ÿ^ century when they ‘shot to prominence’ (Bonnet, 2004).
In order to elucidate the reasons for the high prevalence of CTX-M harbouring 
plasmids I tackled a key question, namely “what is the impact of CTX-M plasmid 
carriage on the phenotype of Enterobacteriaceae strains isolated from pigs”. In 
Chapters 3 and 4 of this thesis I demonstrated that two plasmid types carrying CTX- 
M-1 and CTX-M-14, respectively, were present amongst the panel of outbreak 
strains. The Incll-CTX-M-1 plasmid, pIFM3804, was the most prevalent being
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present in 61 of 65 isolates, with plasmid markers detected in E. co//, K. pneumoniae 
and S. enterica strains originating from all but one of the species of animal tested on 
the farm. The widespread presence o f pIFM3804 like plasmids suggested that this 
plasmid was efficient at mediating its own transfer and that it might be providing its 
harbouring strains with a selective advantage including, but perhaps beyond, 
antibiotic resistance.
In order to confirm that the plasmids preliminary characterised in Chapter 3 were 
indeed a single plasmid type that had spread to all three species of bacteria, full DNA 
sequence of three plasmids isolated from E. coli, K. pneumoniae and Salmonella 
4,5,12,1:-, respectively, was performed. Plasmid sequencing revealed that indeed a 
single plasmid type was present in all the species tested as well as showing that 
pIFM3804 was distinct from other CTX-M harbouring plasmids present in the 
GenBank database, namely pEK204 (Woodford et al., 2009), pEC Bactec (Smet et 
al., 2010) and pESBL-EAll (Ahmed et a l, 2012). Regarding the overall sequence of 
pIFM3804, it was more similar to other non-resistance harbouring plasmids into 
which the resistance gene cassette itself harbouring CTX-M-1 had inserted in a novel 
site within the pilus encoding region. Nevertheless, this comparison can only be made 
against the three Inc I CTX-M plasmids for which full DNA sequence is available and 
it is of note that Incll and CTX-M-1 plasmids are being reported with increasing 
frequency throughout Europe from clinical and food animal samples (Rodriguez et 
al, 2009, Marcadé et a l, 2009, Girlich et a l, 2007, Cloeckaert et a l, 2010, Madec et 
a l, 2011, Dierikx et a l, 2010, Leverstein-van Hall et a l, 2011), although with limited 
molecular characterisation. In fact interrogation of the available data from the Incll 
pMLST database revealed that only one other plasmid submitted so far (as o f August 
2013) displayed the same allelic profile as that of the plasmid pIFM3804 from this 
study, this being an unnamed plasmid harbouring CTX-M (no CTX-M type provided) 
isolated from a pig in China of sequence type STI08. As for the European CTX-M-1 
plasmids present in the pMLST database they mostly belong to clonal complexes 7 
and 3 and shared with pIFM3804 at most three alleles. Therefore it would be 
interesting to study how the Chinese and European plasmids relate to our UK plasmid 
pIFM3804. These studies could be carried out to find out, perhaps using the unique
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marker PCR presented in Chapter 4, as well as others that could be developed, and 
followed by frill DNA sequencing.
In addition to confirming the presence o f what appeared to be a common plasmid 
across the bacterial species present on the farm, full DNA sequencing was also 
performed with two further aims: the first was to identify potential fitness conferring 
genes, such as virulence factors or nutrient utilisation pathways, and the second was 
to assist in the design of an effective curing vector by identifying potential target 
genes including the replicon determinant, Incll common toxin/antitoxin modules, 
such as pndA/C and other toxin/antitoxin modules. Closing the plasmid sequence and 
completing annotation was successful. With regard to the first aim, there were no 
genes present on the plasmid that appeared on preliminary gene function analysis to 
suggest they conferred a significant advantage in terms of metabolic or virulence 
competence. However, a number of genes were not assigned a specific function and 
without gene by gene or perhaps even base by base mutagenesis it is not possible to 
comment on the phenotype generated by those un-ascribed genes. However, function 
is often ascribed by derivation fi*om other similar genes analysed on other plasmids. 
Perhaps further caution needs to be expressed regarding annotated genes in as much 
as we assume iso-functionality irrespective of host plasmid and bacterial background. 
With regard to the second aim, in the first instance a curing vector was constructed 
targeting the Incll replicon and using amikacin resistance gene aac6-Vo for vector 
selection and sacB for vector counter selection, as described in Chapter 5. The three 
sequenced outbreak plasmids, pIFM3791, pIFM3804 and pIFM3844 were 
successfully cured fi-om laboratory strain NEB 10-beta. However, due to problems 
encountered with the selection marker only pIFM3791 was successfully cured fi'om 
its wild type host, K. pneumoniae strain B3791. Nevertheless, the effectiveness of this 
curing approach was further demonstrated by the success in curing unrelated Incll 
CTX-M plasmids fi’om their wild type E. coli hosts. Overall, once the curing vector 
had been generated, putting it to use for curing other Incll harbouring strains was 
quick and relatively straightforward and it avoided multiple passages or exposure to 
mutagens. With the high prevalence o f resistance harbouring Incll plasmids being 
reported among Enterobacteriaceae species having a proven Incll curing tool makes 
for a useful research tool for investigating plasmid phenotypes. One such way that it
159
could be used would be to select Incll harbouring strains from different backgrounds, 
including environmental, veterinary, nosocomial and community and generate 
plasmid cured versions to enable phenotypic comparisons to be may be made between 
plasmid bearing and plasmid free variants. Also, plasmids may be reintroduced to 
explore whether plasmids originating from certain environments confer similar or 
different phenotypes in strains from the same or other environments. Another 
interesting aside is that this proof o f curing concept indicates that there is potential to 
consider developing control measures to reduce the burden o f ESBL carrying 
plasmids by the use of curing systems as described here. Although speculative at 
present there is a real long term potential if delivery systems can be successfully 
developed for specific environments.
By undertaking the studies presented in this thesis it was hoped to identify whether 
any factors beyond antimicrobial resistance might be contributing to the prevalence of 
the outbreak plasmids isolated from the farm. There were a number of hypothesised 
mechanisms by which the plasmids studied in this project could be affecting the 
phenotype o f the harbouring strain that could confer selective advantage to their 
harbouring strains. Plasmid carriage has been previously shown to increase biofilm 
formation (Ghigo, 2002, Dudley et al., 2006), which is known to play a role in 
environmental persistence by increasing attachment to abiotic surfaces and resistance 
to biocides (Giaouris et al., 2012). However, in Chapter 6 it was shown that the 
presence of the outbreak plasmids pIFM3791, pIFM3804 or pIFM3844 had no effect 
on the bio film formation phenotype of either naïve host Salmonella 4,5,12,i:- S348/11 
or wild type host K. pneumoniae B3791. Although the bio film formation assay used 
in this work has been extensively used previously, one of its limitations is that it tests 
the behaviour of monocultures. As in the case o f Incl plasmids the presence o f non 
plasmid harbouring strains triggers pilus de-repression increasing biofilm formation 
(Ghigo, 2002), future studies could involve the use o f mixed culture biofilm 
formation assays which would also better represent environmental conditions. It was 
interesting that in competitive growth studies that will be discussed in greater depth 
below, plasmid free derivatives outcompeted those strains harbouring plasmids. 
However, this was performed in planktonic broth culture and it would be interesting 
to reconsider the experimental design to incorporate both planktonic and bio film
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culture. Another aspect of the biology of the host bacterium which plasmid carriage 
could be affecting was the ability to colonize and, in the case of the Salmonella 
4,5,12,i:-, invade the intestinal epithelium. Higher colonisation might convert into 
higher and longer lasting shedding therefore increasing the chances of spread to 
nearby animals and environmental contamination, but as with biofilm formation no 
effect was seen in either host strain using a mammalian cell culture model of 
infection. Again, the models used were limited and it is possible that differences may 
be seen with the use of other cell lines, 3D cell culture, IVOC or whole animal 
systems.
As mentioned above, a further aspect of plasmid biology that might have an impact 
on the success of their hosts is the influence on growth since faster generation times 
could mean that plasmid bearing strains outgrow plasmid free competitors. To test 
this idea I investigated the growth of the host strains Salmonella 4,5,12,i:- S348/11 
and K. pneumoniae B3791with and without plasmids using two different assays as 
presented in Chapter 6. One assay measured the increase in turbidity over 24hrs o f 
monocultures of each of the strains. This assay was not able to detect any effect of 
plasmid carriage on the growth of strain K. pneumoniae B3791. In the case of 
Salmonella 4,5,I2,i: there was a trend of plasmid bearing strains seemingly growing 
better than their plasmid free counterpart when measuring AUG, however only when 
comparing the strain harbouring pIFM3844 to the plasmid free strain did the 
comparison hold statistical significance. The second assay consisted of growing a 
mixed culture consisting o f plasmid bearing strain and its plasmid free counterpart 
during six days and carrying out counts of each strain daily to see whether one o f the 
strains outcompeted the other. For the Salmonella 4,5,12,i:- host S348/1I it was 
concluded that the carriage of plasmid did not affect the strain’s competitive growth. 
The case for K. pneumoniae was slightly more complex, as the cured derivative 
consistently outgrowing plasmid complemented strains (P<0.05) but only showing a 
trend when competing against wild type plasmid carrying strain B3791 (P=0.08). In 
addition to these growth experiments, for strain B3791 the idea that plasmid carriage 
might encode for a metabolic pathway and allow the strain to grow on nutrient 
sources not available to the plasmid free strain was also investigated using Bio log 
Phenotype Microarray. No drastic differences in nutrient utilization were found this
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way, however for 5 carbon and 7 nitrogen sources the respiration rate of plasmid free 
strain CL32 was significantly higher than at least one of the plasmid harbouring 
counterparts tested. All in all the growth experiments indicated that plasmid carriage 
was neutral or perhaps marginally beneficial to Salmonella 4,5,12,1:- host strain 
S348/11 whilst hindering K. pneumoniae host strain B3791. This was an unexpected 
finding since S348/11 was chosen as a naïve host to the plasmids whereas B3791, 
from which the outbreak plasmid had to be cured before the plasmid biology 
experiments could be investigated and had supposedly had the opportunity to co- 
e volve to better cope with plasmid carriage. However, the clinical history o f the farm, 
as presented in Chapter 3, needs to be considered as antibiotic treatment included 
three antibiotics against which the plasmid conferred resistance, namely amoxicillin, 
florfenicol and sulfadiazine. In light of this, antibiotic treatment could be asserting 
enough selective pressure to grant presence of the plasmids within the K. pneumoniae 
B3791 strain and potentially the other K. pneumoniae strains isolated in the farm. 
Nevertheless, the implications o f the data presented here regarding the longer term 
prevalence of plasmids, with different host strains reacting differently to the outbreak 
plasmid, are significant, since this suggests that certain strains for which the carriage 
of plasmid is neutral or beneficial may act as reservoirs from within which the 
plasmid can again be acquired when antibiotics are prescribed. It would therefore be 
interesting to investigate whether the presence of sub MIC concentrations of 
antibiotics have an effect on the rates o f plasmid transfer. Furthermore, having data 
on the effect of plasmid upon commensal strains would have been advantageous on 
making inferences regarding resistance reservoirs, as they are likely to remain after an 
infection by pathogenic bacteria has been cleared. In these studies curing of an E. coli 
strain was indeed attempted but, due to a weak resistance marker on the curing vector, 
it was not achieved. Future work could involve replacement of the resistance marker 
to produce cured E. coli derivatives. This would certainly have been a valuable goal if 
achieved but we come back to an issue that was not dealt with in depth in this study, 
namely transmissibility by conjugation. Assuming this to be the major means o f 
transfer, although transformation and transduction are also possible, the study did not 
focus on the relative rates of transmission of the same plasmid from different 
bacterial host backgrounds. Also, the relative rate of uptake by recipients that may be 
affected by host restriction and modifications systems, surface exclusion and other
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factors was not investigated. However, the arguments presented here indicate that 
plasmid transmissibility is a key element in the persistence of resistance and may be 
more important than those factors that were investigated such as nutritional benefit, 
virulence, bio film formation as these appeared to be either insignificant or minor. 
Understanding the fate of the plasmid and the CTX-M gene both together and 
separately in the milieu of the various environments in which the isolates analysed in 
this study were found would be intriguing. Furthermore, it could be argued that the 
initial investigation into the resistance on farm introduced bias in that the search was 
for specific organisms with resistance that could grow on certain selective media. Is it 
possible that the plasmid described here may be found more widely in other 
backgrounds that have profound phenotypic impact or perhaps in dead-end hosts?
Although no great apparent differences in phenotype caused by the acquisition of 
novel toxin genes or biochemical pathways are attributable to the carriage of Incll 
CTX-M-1 plasmids pIFM3791, pIFM3804 and pIFM3844 the data presented here 
suggest that for one of the host strains tested plasmid carriage did not have a negative 
impact upon its fitness. One of the aims of this study was to help predict the potential 
success of programs aiming to reverse antibiotic resistance by withdrawing antibiotics 
from use. However, the logical consequence of a plasmid able to mediate its own 
transfer and not imposing a fitness cost is that it will persist, at least in certain strains, 
only for prevalence to increase again once antibiotic use returns. To lend further 
support to this the effects of plasmid carriage should be investigated on a range of 
strains isolated from multiple origins. This problem could now be easily addressed 
since the curing tool constructed in these studies was shown to be effective against 
Incl plasmids originating from the farm as well as two other unrelated plasmids.
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Appendix 1
Strains constructed during the process of cloning curing vectors plFM27 and plFM40.
Strain Parent Species Plasmid Name Vector (insert)
DH5 Alpha NA E. coli NA NA
CLOl DH5 Alpha E. coli plFMOl pCR-blunt (RNAl)
CL02 DH5 Alpha E. coli pIFM02 pCR-blunt (RNAI)
CL03 DH5 Alpha E. coli plFM03 pCR-blunt (RNAI)
CL04 DH5 Alpha E. coli pIFM04 pCR-blunt (RNAI)
CL09 DH5 Alpha E. coli pAKE604A NA
CLIO DH5 Alpha E. coli pAKE604A NA
CLll DH5 Alpha E. coli pAKE604A NA
CL12 DH5 Alpha E. coli pAKE604A NA
CL19 DH5 Alpha E. coli pIFM19 pAKE604 (RNAI)
CL20 DH5 Alpha E. coli pIFM20 pAKE604 (RNAI)
CL21 DH5 Alpha E. coli plFM21 pAKE604 (RNAI)
CL22 DH5 Alpha E. coli pIFM22 pCR-blunt (aac6-Ib)
CL23 DH5 Alpha E. coli pIFM23 pCR-blunt (aac6-Ib)
CL24 DH5 Alpha E. coli pIFM24 pCR-blunt (aac6-Ib)
CL25 DH5 Alpha E. coli plFM25 pCR-blunt (aac6-Ib)
CL26 DH5 Alpha E. coli pIFM26 pCR-blunt (aac6-Ib)
CL27 DH5 Alpha E. coli plFM27 pIFM 19 (aac6-Ib)
CL40 DH5 Alpha E. coli pIFM40 pIFM27(pndB)
CL41 DH5 Alpha E. coli plFM41 pIFM27(pndB)
CL42 DH5 Alpha E. coli pIFM42 pIFM27(pndB)
CL43 DH5 Alpha E. coli pIFM43 pIFM27(pndB)
CL44 DH5 Alpha E. coli pIFM44 pIFM27(pndB)
Appendix 2
Cured lab strains and PCR results
Strain Parent Plasmid CTX-M PCR Vector PCR
CL54 T91a pIFM27 +
CL55 T91a plFM27 +
CL56 T04a pIFM27 +
CL57 T04a plFM27 +
CL58 T44a plFM27 +
CL59 T44a plFM27 +
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Appendix 3
Cured lab strains after removal of pIFM27 and PCR results.
Strain Parent Plasmid CTX-M PCR Vector PCR
CL69 CL54 NA - -
CL70 CL54 NA - -
CL71 CL55 NA - -
CL72 CL55 NA - -
CL73 CL56 NA - -
CL74 CL56 NA - -
CL75 CL57 NA - -
CL76 CL57 NA - -
CL77 CL58 NA - -
CL78 CL58 NA - -
CL79 CL59 NA - -
CL80 CL59 NA - -
Appendix 4
Cured derivatives of wild type E. coli strains LREC215 and LREC447 and PCR 
results.
Strain Parent Plasmid CTX-M PCR Vector PCR
CL61 LREC215 pIFM27 
CL62 LREC215 pIFM27 
CL65 LREC447 pIFM27 
CL66 LREC447 pIFM27
Appendix 5
Cured derivatives of wild type E. coli strains LREC215 and LREC447 after pIFM27 
and PCR results.
Strain Parent Plasmid CTX-M PCR Vector PCR
CL81
CL82
CL83
CL84
CL85
CL86
CL87
CL88
CL61
CL61
CL62
CL62
CL65
CL65
CL66
CL66
NA
NA
NA
NA
NA
NA
NA
NA
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Appendix 6
List of plasmid complemented strains of CL32 and S348/11 as well as plasmid donor 
lab strains T9 la, T04a and T44a.
Strain Parent Species CTX-plasmid
T91a NEB 10-beta E. coli p3791
T04a NEB 10-beta E. coli p3804
T44a NEB 10-beta E. coli p3844
CL32-plFM3791 CL32 K. pneumoniae p3791
CL32-plFM3804 CL32 K. pneumoniae p3804
CL32-plFM3844a CL32 K. pneumoniae p3844
CL32-pIFM3844b CL32 K. pneumoniae p3844
S348/11 NA S. enterica NA
S348/ll-pIFM3791a S348/11 S. enterica p3791
S348/ll-plFM3791b S348/11 S. enterica p3791
S348/ll-pIFM3804a S348/11 S. enterica p3804
S348/ll-plFM3804b S348/11 S. enterica p3804
S348/ll-pIFM3844a S348/11 S. enterica p3844
S348/ll-pIFM3844b S348/11 S. enterica p3844
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Appendix 7
Growth kinetics studies of K. pneumoniae strain B3791and its derivatives. Optical 
density of monocultures of B3791 and its derivatives was automatically monitored 
over 24hrs at 15min intervals. Three features of the curves were analysed, area under 
the curve, maximum growth and growth rate. For each measure the means of every 
strain were compared against the means of every other strains using one way 
ANOVA, no significant differences were revealed (data not shown).
A U C
Strain n M ean Std . D eviation
B 3791 3 13.44 0 .5 6 8 6
CL32 3 1 3 J 3 0 .6 7 8 7
C L33-pIFM 3791 3 13.7 0 .1 6 9 4
C L 32-pIFM 3804 3 14.03 0.3291
C L 32-IFM 3844 3 13.17 0 .717
M axG
Stra in n M ean Std . D eviation
B3791 3 0 .736 0.03215
CL32 3 0 .7325 0 .01919
CL33-pIFM 3791 3 0 .747 0 .01237
C L 32-pIFM 3804 3 0 .7696 0 .01591
C L 32-IFM 3844 3 0 .7206 0 .04934
G Rate
Stra in n M ean Std . D eviation
B3791 3 0 .2283 0 .006065
CL32 3 0 .227 0 .003793
CL33-pIFM 3791 3 0 .2315 0 .0161
C L 32-pIFM 3804 3 0 .2 2 5 7 0 .01096
C L 32-pIFM 3844 3 0.1451 0 .1208
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Appendix 8
Growth kinetics studies (growth rate) of Salmonella 4,5,12,i:- strain S348/11 and its 
derivatives. (A) Optical density of monocultures of B3791 and its derivatives was 
automatically monitored over 24hrs at 15min intervals and the growth rate for each 
strain determined. (B) The mean for every strain was compared against the mean of 
every other strains using one way ANOVA. Plasmid bearing strain S348/11- 
pIFM3791a was significantly slower than all the other strains tested (P < 0.0001).
A)
5 3 4 8 / 1 1  a n d  d e r i v a t i v e s  G  R a t e
Strain n Mean Std. Deviation
5 3 4 8 / 1 1 3 0 . 1 5 8 6 0 . 0 0 6 6 8
5 3 4 8 / l l - p l F M 3 7 9 1 a 3 0 . 0 9 5 5 5 0 . 0 1 1 0 7
5 3 4 8 / l l - p l F M 3 7 9 1 b 3 0 . 1 6 3 8 0 . 0 0 5 5 4 8
5 3 4 8 / l l - p l F M 3 8 0 4 a 3 0 . 1 5 9 7 0 . 0 0 4 6 8 6
5 3 4 8 / l l - p l F M 3 8 4 4 a 3 0 . 1 5 6 7 0 . 0 0 9 2 9 3
B) O n e  w a y  A N O V A  r e s u l t s ;  5 3 4 8 / 1 1  a n d  d e r i v a t i v e s  G R a t e
Tukey's multiple comparisons te st Mean Diff. Significant? Summary
5 3 4 8 / 1 1  v s .  5 3 4 8 / l l - p l F M 3 7 9 1 a 0 . 0 6 3 0 9 Y e s
5 3 4 8 / 1 1  v s .  5 3 4 8 / l l - p l F M 3 7 9 1 b - 0 . 0 0 5 1 2 4 N o n s
5 3 4 8 / 1 1  v s .  S 3 4 8 / l l - p l F M 3 8 0 4 a - 0 . 0 0 1 0 4 4 N o n s
5 3 4 8 / 1 1  v s .  5 3 4 8 / 1  l - p l F M 3 8 4 4 a 0 . 0 0 1 9 7 1 N o n s
5 3 4 8 / l l - p l F M 3 7 9 1 a v s . 5 3 4 8 / l l - p l F I V 1 3 7 9 1 b - 0 . 0 6 8 2 1 Y e s
5 3 4 8 / l l - p l F M 3 7 9 1 a v s .  5 3 4 8 / l l - p l F M 3 8 0 4 a - 0 . 0 6 4 1 3 Y e s
5 3 4 8 / l l - p l F M 3 7 9 1 a v s .  5 3 4 8 / l l - p l F M 3 8 4 4 a - 0 . 0 6 1 1 2 Y e s
5 3 4 8 / l l - p l F M 3 7 9 1 b v s . 5 3 4 8 / l l - p l F M 3 8 0 4 a 0 . 0 0 4 0 8 N o n s
5 3 4 8 / 1  l - p l F M 3 7 9 1 b  v s .  S 3 4 8 / l l - p I F M 3 8 4 4 a 0 . 0 0 7 0 9 5 N o n s
5 3 4 8 / 1  l - p l F M 3 8 0 4 a  v s .  5 3 4 8 / l l - p l F I V 1 3 8 4 4 a 0 . 0 0 3 0 1 5 N o n s
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Appendix 9
Growth kinetics studies (maximum growth) of Salmonella 4,5,12,i:- strain S348/11 
and its derivatives. (A) Optical density of monocultures of B3791 and its derivatives 
was automatically monitored over 24hrs at 15min intervals and the maximum 
achieved value determined. (B) The mean of every strain was compared against the 
mean of every other strain using one way ANOVA. Plasmid bearing strain S348/11- 
pIFM3791a achieved lower OD values than all the other strains tested ( P < 0.0001).
A) 5 3 4 8 / 1 1  a n d  d e r i v a t i v e s  M a x G
Strain n Mean Std. Deviation
5 3 4 8 / 1 1 3 0 . 7 8 4 4 0 . 0 1 6 0 4
5 3 4 8 / l l - p l F M 3 7 9 1 a 3 0 . 6 4 2 7 0 . 0 1 5 7 6
5 3 4 8 / l l - p l F M 3 7 9 1 b 3 0 . 8 0 9 9 0 . 0 3 3 5 4
5 3 4 8 / l l - p l F M 3 8 0 4 a 3 0 . 8 0 1 4 0 . 0 0 5 7 5 7
5 3 4 8 / l l - p l F M 3 8 4 4 a 3 0 . 8 1 4 6 0 . 0 1 5 3 3
B) O n e  w a y  A N O V A  r e s u l t s :  5 3 4 8 / 1 1  a n d  d e r i v a t i v e s  M a x G
Tukey's multiple comparisons te st Mean Diff. Significant? Summary
5 3 4 8 / 1 1  v s .  5 3 4 8 / l l - p l F M 3 7 9 1 a 0 . 1 4 1 7 Y e s
5 3 4 8 / 1 1  v s .  5 3 4 8 / l l - p l F M 3 7 9 1 b - 0 . 0 2 5 5 1 N o n s
5 3 4 8 / 1 1  v s .  5 3 4 8 / 1 1 - p  I F M 3 8 0 4 a - 0 . 0 1 7 0 7 N o n s
5 3 4 8 / 1 1  v s .  5 3 4 8 / 1 1 - p  I F M 3 8 4 4 a - 0 . 0 3 0 2 4 N o n s
5 3 4 8 / 1 1 - p  I F M 3 7 9 1 a  v s .  5 3 4 8 / l l - p l F M 3 7 9 1 b - 0 . 1 6 7 2 Y e s
5 3 4 8 / l l - p l F M 3 7 9 1 a  v s .  5 3 4 8 / l l - p l F M 3 8 0 4 a - 0 . 1 5 8 7 Y e s
5 3 4 8 / l l - p l F M 3 7 9 1 a  v s .  5 3 4 8 / l l - p l F M 3 8 4 4 a - 0 . 1 7 1 9 Y e s
5 3 4 8 / l l - p l F M 3 7 9 1 b  v s .  S 3 4 8 / l l - p l F M 3 8 0 4 a 0 . 0 0 8 4 3 8 N o n s
5 3 4 8 / l l - p l F M 3 7 9 1 b v s . S 3 4 8 / l l - p l F M 3 8 4 4 a - 0 . 0 0 4 7 2 5 N o n s
5 3 4 8 / l l - p l F M 3 8 0 4 a v s .  5 3 4 8 / l l - p l F M 3 8 4 4 a - 0 . 0 1 3 1 6 N o n s
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Appendix 10
Growth kinetics studies (area under the curve) of Salmonella 4,5,12,i:- strain S348/11 
and its derivatives. (A) Optical density of monocultures of B3791 and its derivatives 
was automatically monitored over 24hrs at 15min intervals and the area under the 
kinetic curve determined using the trapezoid method for each strain. (B) The mean of 
every strain was compared against the mean of every other strain using one way 
ANOVA. Plasmid bearing strain S348/ll-pIFM3791a had significantly smaller AUC 
values than all the other strains tested (P<0.0001). Plasmid bearing strain S348/11- 
pIFM3844a had AUC values which were significantly higher than those of its plasmid 
free progenitor S348/11 (P<0.05).
A) 5 3 4 8 / 1 1  a n d  d e r i v a t i v e s  A U C
strain n Mean Std. Deviation
5 3 4 8 / 1 1 3 1 3 . 3 5 0 . 3 7 6 9
5 3 4 8 / l l - p l F M 3 7 9 1 a 3 1 0 . 5 5 0 . 1 1 7
5 3 4 8 / l l - p l F M 3 7 9 1 b 3 1 3 . 8 6 0 . 2 9 1 2
5 3 4 8 / l l - p l F M 3 8 0 4 a 3 1 3 . 8 3 0 . 0 8 3 5 1
5 3 4 8 / l l - p l F M 3 8 4 4 a 3 1 4 . 1 4 0 . 3 3 0 4
B) O n e  w a y  A N O V A  r e s u l t s :  5 3 4 8 / 1 1  a n d  d e r i v a t i v e s  A U C
Tukey's multiple comparisons te st Mean Diff. Significant? Summary
5 3 4 8 / 1 1  v s .  5 3 4 8 / l l - p l F M 3 7 9 1 a 2 . 8 0 2 Y e s
5 3 4 8 / 1 1  v s .  5 3 4 8 / l l - p l F M 3 7 9 1 b - 0 . 5 0 8 8 N o n s
5 3 4 8 / 1 1  v s .  5 3 4 8 / l l - p l F M 3 8 0 4 a - 0 . 4 7 9 N o n s
5 3 4 8 / 1 1  v s .  5 3 4 8 / l l - p l F M 3 8 4 4 a 0 . 7 8 3 2 Y e s
5 3 4 8 / l l - p l F M 3 7 9 1 a  v s .  5 3 4 8 / l l - p l F M 3 7 9 1 b - 3 . 3 1 1 Y e s
5 3 4 8 / l l - p l F M 3 7 9 1 a  v s .  5 3 4 8 / l l - p l F M 3 8 0 4 a - 3 . 2 8 1 Y e s
5 3 4 8 / 1 1 - p  I F M 3 7 9 1 a  v s .  5 3 4 8 / l l - p l F M 3 8 4 4 a - 3 . 5 8 6 Y e s
5 3 4 8 / l l - p l F M 3 7 9 1 b  v s .  5 3 4 8 / l l - p l F M 3 8 0 4 a 0 . 0 2 9 8 3 N o n s
5 3 4 8 / l l - p l F M 3 7 9 1 b  v s .  5 3 4 8 / l l - p l F M 3 8 4 4 a - 0 . 2 7 4 4 N o n s
5 3 4 8 / 1 1 - p l F I V I 3 8 0 4 a  VS. 5 3 4 8 / 1 1 - p l F I V I 3 8 4 4 a - 0 . 3 0 4 2 N o n s
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Appendix 11
Effect of plasmid carriage on the association of S348/11 to monolayers o f HT29-16E. 
(A) Bacterial suspensions of strain S348/11 and its plasmid harbouring derivatives 
were added to monolayers of H29-16E and incubated for two hours followed by 
culture enumeration of associated bacteria (mean in CFU/ml). (B) The mean of every 
strain was compared against the mean of every other strain using one way ANOVA. 
Plasmid bearing strain S348/ll-pIFM3791a had significantly smaller association 
values than all the other strains tested (P<0.05).
A) A s s o c i a t i o n  o f  S 3 4 8 / 1 1  a n d  d e r i v a t i v e s  t o  H T 2 9 - 1 6 E
Strain n Mean Std. Deviation
S 3 4 8 / 1 1 3 6 . 9 1 E + 0 6 1 . 9 6 E m S
S 3 4 8 / l l - p l F M 3 7 9 1 a 3 1 . 6 1 E + 0 6 S .S 5 E - K ) S
S 3 4 8 / l l - p l F M 3 8 0 4 a 3 5 . 4 6 E + 0 6 2 .1 7 E - K ) 6
S 3 4 8 / l l - p l F M 3 8 4 4 a 3 S . 3 3 E + 0 6 2 . 0 2 E + 0 6
B) O n e  w a y  A N O V A  r e s u l t s :  A s s o c i a t i o n  o f  S 3 4 8 / 1 1  a n d  d e r i v a t i v e s  t o  H T 2 9 - 1 6 E
Tukey's multiple comparisons te st Mean Diff. Significant? Summary
5 3 4 8 / 1 1  v s .  5 3 4 8 / 1 1 - p  I F M 3 7 9 l a 5 . 3 0 E + 0 6 Y e s *
5 3 4 8 / 1 1  v s .  5 3 4 8 / l l - p l F M 3 8 0 4 a 1 . 4 4 E + 0 6 N o n s
5 3 4 8 / 1 1  v s .  5 3 4 8 / l l - p l F M 3 8 4 4 a 1 . S 7 E + 0 6 N o n s
5 3 4 8 / 1 1 - p  I F M 3 7 9 1 a  v s .  5 3 4 8 / l l - p l F M 3 8 0 4 a - 3 . 8 6 E + 0 6 N o n s
5 3 4 8 / l l - p l F M 3 7 9 1 a  v s .  5 3 4 8 / l l - p l F M 3 8 4 4 a - 3 . 7 3 E + 0 6 N o n s
5 3 4 8 / 1 1 - p  I F M 3 8 0 4 a  v s .  5 3 4 8 / l l - p [ F M 3 8 4 4 a 1 . 3 0 E + 0 5 N o n s
Appendix 12
Effect of plasmid carriage on the invasion of S348/11 to monolayers of HT29-16E. 
Bacterial suspensions of strain S348/11 and its plasmid harbouring derivatives were 
added to monolayers of H29-16E and incubated for two hours followed, then 
antibiotic used to kill non-invaded bacteria. Invaded bacteria were then quantified by 
culture enumeration (mean in CFU/ml). Although strain S348-pIFM3791a invasion
values were 10 lower than all other strains analysis by one way ANOVA did not 
reveal statistical significance (data not shown).
I n v a s i o n  o f  S 3 4 8 / 1 1  a n d  d e r i v a t i v e s  t o  H T 2 9 - 1 6 E
Strain n Mean Std Deviation
5 3 4 8 / 1 1 3 7 . 4 6 E + 0 3 1 . 3 6 E + 0 3
5 3 4 8 / l l - p l F M 3 7 9 1 a 3 9 . 6 3 E + 0 1 5 . 2 8 E + 0 1
5 3 4 8 / 1 1 - p  ! F M 3 8 0 4 a 3 9 . 7 9 E + 0 3 8 . 0 5 E 4 0 2
5 3 4 8 / 1 1 - p l F I V I 3 8 4 4 a 3 9 . 1 3 E + 0 3 7 . 6 0 E + 0 3
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Appendix 13
Effect of plasmid carriage on the association of S348/11 to monolayers of IPEC-J2.
(A) Bacterial suspensions of strain S348/11 and its plasmid harbouring derivatives 
were added to monolayers of H29-16E and incubated for two hours followed by 
culture enumeration of associated bacteria (mean in CFU/ml). (B) The mean of every 
strain was compared against the mean of every other strain using one way ANOVA. 
Plasmid bearing strain S348/11 -pIFM3791 a had significantly smaller association 
values than strain S348/11 (P < 0.01) and strains S348/1 l-pIFM3804a and s348/ll- 
pIFM3844a (P<0.05).
A) . . . . . .
Strain n Mean Std. Deviation
5 3 4 8 / 1 1 7 3 . 3 9 E + 0 6 1 . 6 8 E + 0 6
5 3 4 8 / l l - p l F M 3 7 9 1 a 4 2 . 3 1 E + 0 5 9 . 8 8 E + 0 4
5 3 4 8 / l l - p l F M 3 7 9 1 b 3 2 . 1 0 E + 0 6 1 .0 3 E - K ) 6
5 3 4 8 / 1 1 - p l F I V I 3 8 0 4 a 4 2 . 9 1 E + 0 6 8 . 7 2 E + 0 5
5 3 4 8 / 1 1 - p l F I V I 3 8 4 4 a 4 3 . 1 1 E 4 0 6 6 . 8 4 E + 0 5
O n e  w a y  A N O V A  r e s u l t s :  A s s o c i a t i o n  o f  5 3 4 8 / 1 1  a n d  d e r i v a t i v e s  t o  I P E C -J 2
Tukey's multiple comparisons te st_________ Mean Diff. Significant? Summary
5 3 4 8 / 1 1  v s .  5 3 4 8 / l l - p l F M 3 7 9 1 a  
5 3 4 8 / 1 1  v s .  5 3 4 8 / l l - p l F M 3 7 9 1 b  
5 3 4 8 / 1 1  v s .  5 3 4 8 / 1 1  p l F M 3 8 0 4 a  
5 3 4 8 / 1 1  v s .  5 3 4 8 / 1 1 - p  I F M 3 8 4 4 a  
5 3 4 8 / 1 1  p l F M 3 7 9 1 a  v s .  5 3 4 8 / l l - p l F M 3 7 9 1 b
5 3 4 8 / l l - p l F M 3 7 9 1 b  v s .  5 3 4 8 / l l - p l F M 3 8 0 4 a  
5 3 4 8 / 1 1 - p  I F M 3 7 9 1 b  v s .  5 3 4 8 / l l - p l F M 3 8 4 4 a  
5 3 4 8 / 1 1 - p l F I V I 3 8 0 4 a  v s .  5 3 4 8 / l l - p l F M 3 8 4 4 a
3 . 1 5 E + 0 6 Yes
1 . 2 8 E + 0 6 N o n s
4 .7 2 E - K ) 5 N o n s
2 . 8 0 E + 0 S N o n s
1 . 8 7 E 4 0 6 N o n s
2 . 6 8 E + 0 6 Y e s *
2 . 8 7 E + 0 6 Y e s *
8 .0 9 E -K D 5 N o n s
l .O O E + 0 6 N o n s
1 . 9 3 E + 0 5 N o n s
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Appendix 14
Effect of plasmid carriage on the invasion of S348/11 to monolayers o f IPEC-J2. (A) 
Bacterial suspensions of strain S348/11 and its plasmid harbouring derivatives were 
added to monolayers of IPEC-J2 and incubated for two hours, then antibiotic used to 
kill non-invaded bacteria. Invaded bacteria were then quantified by culture 
enumeration (mean in CFU/ml). (B) The mean of every strain was compared against 
the mean of every other strain using one way ANOVA. Plasmid bearing strain 
S348/1 l-pIFM3791a had significantly smaller association values than all strain 
S348/11 (P<0.05).
A)
Strain n Mean Std. Deviation
S 3 4 8 / 1 1 7 1 . 6 6 E - f 0 4 1 . 0 2 E + 0 4
S 3 4 8 / l l - p l F M 3 7 9 1 a 4 9 . 7 3 E + 0 1 7 . 5 1 E + 0 1
S 3 4 8 / l l - p l F M 3 7 9 1 b 3 1 . 7 1 E + 0 4 3 . 2 7 E 4 0 3
S 3 4 8 / l l - p l F M 3 8 0 4 a 4 1 . 4 4 E + 0 4 1 .1 1 E - K ) 4
S 3 4 8 / l l - p l F M 3 8 4 4 a 4 1 . 6 1 E + 0 4 7 . 9 5 E 4 0 3
B) O n e  w a y  A N O V A  r e s u l t s :  I n v a s i o n  o f  S 3 4 8 / 1 1  a n d  d e r i v a t i v e s  t o  IP E C -J Z  
Tukey's multiple comparisons te st_________ Mean Diff. Significant? Summary
5 3 4 8 / 1 1  v s .  5 3 4 8 / l l - p l F M 3 7 9 1 a 1 .6 5 E - K ) 4 Y e s *
5 3 4 8 / 1 1  v s .  5 3 4 8 / l l - p l F M 3 7 9 1 b - 5 . 5 8 E + 0 2 N o n s
5 3 4 8 / 1 1  v s .  5 3 4 8 / l l - p l F M 3 8 0 4 a 2 .1 4 E - K ) 3 N o n s
5 3 4 8 / 1 1  v s .  5 3 4 8 / l l - p l F M 3 8 4 4 a 5 . 0 8 E + 0 2 N o n s
S 3 4 8 / l l - p l F M 3 7 9 1 a v s . 5 3 4 8 / l l - p l F M 3 7 9 1 b - 1 . 7 0 E - K ) 4 N o n s
5 3 4 8 / l l - p l F M 3 7 9 1 a  v s .  5 3 4 8 / l l - p l F M 3 8 0 4 a - 1 . 4 3 E + 0 4 N o n s
5 3 4 8 / 1 1  p l F M 3 7 9 1 a  v s .  5 3 4 8 / 1 1  p l F M 3 8 4 4 a - 1 . 6 0 E + 0 4 N o n s
5 3 4 8 / l l - p l F M 3 7 9 1 b v s . 5 3 4 8 / l l - p l F M 3 8 0 4 a 2 .7 0 E - K ) 3 N o n s
5 3 4 8 / l l - p l F M 3 7 9 1 b v s . 5 3 4 8 / l l - p l F M 3 8 4 4 a 1 .0 7 E - K ) 3 N o n s
5 3 4 8 / 1 1 - p  1F M 3 8 0 4 a  v s .  5 3 4 8 / l l - p l F M 3 8 4 4 a - 1 . 6 4 E + 0 3 N o n s
Appendix 15
Effect of plasmid carriage on the association of B3791 to monolayers o f IPEC-J2. 
Bacterial suspensions of strain B3791 and its derivatives were added to monolayers of 
IPEC-J2 and incubated for two hours followed by culture enumeration of associated 
bacteria (mean in CFU/ml). Analysis with one way ANOVA did not reveal any 
statistically significant differences (data not shown).
A s s o c i a t i o n  B 3 7 9 1  a n d  d e r i v a t i v e s  t o  I P E C -J 2
Strain n Mean Std. Deviation
B 3 7 9 1 3 3 .4 1 E - K 3 4 2 . 5 1 E + 0 4
C L 3 2 3 3 . 0 2 E + 0 4 2 . 3 2 E + 0 4
C L 3 2 - P I F M 3 7 9 1 3 3 . 0 9 E + 0 4 2 . 3 2 E + 0 4
C L 3 2 - P I F M 3 8 0 4 3 3 . 5 8 E + 0 4 2 . 2 2 E + 0 4
C L 3 2 - p l F M 3 8 4 4 a 3 4 . 3 4 E + 0 4 3 . 0 0 E 4 C 4
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Appendix 16
Effect of plasmid carriage on biofilm forming abilities of Salmonella 4,5,12,i:- strain 
S348/11. Crystal violet assays of bio film formation were carried out on S348/11 and
its plasmid harbouring derivatives. Analysis with one way ANOVA did not reveal any
0 0
statistically significant differences in biofilm formation at either 25 C (A) or 37 C
(B).
A) B i o f i l m  2 5 ° C
Strain i1 Mean Std. Deviation
5 3 4 8 / 1 1
5 3 4 8 / l l - p l F M 3 7 9 1 a  ! 
5 3 4 8 / l l - p l F M 3 7 9 1 b  : 
5 3 4 8 / l l - p l F M 3 8 0 4 a  : 
5 3 4 8 / l l - p l F M 3 8 4 4 a  !
3 0 . 1 0 8 9  
3 0 . 0 6 6 2 2  
3 0 . 1 1 9 5  
3 0 . 1 2 5 4  
3 0 . 1 1 0 8
0 . 0 5 9
0 . 0 1 4 8 3
0 . 0 6 0 7 3
0 . 0 7 3 1 1
0 . 0 2 5 9 1
)  B i o f i l m  3 7 ° C
Strain r1 Mean Std. Deviation
5 3 4 8 / 1 1  2  
5 3 4 8 / l l - p l F M 3 7 9 1 a  3 
5 3 4 8 / l l - p l F M 3 7 9 1 b  3  
5 3 4 8 / l l - p l F M 3 8 0 4 a  3 
5 3 4 8 / l l - p l F M 3 8 4 4 a  3
; 0 . 0 5 6  
; 0 . 0 9 2 8 9  
1 0 . 0 6 9 5 6  
i 0 . 0 5 8  
; 0 . 0 6 6 8 9
0 . 0 1 0 1 5
0 . 0 2 1 2 8
0 . 0 2 2 4 4
0 . 0 1 2
0 . 0 2 1 8
Appendix 17
Effect of plasmid carriage on biofilm forming abilities of K. pneumoniae strain 
B3791. Crystal violet assays of biofilm formation were carried out on B3791 and its 
plasmid cured and plasmid complemented derivatives. Analysis with one way 
ANOVA did not reveal any statistically significant differences in biofilm formation at
either 25 C (A) or 37 C (B).
A) B i o f i l m  2 5 ° C
Strain n Mean Std. Deviation
B 3 7 9 1 3 0 . 5 1 1 1 0.1121
C L 3 2 3 0 . 4 8 8 6 0 . 1 5 2 3
C L 3 3 - P I F M 3 7 9 1 3 0 . 5 5 3 0 . 1 7 3 5
C L 3 2 - P I F M 3 8 0 4 3 0 . 5 1 4 4 0 . 1 5 8 4
C L 3 2 - P I F M 3 8 4 4 3 0 . 5 4 1 6 0 . 1 3 3 5
1 B i o f i l m  3 7 ° C
Strain n Mean Std. Deviation
B 3 7 9 1 3 0 . 4 1 7 8 0 . 0 5 9 2 1
C L 3 2 3 0 . 4 4 3 2 0 . 0 5 4 3 7
C L 3 3 - P I F M 3 7 9 1 3 0 . 4 9 7 0 . 0 1 7 0 4
C L 3 2 - P I F M 3 8 0 4 3 0 . 4 5 5 7 0 . 0 6 1 3 4
C L 3 2 - P I F M 3 8 4 4 3 0 . 4 6 7 0 . 0 3 3 6 2
B)
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